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Abstract 
Background:  While nutritional status is considered important in preventing 
coronary heart disease (CHD) and early mortality, there are numerous nutritional 
topics needing closer scrutiny. For example, it is unclear to what degree weight 
changes in older people are associated with mortality. Further, limiting intake of 
saturated fatty acids (SFA) often leads to increased intake of carbohydrates, and some 
types of carbohydrates have been shown to associate with increased risk of CHD. 
Further, studies suggest that cheese, a large contributor to SFA intake and vitamin K2 
in the Nordic countries, associate with decreased risk of CHD.    
Objectives: 1) To study the association between weight change and mortality in older 
individuals; 2) To evaluate the importance of the interplay between SFA and total 
carbohydrates, including food sources, when evaluating the association between SFA 
and CHD, and 3) to evaluate the association between dietary vitamin K with CHD in 
middle-aged adults.  
Material and methods: Cohort study with participants from the Hordaland Health 
Study. In Paper I, 2935 men and women, age 71-74 years with weight measured both 
in 1992-93 and 1997-99 were followed for mortality through 2012. Multivariable Cox 
regression estimated Hazard ratios (HRs) and 95% confidence intervals (CIs) 
comparing individuals who lost (≥5%) or gained (≥5%) weight to those with stable 
weight (±<5% weight change).  Cox regression with penalized spline was also used to 
evaluate the association between weight change (in kg) and mortality. Analyses 
adjusted for age, sex, physical activity, smoking, diabetes mellitus, hypertension, and 
previous myocardial infarction or stroke.  
Papers II and III included 2995 and 2987 men and women, respectively, age 
46-49 years at baseline in 1997-99. Participants were followed through 2009 to 
evaluate associations between intake of SFA, carbohydrates and vitamin K and 
incident CHD. Baseline diet was assessed by a past-year food frequency 
questionnaire. Energy- adjusted nutrient intakes were categorized into quartiles. 
Information on incident CHD events was obtained from the Cardiovascular Disease 
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in Norway (CVDNOR) Project. Multivariable Cox regression estimated HRs and 
95% CIs with test for linear trends across quartiles. Analyses were adjusted for age, 
sex, energy intake, physical activity, smoking and education. Cox regression with 
penalized spline was used to evaluate the associations between the dietary predictors 
and incident CHD.  
 
Results: 
Paper 1  
In the adjusted analyses, participants who lost ≥5% weight had an increased mortality 
risk (HR 1.59; 95% CI 1.35, 1.89) compared to those with stable weight. In contrast, 
those with a weight gain of ≥5% had a similar risk of CHD as those with a stable 
weight (HR 1.07; 95% CI 0.90, 1.28). Penalized spline analyses, however, identified 
that those who lost more than three kg or gained more than 12 kg had increased 
mortality risk. 
Paper II 
In the adjusted analyses, SFA associated with lower risk of CHD (HRQuartile(Q)4vsQ1 
0.ּ44; 95%CI 0.26, 0.76), p-trend 0.002). For carbohydrates, the opposite pattern was 
observed (HRQ4vsQ1 2.10; 95%CI 1.22, 3.63, p-trend 0.003). SFA from cheese 
associated with lower CHD risk (HRQ4vsQ1 0.44; 95%CI 0.24, 0.83, p-trend 0.006). A 
5 energy percent (E%) substitution of carbohydrates with total fat, associated with 
lower CHD risk (HR 0.75; 95% CI 0.62, 0.90). 
Paper III 
In the adjusted analyses, there was no association between intake of vitamin K1 and 
CHD (HRQ4vsQ1 0.92; 95%CI 0.54, 1.57, p-trend 0.64), while there was a lower risk of 
CHD associated with higher intake of vitamin K2 (HRQ4vsQ1 0.52; 95% CI 0.29, 0.94, 
p-trend 0.03). Further adjustment for potential dietary confounders slightly attenuated 
the association for K2 (HRQ4vsQ1 0.58; 95% CI 0.28, 1.19). 
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Conclusions and implications:  
Even a minor weight loss of ≥5% or >3 kg was associated with increased risk of 
mortality in older people, whereas a weight gain had to be more substantial to 
increase mortality risk. Thus, weight should be routinely monitored in older adults. 
A high intake of carbohydrates, reflecting low-fiber and relatively higher 
sucrose/fructose dietary sources, and a low intake of SFA were associated with higher 
CHD risk in the current study population. Substituting carbohydrates with total fat 
was associated with lower risk. Also, SFA from cheese was associated with lower 
risk of CHD. There is a need to clarify the relative health trade-offs between 
replacing carbohydrate intake with fat intake in study populations with diverse 
dietary habits and a wider range in carbohydrate and SFA intakes. In addition, results 
of our study suggest that dietary guidelines development and their communication to 
the public, especially regarding reductions in certain foods and nutrients need to 
consider the potential health impact of alternative sources of energy.   
A higher intake of vitamin K2 was associated with lower risk of CHD, while 
there was no association between intake of vitamin K1 and CHD. Current dietary 
guidelines are based on insufficient knowledge with regard to vitamin K metabolism 
and the different characteristics of K1 and K2. Therefore, our results indicate a need 
for more studies on the association between K2 and CHD. In addition, more 
knowledge about the absorption, transport and bioactivity of K2 is warranted.   
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1. Background  
Life expectancy has increased in developed countries the last century.1 In 2018, life 
expectancy in Norway was 81.0 and 84.5 years for men and women, respectively.2 
Due to longer life span and decreasing fertility rates,3 the older population is the 
fastest growing age group in western societies and greater knowledge is required to 
improve the health and well-being of older individuals.  
 Paper I evaluated weight change in an older population while Papers II and III 
evaluated dietary characteristics in a middle-aged population. The health 
consequences of weight change in the elderly are complex as weight change also 
reflects underlying disease processes which are not as prevalent in younger 
populations. Therefore, Paper I focus on the elderly. For the dietary evaluations of 
Papers II and III, the focus was on a middle-aged population 
because previous literature has found that associations between diet and coronary 
heart disease (CHD) weaken with older age.4   Also, improving dietary habits and 
health in midlife will influence health at older ages.5  The period of middle-age 
begins between the ages of 35 - 45 years and end at 65 years, while the period of old 
age starts at the age of 65.6  
1.1 Weight change in older people 
Advancing age associates with decreases in fat free mass and increases in fat mass7 
both visceral, abdominal and intramuscular due to a decline in growth hormone and 
testosterone production.8, 9 In both sexes, height decreases with age, and a reduction 
in height of 1 – 2 cm per decade after the age of 65 years is expected, due to changes 
of vertebral discs, as well as loss of muscle tone and bone mineral density.7, 10 Also 
weight is often seen to decrease with age,11 and reasons for weight loss in older 
people may be sarcopenia, cachexia and wasting. Sarcopenia consists of low muscle 
mass and poor physical performance 12 that may be due to chronic inflammation, 
atrophy of motor neurons or reduced protein intake. It may be age-related (primary) 
or functionally (secondary) when it is associated with sedentary lifestyle, 
malnutrition, organ failure and/or inflammatory disease.13 Cachexia is loss of muscle 
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mass with or without loss of fat mass, triggered by an underlying illness.12 It is 
defined as weight loss ≥5% during less than 12 months, and 3 or more of the 
following conditions: decreased muscle strength, fatigue, anorexia, low fat free mass, 
or abnormal laboratory tests such as increased inflammatory markers, anemia or low 
serum albumin.14 Wasting is a result of fasting or malnutrition due to physiological 
and non-physiological causes.15 Hence, weight loss in older people can result from 
natural aging processes, disease, or reduced food intake, and can either be intentional 
(dieting or/and increased physical activity), or unintentional (consuming less than the 
usual number of calories due to different reasons).16 Unintentional weight loss occurs 
in 15-20% of people 65 years or older, and is clinically relevant if ≥5% of body 
weight is lost in six to 12 months.17, 18 Causes can be organic or psychosocial, and the 
most common causes are malignancy, nonmalignant gastrointestinal disease, 
depression and dementia.19 Also oral ulcers18 and swallowing problems20may lead to 
unintentional weight loss. 
 Even though weight loss is seen to be common among older people due to 
several reasons, older people may also gain weight.21     
 Factors associated with weight change and mortality  
Factors that are associated with both weight change and mortality include, among 
others, sex, physical activity, smoking habits, diabetes mellitus, myocardial infarction 
(MI), stroke and hypertension. 
Body composition differs between sexes; men have more lean mass and women 
have more fat mass, and also changes in body composition with advancing age differ 
between men and women.7, 11 Also, women have a longer life expectancy than men.2 
Physical activity can contribute to weight change22 and has also been associated with 
decreased risk of mortality.23 People who quit smoking typically gain weight,24 while 
smoking cessation is likely to lead to reduced mortality.25  
There are complex inter-relationships between changes in weight and chronic 
disease and mortality risks. Unexplained weight loss may be a symptom of diabetes 
mellitus, and diabetes mellitus increases mortality risk.26 Further, reduced nutrient 
and energy intake before hospitalization has been found among patients hospitalized 
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for cardiovascular events such as MI and stroke,27 which, in turn, increase risk of 
mortality.26 In addition, overweight and obese persons with hypertension are 
counselled to change lifestyle which again may result in weight loss,28 at the same 
time hypertension is clearly associated with mortality.29  
 
Table 1. Overview of current literature published 2000-2020 on the association 








 N Main findings  
HR/RR (95% CI) 
Dey et al 2001 
Sweden30 
M & W  
75-85y 
WL & WG  
10y  
2628 M (WL 5–9.9%): 1.11 (0.77, 1.59) 
W (WL 5–9.9%): 1.33 (0.81, 2.16) 
M (WG ≥5%): 1.01 (0.72, 1.42) 
W (WG ≥5%): 1.43 (0.95, 2.17) 
Newman et al 
2001 USA31 
M & W 
≥65y  
WL & WG 
≥5% 4y 
4714 WL: 1.66 (1.18, 2.33) 
WG: 0.86 (0.54, 1.36) 
Wedick et al 
2002 USA32 
M & W 
≥65y  
WL ≥ 10 
pounds 12y 
597 M: 1.39 (P<0.05) 
W: 1.74 (P<0.01) 
Wannamethee 




WL & WG  
7y 
2762 Intentional WL:  
Personal reasons: 0.73 (0.41, 1.30) 
Healthy reasons: 1.38 (0.90, 2.10)  
Unintentional WL: 1.66 (1.35, 2.04)  
WG: 0.92 (0.75, 1.13) 
Knudtson et al 
2005 USA34 




1989 M: 1.19 (1.06, 1.33) 
W: 1.23 (1.13, 1.35)  
Amador et al 
2006 Mexican 
American35 
M & W 
≥65y 
WL & WG 
>5% 5y 
1749 WL: 1.41 (1.03, 1.93) 
WG: 0.94 (0.64, 1.39) 
Locher et al 
2007 USA36 




983 Intentional: 0.62 (0.27, 1.42) 
Unintentional: 1.67 (1.14, 2.45)   
Luchsinger et 
al 2008 USA37 
M & W 
≥65y 
WL & WG 
>1kg/yr 7y 
1113 WL: 1.5 (1.2, 1.9) 
WG: 1.1 (0.8, 1.5) 
Arnold et al 
2010 USA38 
M & W 
≥65y  
WL & WG 
≥5% 7y 
3278 WL: 1.58 (1.33, 1.88) 
WG:  1.10 (0.89, 1.36) 
Atlantis et al 
2010 
Australia39 
M & W 
≥65y 
WL & WG 
5kg 12y 
986 Unintentional:  
WL: 0.46 (0.32, 0.66) 
WG: 0.78 (0.46, 1.32) 




WL & WG 
>5% 9y 
4331 WL:1.84 (1.50, 2.26) 
WG: 1.04 (0.71, 1.51) 
De Hollander 
et al 2013 
Europe41 
M & W  
70-77y 
WL & WG  
6y 
1053 WL (≥3.2kg): 1.48 (0.99, 2.20) 
WL (3.2 - 1.0 kg): 1.25 (0.84, 1.88) 
WG (0.7–2.7 kg): 1.14 (0.76, 1.72) 
WG (≥2.8 kg): 0.94 (0.62, 1.41) 
Murphy et al 
2014 USA42 
M & W  
70-79y 
WL & WG 
≥5% 8y 
1975 M (WL): 1.24 (0.92, 1.67) 
W (WL): 1.30 (0.92, 1.83) 
M (WG): 1.31 (0.91, 1.89) 





M & W 
71-74y 
WL & WG 
≥5% 14y 
2935 WL: 1.59 (1.35, 1.89) 
WG: 1.07 (0.90, 1.28) 
Santanasto et 
al 2017 USA44 
M & W  
70-79y 
WL per 4.9kg 
12y 
1803 M: 1.12 (1.02, 1.24) 
W: 1.27 (1.16, 1.40) 
Mulligan et al 
2018 Europe45 
M & W 
≥65y 
WL & WG  
15y 
3329 WL (>5kg): 1.80 (1.48, 2.19) 
WL (>2.5–<5kg): 1.28 (1.10, 1.51) 
WG (>2.5–<5kg): 0.95 (0.83, 1.09) 
WG (>5–<10kg): 1.02 (0.84, 1.24) 
Park et al 2018 
USA46 
M & W  
65-75y  
WL & WG  
7.3y  
63040 WL (>5–10kg): 1.65 (1.50, 1.82) 
WL (>2.5–5kg): 1.30 (1.18, 1.44) 
WG (>2.5–5kg): 0.94 (0.82, 1.07) 
WG (>5–10kg): 0.98 (0.84, 1.14) 






1323 WL (≤8.99kg): 1.22 (1.02, 1.47) 
WL (>8.99kg): 1.74 (1.37, 2.20) 
Lee et al 2018 
Taiwanese48 
M &W  
≥65y 
WL & WG 
>5% 10y 
627 WL: 2.3 (1.3, 4.1) 
WG: 0.8 (0.4, 1.8) 
Nishida et al 
2019 Japan49 
M & W 
≥65y 
WL & WG  
3y 
1229 WL >4.8%: 2.85(1.12, 7.27) 
WG >3.1%: 2.71(0.95, 7.76) 
Son et al  
2020 Korea50 
M & W 
≥65y  
WL & WG 
>5% 12y 
1100256 WL: 1.68 (1.65, 1.72) 
WG: 1.10 (1.07, 1.13) 
This literature review is restricted to epidemiological cohort studies published after year 
2000, evaluating weight change in kilograms as exposure in community-living people at or 
above 65 years with a follow-up of at least 1 year. When more than one age cohort is 
evaluated and there are several weight change categories, only results from the oldest 
cohort and non-extreme weight change categories are reported. All results are from the fully 
adjusted models. The literature was identified through searches in PubMed, Web of Science 
and Embase. Search terms included “weight change”, “weight gain”, “weigh loss”, “older 
people”, “older adults”, “the elderly”, “mortality”, “death”, “cohort study” and “English 
language”. In addition, an evaluation of studies included in relevant review and meta-
analyses was made. The last search was performed on December 5th 2020. M indicates men; 
W, women; y, years; N, number included in the study population; HR, Hazard ratio; RR, 
Risk ratio; CI, Confidence interval; WL, weight loss; WG, weight gain; kg, kilograms.     
 Weight change and mortality in older people 
Table 1 provides an overview of cohort studies evaluating weight change and 
mortality in older people. There seems to be an association between weight gain and 
mortality in older people, despite mixed results from cohort studies.21, 30, 31, 33, 35, 37-42, 
45, 46, 48-50 Son et al found a weight gain of >5% to be associated with increased risk of 
mortality,50 and in several studies, weight gain seemed to be associated with 
increased risk of mortality, though not significantly.30, 37, 38, 40, 42, 45, 49 Further, Bamia 
et al found that weight gain especially amongst those overweight/obese were 
associated with increased mortality when evaluating people ≥60 years at enrollment.51 
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In contrast, some studies also found weight gain to be inversely associated with total 
mortality, although not significantly.31, 33, 35, 39, 41, 46, 48  
Weight loss in overweight and obese individuals improves health status by 
reducing hypertension, hypercholesterolemia, and insulin resistance,28, 52, 53 but 
evidence that weight reduction lowers mortality is limited.33, 36, 39 In older individuals, 
weight loss has been shown to associate with higher mortality across all body mass 
index (BMI) categories.32, 51 However, the importance of whether the weight loss is 
unintentional or intentional is unclear.31, 33, 36, 39 An association between weight loss 
and increased mortality has been found in a large number of studies.21, 30-38, 40-42, 44-50     
Meta-analyses and reviews conducted in recent years of studies including 
people 60 years and above, concluded that weight gain, weight loss, and weight 
fluctuations are associated with higher mortality risk among adults ≥60 years.21, 54 
Further, a study including middle-aged people, concluded that advising overweight or 
obese individuals who are otherwise healthy to lose weight as a means of prolonging 
life is not recommended.55   
1.2 Coronary heart disease 
CHD is one of the diseases included in the definition of cardiovascular disease 
(CVD), together with stroke, congenital heart defects and peripheral artery disease. It 
is a non-communicable chronic disease resulting from genetic, physiological, 
environmental and behavioral factors. The leading metabolic risk factors globally are 
raised blood pressure, overweight/obesity and raised blood glucose.26, 56  
 Vascular calcification can be classified depending on its location within the 
arterial intima or media. Medial calcification mostly affects the peripheral arteries, 
while intimal calcification is the dominant type of calcification seen in coronary 
arteries,57 and therefore also the type involved in coronary artery disease (CAD). 
CAD is the pathologic process affecting the coronary arteries (usually 
atherosclerosis) whilst CHD, also known as ischemic heart disease (IHD), includes 
diseases that occur mainly as a consequence of atherosclerosis. CHD is therefore 
mainly a result of CAD, however, a MI may also evolve without atherosclerosis.58 
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CHD includes stable and unstable angina, MI and sudden cardiac death, and also 
silent myocardial ischemia, that is myocardial ischemia in the absence of clinical 
symptoms.59, 60  
 Lipids, lipoproteins and coronary atherosclerosis 
Unmodifiable risk factors for atherosclerosis are age, sex, race and family history 
(genetics), whereas lipid concentrations, smoking habits, diabetes mellitus, obesity 
and hypertension may be modified.61  
Coronary atherosclerosis is an inflammatory process characterized by 
accumulation of lipids, macrophages and smooth muscle cells in intimal plaques in 
the large and medium-sized epicardial coronary arteries. The plaque lays on the 
arterial wall and may become unstable, undergo thrombosis, and result in an 
obstruction.62  
The various lipids and lipoproteins have different roles when it comes to 
accumulation in the arterial wall. High low-density lipoprotein (LDL) cholesterol 
increases risk of atherosclerosis. However, unmodified LDL particles are, to only a 
small extent, taken up in the artery wall; in contrast to modified LDL which are 
incorportated.62 Modified LDL has an important function in the development of 
endothelial dysfunction, an early marker of atherosclerosis.62, 63 Further, small dense 
LDL (sdLDL) are less easily cleared from the circulation due to reduced receptor-
mediated uptake, and they also have higher susceptibility to oxidation compared to 
unmodified LDL.64 High-density lipoprotein (HDL) cholesterol performs reverse 
cholesterol transport by stimulating the removal of cholesterol from cells and 
delivering it to the liver where some may be secreted in bile and excreted.65 
Triglycerides are carried primarily within large lipoproteins, chylomicrons, and very-
low density lipoproteins (VLDL), which are also rich in cholesterol and like LDL can 
stimulate atherosclerosis.66 However, in hypertriglyceridemia, higher CHD risk seems 
to be mainly due to reduced HDL cholesterol, and triglyceride-rich particles are 
weakly independently associated with CHD risk.67 
Atherogenic dyslipidemia associated with atherosclerosis, comprises increased 
blood concentrations of sdLDL cholesterol, decreased HDL cholesterol and increased 
triglycerides.68 Further, the combination of high serum cholesterol and low HDL 
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cholesterol is strongly associated with atherosclerosis, whereas a high HDL 
cholesterol and a low LDL:HDL cholesterol ratio reduce risk of atherosclerosis.69 
A high intake of carbohydrates increases hepatic triglycerides that drives the 
secretion of larger VLDL, enriched with triglycerides. These particles are lipolyzed to 
remnant lipoproteins that are then catabolized to sdLDL particles (Figure 1).70  
Saturated fatty acids (SFA) 
increase plasma concentrations of 
larger LDL particles, both by reducing 
their plasma clearance through 
suppression of LDL receptor activity, 
and by influencing the LDL production 
rate.64, 70 However, SFA with <12 
carbon atoms are thought not to 
increase cholesterol concentrations,71 
while the strength of the LDL-raising 
effects of the longer SFAs are as follows: 
lauric acid (C12:0) > myristic acid (C14:0) 
> palmitic acid (C16:0). Lauric acid may 
also increase HDL cholesterol. Stearic acid (C18:0) mostly has a neutral effect on 
lipid and lipoprotein profiles.72  
High plasma lipoprotein(a) concentrations can occur in patients with otherwise 
normal lipid levels and is a genetic risk factor for CHD.73 Lipoprotein(a) 
concentrations have been thought to be only minimally altered by diet, however, a 
defined plant-based diet has shown to substantially reduce the concentration of 
lipoprotein(a).74 When effect of SFA replacement on lipoprotein(a) was evaluated in 
a recent review, results were heterogeneous, although lipoprotein(a) often increased 
when SFA were replaced by other macronutrients.75  
Apolipoprotein A1 represents the major protein in HDL and is the main 
acceptor of cholesterol when HDL transports cholesterol from the tissue to the liver.76  
Non-HDL cholesterol is a measure of cholesterol content of VLDL, 
intermediate density lipoprotein (IDL), LDL, chylomicron remnants and 
Figure 1. Pathway of lipoprotein metabolism after 
intake of carbohydrates. Reprinted with permission 
from The Annual Review of Nutrition70  
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lipoprotein(a).77 Apolipoprotein B is the major structural protein in VLDL, IDL, LDL 
and lipoprotein(a). 78  
A cross-sectional Swedish population-based study that examined the 
associations between diet and apolipoprotein concentrations found that intake of 
sucrose and food products containing added sugar was negatively correlated with 
apolipoprotein A1 concentrations and positively correlated with apolipoprotein B 
concentrations.76 The intake of fermented dairy products was positively correlated 
with apolipoprotein A1 concentrations.76 Recent research suggests that non-HDL 
cholesterol and apolipoprotein B are superior to LDL cholesterol in predicting 
coronary atherosclerosis.78, 79  
 Prevention of coronary heart disease 
CHD mortality has declined in western countries over the last decades,80 but CHD is 
still a major contributor to deaths in people >35 years.81, 82 Norway has had a decrease 
in death rates due to CHD of the last ten years, and the decrease appears to be 
continuing.2 Also, the incidence of acute MI decreased from 2001 to 2014, including 
both fatal and nonfatal events.83 However, despite falling CHD rates, the Global 
Burden of Disease Study report that CHD was the leading cause of years of life lost 
in 2017; the global rates of CHD increased for the first time since the 1970s.26   
The IMPACT model can be used to estimate the proportion of the observed 
change in mortality that can be attributed to either treatment or risk factor changes 
and has been used to explore the contributions of changes in risk factors and 
treatment in >15 countries. The model estimated that among different countries about 
40-75% of the CHD mortality fall could be attributed to changes in risk factors and 
the remaining 25-60% to advances in treatment.84 When it comes to the disease 
burden of CHD, most of it can be attributed to lifestyle factors such as smoking, 
unhealthy diet, alcohol abuse and physical inactivity.82, 84 
 Factors associated with diet and coronary heart disease 
In Papers II and III, focus is on associations between diet and CHD. However, there 
are several factors that may influence both diet and risk of CHD. Among these are 
sex, physical activity, smoking habits, socioeconomic status, and family history of 
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CHD. Diet has shown to differ between men and women,85 and male sex is associated 
with higher risk of CHD.83  As people who perform physical activity need more 
energy (calories), physical activity influence the diet of people,86 at the same time a 
high level of physical activity is associated with decreased risk of CHD.82 
Researchers have found that smoking habits may influence diet,87 at the same time, 
smoking is also clearly associated with risk of CHD.82 Education as a measure of 
socioeconomic status is associated with dietary patterns,88 and higher education is 
associated with decreased CHD risk.89 Further, family history of diseases have been 
found to be associated with a healthy diet,90 but a family history of CHD is also 
associated with risk of CHD.91  
 Diet 
The Global Burden of Diseases, Injuries, and Risk Factors Study quantified the 
impact of poor dietary habits on non-communicable disease mortality in 2017 and 
found that approximately 11 million deaths were attributable to dietary risk factors.92 
Dietary habits may influence risk of CHD through adverse effects on serum lipids 
and lipoproteins, blood pressure, body weight and insulin sensitivity.93  
Carbohydrates  
In Norway, carbohydrates are recommended to make up 45 – 60 energy percent (E%) 
of the diet.94 Carbohydrates are composed of carbon, hydrogen and oxygen, with the 
main carbohydrates being monosaccharides, disaccharides, oligosaccharides, and 
polysaccharides.95 Monosaccharides as glucose, galactose, and fructose have three to 
seven carbons. Disaccharides as sucrose, lactose, and maltose are formed by 
combining monosaccharides.95 Oligosaccharides contains three to ten 
monosaccharide units, while polysaccharides constitute >10 monosaccharide units. 
Starch comprises amylose that is <1% branched and amylopectin that is highly 
branched. Dietary fiber are intact plant components not digestible by gastrointestinal 
enzymes.95  
Carbohydrates are digested into monosaccharides by α-amylase and brush-
border digestive enzymes.95 Once digested, glucose is absorbed across the intestinal 
cell and transferred to the liver. The liver removes approximately 50% of glucose for 
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oxidation and storage as glycogen. After leaving the liver, glucose enters the systemic 
circulation and is available for insulin-dependent uptake by peripheral tissue.95 Blood 
glucose concentration depends on the amount and digestibility of carbohydrate, 
absorption and degree of liver uptake, insulin secretion, and sensitivity of peripheral 
tissues to insulin action.95 
Carbohydrates’ primary role is to maintain blood glucose concentrations 
between 3.5-8.0mmol/L between feedings in healthy individuals.61 High intake of 
carbohydrates releases insulin for glucose uptake and subsequent synthesis of 
glycogen and fat, in order to get blood glucose to drop to a normal range. It takes 
approximately two hours after a meal before the intestinal absorption is complete.61  
Parameters of carbohydrate quality are glycemic index (GI), glycemic load 
(GL) and fiber content. GI is used to rank carbohydrates by their ability to raise blood 
glucose levels as compared with a reference food where portions of both the 
reference foods and test foods contain 25 or 50g available carbohydrate.96 The GL of 
a food is the GI of the carbohydrate divided by 100 and multiplied by its amount of 
available carbohydrate content in grams.96 The first GI table was published in 1995 
and contained >750 different types of foods 96. However, GI has limitations: 1) there 
are low correlations between GI values and fiber content of foods,96 2) values vary for 
similar foods,96 3) foods high in fat and protein do not have GI values, 4) 
carbohydrates increase plasma triglycerides, independent of the GI value,97 and 5) 
Nordic food items lack reliable GI values.98 A study in outpatients with type 1 
diabetes mellitus showed that bread and pasta contribute most to the overall dietary 
GI 99 and Norwegians consume large amounts of bread 100, 101 with medium to high 
GI.102 
Fatty acids 
In Norway, fat are recommended to make up 25 – 40 E% of the diet and SFA <10E% 
of the diet.94 Fatty acids are classified according to the number of carbons, the 
number of double bonds, and the position of the double bonds in the chain.95 Short-
chain-fatty-acids have 4 - 6 carbons, medium-chain fatty acids have 8 - 14, and long-
chain fatty acids have ≥16 carbons. In SFAs, all carbon binding sites not linked to 
another carbon are linked to hydrogen, while in monounsaturated fatty acid (MUFA) 
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one double bond forms between carbons, and in polyunsaturated fatty acid (PUFA) 
two or more double bonds form between carbons.95 Hydrogen can be added both in 
the cis position that is when two carbons bind a hydrogen on the same side of the 
bond, and in the trans position, that is when two carbons bind a hydrogen on opposite 
sides of the double bond. While the cis double bonds make the fatty acids to pack 
loosely, fatty acids with trans double bonds is packed tightly into the membrane.95  
Natural trans fatty acids (TFA) are formed by bio-hydrogenation in the rumen 
of ruminant animals (e.g., cattle, sheep, and goats), while industrial TFA are formed 
by hydrogenation of vegetable and marine oils.103 Already in the 1950s, Ancel Keys 
speculated that TFA were associated with heart disease.104 However it was first in the 
1990s that experimental evidence found that TFAs may increase risk of CHD 105 
through raised LDL cholesterol, apolipoprotein B and fasting triglyceride levels and 
decreased HDL cholesterol.106 Food industry have used industrial TFA in processed 
foods for decades, and especially partially hydrogenated fish oil was used in 
Norway.107 TFA from partially hydrogenated fish oil increased LDL cholesterol and 
reduced HDL cholesterol the most when compared with TFA from partially 
hydrogenated soybean oil and with butter.108 Currently, the use of partially 
hydrogenated fish oils has been reduced or discontinued in industrialized countries,106 
but emerging evidence suggests that ruminant TFA may have similar adverse effects 
on blood lipids as partially hydrogenated oils.109  
Fat allows digestion, absorption, and transport of essential nutrients, it 
promotes digestion by decreasing gastric secretion, slowing gastric emptying and 
stimulating biliary and pancreatic flow, and it gives textural properties to foods.95 
Shift from intake of fat to intake of carbohydrates 
In Finland, CVD mortality rates for middle-aged men were the highest in the world in 
the late 1960s.110 The Finnish diet has traditionally been high in SFA,  but underwent 
major changes between 1982 to 2007 due to recommendations based on the assumed 
association between fat and serum cholesterol.111 Consumption of high-fat milk 
products and butter fat decreased by 86% and 67% respectively. Furthermore, since 
the early 1980s the annual consumption of vegetables and fruit and berries increased 
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considerably.112 The decreased intake of SFA are reported to explain 41% and 47% of 
the decrease in total cholesterol between 1982 to 2007 in women and men in Finland, 
respectively.111  
Similarly as in Finland, the US population was recommended to reduce fat 
intake in order to lower the incidence of CVD. In the US, fats were replaced 
principally with carbohydrates,71 and also in Finland the intake of sucrose/fructose 
carbohydrate sources increased between 1970 and 2000.112  In Norway, a decreased 
consumption of dietary fats may explain a large part of the changes in mortality from 
CHD between 1960 and 1992, although this change was smaller than predicted in 
Finland and the US.113 The decrease in intake of total fat and SFA was followed by an 
increased intake of carbohydrate sources rich in sucrose and fructose also in 
Norway.113, 114 Further, in Norway there has been a strong shift in fat supply from 
milk and butter to cheese, especially over the last decades.114    
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Table 2. Overview of current literature published 2000-2020 on the associations 
between dietary saturated fatty acids / carbohydrates with coronary heart disease.  
Author, year, 
country 
Sex, age Exposure, 
Follow-
up time 
Event  N Main findings  
HR/RR (95% CIs) 




CH 10y CHD 75521 Q5vs.Q1: 1.23 (0.86, 1.75) 
Jakobsen et al 
2004 
Denmark4 






CHD 3686 Wper5E%forCH: 2.68 (1.40, 5.12) 
W per5E%: 2.48 (1.33, 4.65) 
Mper5E%forCH: 1.29 (0.87, 1.91) 
M per5E%: 1.29 (0.92, 1.80) 




SFA 20y CHD 78778 Q5vs.Q1: 0.97 (0.73, 1.27) 
Xu et al 2006 
USA117 
M & W 
45-74y 




M & W 
≈59y 
SFA 8.4y Acute 
coronary 
events 
28098 WQ4vs.Q1: 0.81 (0.53, 1.24) 
MQ4vs.Q1: 1.02 (0.76, 1.37) 
Jakobsen et al 
2009 USA/ 
Europe119 





CHD 344696 Per 5E%: 1.07 (1.01, 1.14) 
Sieri et al 
2010 Italy120 
M & W  
35-74y 
CH 7,9y CHD 47749 WQ4vs.Q1: 2.00 (1.16, 3.43) 
MQ4vs.Q1: 0.91 (0.64, 1.30) 
Jakobsen et al 
2010 
Denmark121 




MI 53644 Per 5E%: 1.04 (0.92, 1.17) 
Burger et al 
2011 The 
Netherlands122 
M & W  
21-64y 
CH 11.9y CHD 19608 WperSD: 1.04 (0.82, 1.33) 











WQ5vs.Q1: 1.17 (0.81, 1.68) 
MQ5vs.Q1: 1.21 (0.92, 1.59) 
SFA: 
WQ5vs.Q1: 0.67 (0.46, 0.97)  
MQ5vs.Q1: 0.86 (0.66, 1.13) 
Dilis et al 
2012 
Greece124 
M & W  
20 – 86y 








MI 81931 Q5vs.Q1:1.39 (0.93, 2.08) 








CHD 21955 Per 2E%: 0.97 (0.94, 0.99) 
Yu et al 2013 
China127 





CHD 117366 Q4vs.Q1: 2.88 (1.44, 5.78) 







CHD 1981 FatalQ4vs.Q1: 0.88 (0.48, 1.62) 
Non-fatalQ4vs.Q1: 1.05 (0.70, 
1.57) 
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Li et al 2015 
USA129 





CHD 127536 SFAQ5vs.Q1: 0.93 (0.82, 1.05) 
CHQ5vs.Q1: 1.04 (0.94, 1.14) 
Praagman et 
al 2016 The 
Netherlands130 






CHD 4722 SFAper5E%: 1.13 (0.94, 1.36) 
Per 5E%: 0.90 (0.80, 1.02) 
Praagman et 
al 2016 The 
Netherlands131 





IHD 35597 SFAper5E%: 0.83 (0.74, 0.93) 
Per 5E%: 1.23 (1.09, 1.40) 
Dehghan et al 
2017 Five 
Continents132 




MI 135335 SFAQ5vs.Q1: 1.17 (0.94, 1.45) 
CHQ5vs.Q1: 0.90 (0.73, 1.10) 
Sluijs et al 
2017 The 
Netherlands133 
M & W  
20-70y 
SFA 15y CHD 36520 Q4vs.Q1: 0.96 (0.82, 1.12) 
AlEssa et al 
2018 USA134 
M & W  
30-75y 




M & W 
46 – 49y  
SFA & 
CH  
CHD 2995 SFAQ4vs.Q1: 0.44 (0.26, 0.76) 
CHQ4vs.Q1: 2.10 (1.22, 3.63) 
Sieri et al 
2020 
Europe136 
M & W  
35-70y 
CH 12,8y CHD 338325 Q5vs.Q1: 1.15 (1.00, 1.32) 
The literature review is restricted to epidemiological cohort studies published after year 
2000, evaluating the association between total saturated fatty acids and/or carbohydrates 
with CHD. Studies with an exclusively older population and studies only evaluating fatal 
CHD events or CVD were excluded.  In studies reporting estimates both for the middle-aged 
and the older population, only estimates for the middle-aged population are reported. When 
studies have evaluated different carbohydrate quality as exposure, only results for total 
carbohydrates are included. All results are from the fully adjusted models. The literature 
was identified through search in PubMed, Web of Science and Embase. Search terms 
included “SFA”, “saturated fatty acids”, “fat”, “carbohydrates”, “dietary”, “intake”, 
“CHD” “coronary heart disease”, “middle-aged”, “cohort study” and “English 
language”. In addition, an evaluation of studies included in relevant review and meta-
analyses was made. The last search was performed 5th of December 2020. MI indicates 
myocardial infarction; CHD, coronary heart disease; IHD, ischemic heart disease; M, men; 
W, women; y, years; N, number included in the study population; HR, Hazard ratio; RR, 
Risk ratio; CI, Confidence interval; SFA, saturated fatty acid; CH, carbohydrates; Q4, 




Intake of saturated fatty acids and coronary heart disease 
Dietary SFA were first linked to increased CHD risk in the Seven Countries Study.137, 
138 Keys et al. related the mean intake of dietary factors from 16 populations in seven 
countries to CHD mortality, and found that death rates were positively related to the 
average percentage of dietary energy from SFA.137     
Possible positive effects of SFA substitution scenarios on CHD risk factors 
other than lipids and lipoproteins are unclear.70, 139  
A Cochrane review including 15 randomized controlled trials (RCTs) that 
assessed the effect of reducing SFA on mortality and cardiovascular morbidity 
reported no clear reduction in total MI or total CHD events (Relative Risk (RR) 0.83; 
95% Confidence interval (CI) 0.68, 1.01) when reducing dietary SFA.140 Further, a 
recent review evaluating the efficacy of dietary interventions for CVD prevention 
concluded that the certainty of evidence for an effect of reduced SFA intake was low 
for MI and very low for CHD.141 On the other hand, a recently published prospective 
cohort study assessing dietary fat intake in relation to total and cause-specific 
mortality found a positive association between intake of SFA and CVD mortality 
(Hazard Ratio (HR) 1.07; 95% CI 1.05, 1.09) when 1 Standard deviation (SD) 
increment in SFA was substituted for carbohydrates.142   
Results from cohort studies evaluating the association between SFA and CHD 
are diverse, as shown in Table 2. In a study by Jakobsen et al, of 3686 Danish men 
and women, a strong positive association between SFA and CHD was found only 
among younger women (HR 2.48; 95% CI 1.33, 4.65).4 On the other hand, in a cohort 
study by Praagman et al a reduced risk of IHD with increased intake of SFA was 
found (HR 0.83; 95% CI 0.74, 0.93).131 Similar results have been reported among 
women in a cohort study by Wallström et al (HR 0.67; 95% CI 0.46, 0.97).123   
Meta-analyses of prospective cohort studies have not shown a clear association 
between intake of SFA and CHD.143-145 Siri-Tarino et al found no association between 
SFA intake and risk of CHD (RR 1.07; 95% CI 0.96, 1.19).143 Further, meta-analyses 
by Chowdhury et al,  that included four additional studies 144 as well as by de Souza 
et al, with 12 studies,145 observed no association between SFA intake and risk of 
CHD. However, a recent published meta-analysis of 29 prospective cohort studies 
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evaluating the association between dietary fat and all-cause and cause-specific 
mortality found a positive association between SFA intake and CHD mortality (HR 
1.10; 95% CI 1.01, 1.21).146 Also, Wang et al, found that the proportional attributable 
CHD deaths (percent of total CHD deaths) due to higher SFA intake (>10E%) in 
Western Europe was  4.5 (uncertainly interval 4.3, 4.8).147 
A recent paper summarizing the debate around SFA and CVD, briefly 
described topics of agreement, disagreement and research needed, stated that  
“Advice to maximally reduce SFAs can have unintended consequences if 
implementation is done inappropriately with respect to the nutrients and foods that 
are substituted.”139  
Intake of carbohydrates and coronary heart disease 
Seidelmann et al recently published a large prospective cohort study and meta-
analysis which found that both high and low percentages of carbohydrates in diets to 
be associated with increased mortality, with lowest risk observed at 50-55 E% 
carbohydrate intake.148 However, sources of carbohydrates are diverse, and high-
carbohydrate foods are heterogenous in their associations with CHD. Higher intake of 
carbohydrates at the expense of SFA have been positively associated with the 
prevalence of atherogenic dyslipidemia.149 Sugar, also from fruit, contributes to 
atherogenic dyslipidemia.70, 150 However, Bhupathiraju et al found that those in the 
highest quintile of fruit intake had lower risk of CHD (RR 0.88; 95% CI 0.80, 
0.96).151 In contrast, there are several examples of studies that have found a positive 
association between sugar containing products and CHD events.152  
RCTs have shown that increased consumption of whole grains high in fiber 
associate with a decrease in blood pressure, 153 improved lipid profiles,154 and an 
increase in insulin sensitivity.155 Further, Barret et al recently published a review of 
observational studies reporting whole grain and cereal fibre or bran intake in 
association with any CVD-related outcome, concluding that intake of whole grain, 
cereal fibre and bran were similarly associated with lower risk of CVD-related 
outcomes.156 On the other hand, a Cochrane review including 21 randomized studies 
evaluating low GI diets for the prevention of CVD, concluded that there was 
insufficient evidence from RCTs to recommend consumption of low GI diets for the 
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purpose of improving blood lipids or blood pressure.157 Ho et al investigated the 
nonlinear associations between macronutrient intake and incident CVD, and found a 
positive association between intake of sugar and CVD, while dietary fiber intake was 
weakly inversely related to incident CVD.158  
Several cohort studies have evaluated the association between intake of 
carbohydrates and CHD (Table 2). In a pooled analysis of 11 cohort studies, 
Jakobsen et al reported that replacement of 5E% from SFA with carbohydrates was 
associated with a higher risk of coronary events (HR 1.07; 95% CI 1.01, 1.14).119 In a 
later study by Jakobsen et al, including 53644 men and women, and considering the 
carbohydrate quality, they found that only when substituting SFAs with high GI 
carbohydrates it was associated with increased risk of MI (HR 1.33; 95% CI 1.08, 
1.64), while the association was opposite when substituting SFAs with whole grains 
(HR 0.88; 95% CI 0.72, 1.07).121 The same associations were also found in a study by 
Li et al. They found that replacing 5E% from SFA with carbohydrates from whole 
grains was associated with a 9% lower risk of CHD, while when replacing it with 
carbohydrates from refined starches/added sugars there seemed to be a weak 
increased risk of CHD.129 This association was not replicated in a later study. 
However, this study combined SFA and TFA in one category, which may have 
influenced the results.126 A Food and Agriculture Organization (FAO) report found 
that replacement of fat with refined carbohydrates may increase risk of the metabolic 
syndrome, but not CHD,159 and the Cochrane study by Hooper et al, including RCTs, 
found that replacement of SFA with carbohydrates was not associated with a 
decreased risk of neither total MI (RR 0.96; 95% CI 0.86, 1.06) nor total CHD events 
(RR 0.93; 95% CI 0.78, 1.11). 140  
One of the conclusions of the American Heart Association’s Presidential 
Advisory on dietary fats and CVD published in 2017 was that a dietary strategy of 
reducing intake of total fat, including SFA, and replacing it mainly with unspecified 
carbohydrates does not prevent CVD.160 Also, a systematic review of the effect of 
dietary SFA on heart disease concluded that reducing SFA and replacing it with 
carbohydrates will not lower CHD events, while replacing it with PUFA, MUFA or 
high-quality carbohydrates will lower CHD events.161    
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Shift from focus on single nutrients to foods and dietary patterns 
In recent years, dietary guidelines as well as research, to a certain degree, have 
changed their focus from single nutrients to foods and dietary patterns in order to 
make recommendations more relevant to consumers. Also, there has been greater 
awareness of nutrient and food matrix interactions which further supports the need for 
shifting focus from individual nutrients to dietary patterns.162 
Bechthold et al conducted a systematic review and dose-response meta-
analysis of prospective studies evaluating the associations between food groups and 
risk of CHD.163 Regarding high-carbohydrate foods, they found an inverse 
association between consumption of whole grains, vegetables and fruits with CHD 
risk, while there was a positive association between consumption of sugar-sweetened 
beverages and CHD risk.163 They found a positive association between red meat and 
processed meat, high in SFAs, with CHD risk.163  
Kwok et al summarised the highest level of evidence and ranked the risk 
associated with each individual component of diet within its food group and found 
that among carbohydrates and SFA sources, grains and vegetables appeared to be 
beneficial for CVD, while processed meat and canned fruit appeared to be harmful.164 




Forms of vitamin K 
Vitamin K appears as phylloquinone, also 
known as vitamin K1 (K1), menaquinone 
(MK), also known as vitamin K2 (K2), and 
menadione, also known as vitamin K3 (K3). 
All vitamin K forms have a 2-methyl-1,4-
napthoquinone ring but differ in whether 
they have a side chain and also in the 
structures of the side chain.166 K1 has a side 
chain of isoprenoid residues were three are 
saturated, while K2 has a 3-substituted lipophilic side chain and side chains with 
mostly unsaturated isoprene residues (Figure 2). The number of isoprenoid units, and 
the degree of saturation, gives rise to the MKs nomenclature. K3 constitutes of the 2-
methyl-1,4-napthoquinone ring only.166  
 
Mechanisms 
The vitamin K cycle is essential for the 
posttranslational carboxylation of glutamic acid 
residues (Glu) in proteins to form 
carboxyglutamate residues (Gla) by the enzyme 
ɣ-glutamyl carboxylase.167 The active cofactor 
form of vitamin K required by the enzyme is the 
reduced form vitamin K quinol (KH2). During 
carboxylation, the carboxylated Gla proteins are 
secreted into the circulation and KH2 becomes 
oxidized to vitamin K epoxide. This epoxide 
metabolite is reduced to vitamin K quinone by the 
enzyme VKOR. Vitamin K quinone is then further 
reduced to KH2 by a vitamin K reductase activity to complete the cycle (Figure 3).168  
Figure 3. Metabolism of vitamin 
K via the vitamin K-epoxide 
cycle. Reprinted with permission 
from Journal of lipid research. 168  
Figure 2. Chemical structure of 
vitamin K1 (A) and vitamin K2 (B). 
Reprinted with permission from The 
Lancet.166 
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Vitamin K dependent Gla proteins include, but are not limited to, seven 
involved in blood coagulation, osteocalcin in bone, matrix Gla protein (MGP) mainly 
in cartilage and vessel walls and growth arrest-specific protein 6 (Gas-6) in cell 
proliferation.169 Further, clinical studies have reported several properties of vitamin 
K, including having antioxidant activity.170 While K1 preferentially assists 
carboxylation of clotting factors in the liver, long chain K2 are available for extra-
hepatic tissues.171 Together, MGP and Gas-6 perform local vascular regulation, and a 
failure of these mechanisms might lead to vascular calcification.167 Due to the 
mechanisms of the vitamin K dependent proteins, vitamin K is assumed to inhibit the 
development of atherosclerosis.  
Warfarin is used to treat atrial fibrillation, venous thromboembolism, and 
valvular stenosis,172 however, it disrupts the vitamin K cycle and may increase risk 
for vascular calcification.168 
Sources of vitamin K 
K1 is found in green, leafy vegetables, including kale, broccoli and spinach, and also 
in oils, such as rapeseed, sunflower and olive oils.173 K2 is mainly found in animal 
products such as meat and dairy products.173 However, K1 is also converted into MK-
4, probably in the intestine, and it accumulates in extrahepatic tissues.174 It was 
previously assumed that much of the daily requirement for vitamin K was supplied 
from production of K2 in the colon, while today we know that the absorption from 
colon is probably low.175 K1 constitutes most of the vitamin K intake, while 10-25% 
seems to be provided by K2, primarily from dairy sources. 173  Still, the contribution 
of K2 to vitamin K status is at least equal to that of K1, due to differences in 
bioavailability.173, 176 K3 is a synthetic form of vitamin K, but natural occurrence in 
staphylococcus aureus has been reported, and it seems to also be a biosynthetic 
precursors of other forms of vitamin K.177 
Vitamin K and fat contents in dairy products are proportional, and MK9-11 
accounts for approximately 90% of vitamin K in dairy foods.178 Vitamin K content of 
cheeses ranged from 40µg/100g to ≤850µg/100g in a study by Fu et al.178 Lactic acid 
bacteria used as starters in dairy and fermented food include a variety of bacterial 
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strains. The specific strains used and production conditions during fermentation, such 
as pH, temperature and duration affect the concentrations and forms of K2 in food 
products.175, 179 Presence of K2 in nonfermented products may come from the 
microbial content of the ruminant digestive system, but contents in meat and fish are 
low.173, 179  
Recommended intake  
Guidelines on vitamin K intake differs globally, are mainly given for intake of K1 
and is based on information about daily intake of K1 in healthy individuals and the 
requirement in order to achieve proper blood coagulation.180-182 The European Food 
Safety Authorities (EFSA) has set Adequate Intakes (AI) to be 1µg K1 /kg body 
weight per day giving the recommended intakes of 90 and 120µg/day for women and 
men, respectively,181 while the World Health Organization (WHO) and the FAO 
recommend a dosage of 65µg/d for men and 55µg/d for women.180 The Nordic 
Nutrition Recommendations 2012 gives only a provisional recommendation of 1µg of 
vitamin K/kg body weight per day for both children and adults.182  
Vitamin K deficiency is characterized by a bleeding tendency due to impaired 
blood coagulation.181 Clinically indicated use of vitamin K is a prophylactic against 
vitamin K deficiency bleeding in neonates,183 as an antagonist in patients on vitamin 
K antagonist treatment prior to surgery or when international normalization ratio 
(INR) values are high and give prolonged bleeding.184, 185 However, the triage theory 
that when the availability of a micronutrient is inadequate, there may be 
compensatory mechanisms protecting short-term survival,169, 186 may apply for 
vitamin K. The recommended intake may not be sufficient for optimal function of all 





Table 3. Overview of current literature published 2000-2020 on the association 









Event N Main findings 
HR/RR (95% CI) 
Geleijnse et al  
2004 The 
Netherlands187  
M & W 
≥55y 
K1 & K2 
7.2y 
CHD 4807 K1T3vs.T1: 0.89 (0.63, 1.25) 
K2 T3vs.T1: 0.59 (0.40, 0.86) 
Erkkila et al 
2005 USA188  
W 
38-65y 
K1 16y CHD   72 874 Q5vs.Q1: 0.84 (0.71, 1.00) 
Erkkila et al  
2007 USA189  
M  
40-75y 
K1 14y CHD 40 087  Q5vs.Q1: 0.91 (0.77, 1.06) 





K1 & K2 
8.1y 
CHD 16 057 K1per10µg: 1.00 (1.00, 1.02) 





2014 Spain191  
M & W 
55-80y  




7216 K1Q4vs.Q1:  0.63 (0.31, 1.28) 
K2Q4vs.Q1: 1.18 (0.60, 2.34) 
K1increase during follow-up:  
0.52 (0.31, 0.86) 
K2increase during follow-up:  
0.76 (0.44, 1.29) 
Zwakenberg  
et al 2017 The 
Netherlands192  
M & W 
20-70y 




33 289 K1Q4vs.Q1: 0.85 (0.59, 1.24) 




M & W 
46-49y 
K1 & K2 
11y 
CHD 2987 K1Q4vs.Q1: 0.69 (0.38, 1.27) 
K2Q4vs.Q1: 0.58 (0.28, 1.19) 
Due to few publications in the field, the literature review includes cohort studies published 
after year 2000 evaluating the association between vitamin K with total CHD, CHD 
mortality and CVD mortality. All results are from the fully adjusted models. The literature 
was identified through search in PubMed, Web of Science and Embase. Search terms 
included “vitamin K”, “vitamin K1”, “phylloquinone”, “vitamin K2”, “menaquinone” 
“coronary heart disease”, “CHD”, “cardiovascular disease”, “CVD”, “middle-aged”, 
“cohort study” and “English language”. In addition, an evaluation of studies included in 
relevant review and meta-analyses was made. The last search was performed 5th of 
December 2020. CHD indicates coronary heart disease; CVD, cardiovascular disease; M, 
men; W, women; y, years; N, number included in the study population; HR, Hazard ratio; 
RR, Relative risk, CI, confidence interval; K1, vitamin K1; K2, vitamin K2; T3, tertile; Q4, 
quartile; Q5, quintile.    
 
Vitamin K and coronary heart disease 
Few cohort studies have investigated the association between dietary vitamin K and 
incident CHD, therefore studies with CVD as the event will also be evaluated here 
(Table 3). Geleijnse et al examined whether dietary K1 and K2 were related to aortic 
calcification and CHD in the Rotterdam Study.187 They found that dietary K2 was 
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associated with reduced risk of incident CHD (RR 0.59; 95% CI 0.40, 0.86) in a 
model adjusted for age, sex, total energy intake, BMI, smoking, diabetes mellitus, 
education and dietary factors, while K1 was not associated with incident CHD.187  
Gast et al examined the relationship between dietary K1 and K2, and its subtypes, and 
incident CHD and found an inverse association between K2 and risk of CHD with a 
HR of 0.91 (95% CI 0.85, 1.00) per 10µg/d vitamin K2 intake.190 Erkkila et al 
examined the feasibility of using K1 as a marker of CHD risk in women and found 
that after adjustment for age, lifestyle factors and dietary factors and comparing the 
highest with the lowest intake quintile, there was a reduced risk of CHD (RR 0.84; 
95% CI 0.71, 1.00). However, they concluded that dietary and lifestyle patterns 
associated with K1 intake might account for all or part of the association.188 Later, 
when Erkkila et al examined the association between dietary K1 and risk of CHD in 
men, they found that in the model adjusted for age, BMI, smoking, history of elevated 
blood pressure and serum cholesterol, diabetes mellitus, parental history of MI, 
physical activity, aspirin use, alcohol intake, use of multivitamin supplements, energy 
intake and dietary factors, RR of total CHD events when comparing the fifth with the 
first quintile was 0.91 (95% CI 0.77, 1.06).189 Zwakenberg et al.found that only high 
intakes of long chain K2 were borderline associated with lower CHD mortality with a 
HR per 10µg/d of 0.86 (95% CI 0.74, 1.00).192 Juanola-Falgarona et al studied the 
association between dietary K1 and K2 with mortality in a cohort with high CVD 
risk, and found that only increased intake of K1 during follow-up was associated with 
a reduced risk of CVD mortality (HR 0.52; 95% CI 0.31, 0.86).191 
A review from 2012 concluded that based on observational studies of dietary 
vitamin K, intake of K2 may be more likely to protect against vascular calcification 
than K1.194 However, there is evidence that K1 supplementation is of importance to 
vascular calcification.195 In 2018, Zhang et al performed a meta-analyses on the 
association between intake of K1 and K2 with CVD mortality, concluding that 
neither were associated with CVD mortality.196 In 2019 Chen et al performed a meta-
analyses on the association between vitamin K and CVD events and all-cause 
mortality. They found an inverse association of both vitamin K1 and K2 with total 
CHD.197  However, both meta-analyses included few studies (≤ 4 studies).196, 197  
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2. Study rationale and aims 
In Paper I the aim was to investigate the effect of weight change on risk of mortality 
in community-dwelling older people, whose weight and height were measured in 
their mid-sixties and again in their early seventies, with subsequent 14 years follow-
up with regard to mortality.  
In Paper II the aim was to evaluate associations and possible interplay of 
carbohydrate and SFA intakes with incident CHD events in a sample of middle-age 
community-dwelling adults. 
In Paper III the aim was to evaluate associations between intake of vitamins K1 and 
K2 and incident CHD events among middle-age community-dwelling adults. 
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3. Material and methods 
 
3.1 Data sources  
 The Hordaland Health Studies (HHS) 
The Hordaland Health Studies (HHS) (https://husk-en.w.uib.no/) were conducted in 
1992-93 (The Hordaland Homocysteine Study) and in 1997-99 (The Hordaland 
Health Study, HUSK). Both surveys were conducted as a joint project between the 
University of Bergen, the Norwegian Health Screening Service (SHUS) (now part of 
the Norwegian Institute of Public Health) and the Municipal Health Service in 
Hordaland.198 The Hordaland Health Study is included in Cohort of Norway 
(CONOR).199 CONOR is a multipurpose study, with the aim to study aetiological 
factors for a range of diseases, and also to describe Norwegian men and women in 
terms of distribution of exposures and health status according to time, place and 
socio-economic factors.199  
About 7,000 of those who participated in the 1992-93 survey also participated 
in 1997-99.198 Participants included in this project, from The Hordaland Health 
Study, included 2.291 men and 2.558 women born 1950-51 and 1.868 men and 2.470 
women born 1925-27 who had also participated in the study in 1992-93. Participation 
rates in these groups in 1997-99 were 73 %, 81 %, 79 %, and 76 %, respectively.200 
Baseline measurements in 1997-99 included height, weight, waist and hip 
circumferences, blood pressure, heart rate, non-fasting analyses of serum total 
cholesterol, HDL cholesterol, triglycerides, and glucose. Self-administered 
questionnaires provided information on various health behaviors including physical 
activity and smoking habits. Serum lipids were analyzed at the Department of 
Clinical Chemistry, Ullevål Hospital, Oslo using a Hitachi 911 analyzer. This 
analyzer came with adapted reagents and measurement methods from the company 
Boehringer Mannheim FRG (now: Roche, Basel, Switzerland).201 Cholesterol and 
triglycerides were measured by enzymatic methods.  HDL cholesterol was measured 
by a direct, enzymatic inhibition method.200  
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 The National Population Register 
The National Population Register (https://www.skatteetaten.no/en/person/national-
registry) contains information of everyone who resides or have resided in Norway, 
and includes information on, among others, vital status (alive, emigrated, or dead).202 
The unique 11-digit personal identification number assigned to all Norwegian 
residents facilitates linkage between HUSK and The National Population Register.   
 The Cardiovascular Disease in Norway 1994-2009 Database 
As described on https://cvdnor.w.uib.no/: The Cardiovascular Disease in Norway 
(CVDNOR) project was established as a collaborative research project between the 
University of Bergen and the Norwegian Knowledge Centre for the Health Services 
(now part of the Norwegian Institute of public Health).203, 204 Information on hospital 
stays with a CVD-related diagnosis (International Classification of Diseases (ICD)9: 
390-459, ICD10: I00-99, G45), diabetes mellitus (ICD9: 250, ICD10: E10-14) or 
congenital malformations of the circulatory system (ICD9: 745-747, ICD10: Q20-28) 
(either primary or secondary diagnoses) were retrieved from the electronic Patient 
Administrative Systems (PAS) of all Norwegian somatic hospitals during 1994-2009, 
using a semi-automatic program named FS (Forskning i Sykehus [English: Research 
in hospitals]) established by Tomislav Dimoski. In addition, all related diagnostic and 
interventional procedures performed during the hospitalization were obtained.204  
From the CVDNOR project we received information on patient`s age at 
hospitalization, sex, municipality of residence, time and date of hospitalization and 
discharge, hospital, department and ward codes, main and secondary diagnosis (≤ 
20), medical procedures (≤30) performed during the hospital stay, and information 
about whether the hospitalization was acute or elective. Hospitalizations less than 24 
hours apart were merged and counted as one.204  
 The Norwegian Cause of Death Registry 
The Cause of Death Registry (https://www.fhi.no/en/hn/health-registries/cause-of-
death-registry/), established in 1951, covers all deaths in Norway.205 Deaths are 
reported by physicians who are required to complete a death certificate. The official 
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cause of death statistics are prepared in accordance with the ICD, and the 10th 
revision of ICD was implemented in Norway in 1996.205, 206  
From The Cause of Death Registry we received information on the time of 
death (date), age at death, underlying cause of death, municipality code for residency 
at the time of death, place of death (hospital/institution/during transport/outside 
institution), municipality code for place of death and basis for the diagnosis.  
3.2 Study design 
The study design in Papers I-III was community-based cohort studies. The follow-up 
period started in 1997-99 in all three studies, but ended in 2012 in study I, and in 
2009 in study II and III.  
3.3 Definition of exposures, endpoints and covariates 
 Exposures 
In Paper I, exposure included change in weight between 1992-93 and 1997-99. 
Weight was measured both in 1992-93 and 1997-99, wearing light clothes without 
shoes to the nearest half-kg on a calibrated scale.207 Weight change has been 
evaluated both as change in BMI and change in weight in previous studies.21 Since 
weight change in kg tend to capture increases in fat mass more precisely than BMI 
change,208 and since it also is a more intuitive concept that more easily can be 
communicated in recommendations,209 weight change in kg were used in this project. 
Change in weight between the first and second measurements was categorized into 
loss (≥5%), stable (±<5%), and gain (≥5%).  
As described in Papers II and III, exposures were obtained using a 169-item 
past-year semi-quantitative Food Frequency Questionnaire (FFQ), a modified version 
of a previously described FFQ,210 completed by 87% of the participants.200 FFQ 
provides time-integrated data that in these two papers represented usual intake the 
past year. It is the most affordable and easily administered diet assessment method, 
with the lowest respondent burden. The FFQ was handed out on the day of the health 
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examination, filled out at home, and returned by mail to the HUSK project center. It 
includes frequency alternatives (from once a month to several times per day), the 
number of units eaten and portion sizes (e.g., slices, glasses, spoons) to capture the 
habitual diet during the past year. The information is presented as individual food or 
beverage items, food groups and nutrients. Daily nutrient intakes were computed 
from a database and software system developed at the Department of Nutrition, 
University of Oslo (Kostberegningssystemet, version 3.2). The nutrient database is 
primarily based on the official Norwegian food composition table 211, and in Paper II, 
exposures were the total dietary amount of SFA and carbohydrates, as well as intake 
of SFA and carbohydrates from different food items. All are expressed as E%. We 
also evaluated SFA after excluding the contribution from cheese for their associations 
with incident CHD.  
As described in Paper III dietary data from other sources in addition to the 
Norwegian food composition tables were needed, and information on vitamin K 
primarily came from available literature from other countries.173 Data for K1 also 
came from public authorities in Finland,212 Sweden213  and USA.214 For some food 
products, analyses had been performed using high performance liquid 
chromatography of fermented foods.215 K2 was evaluated with no distinction between 
the different menaquinones. Vitamin K intake reflects dietary sources only. Both 
energy-adjusted residuals and actual intake of K1 and K2 were used as the final 
exposure.  
 Endpoints  
In Paper I endpoints were all-cause mortality, obtained by linkage to the National 
Population Register. Participants were followed from baseline through 31.12.2012 for 
death events (Figure 4).  There were 1159 events during follow-up.  
In Papers II and III, endpoints were incident (first time) hospitalization with CHD 
(ICD9 codes 410-414, ICD10 codes I20-I25) as primary or secondary diagnosis or 
death with CHD as the underlying cause of death. Participants were followed from 
baseline through 31.12.2009 for CHD events through the 
CVDNOR (www.cvdnor.no)203, 216 project and The Cause of Death Registry (Figure 
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4). There were 107 non-fatal and 5 fatal episodes; 41 participants experienced a MI 



















Paper I: age 71-74y
Papers II & III: age 
46-49y
Followed until: 
Paper I: 31.12.2012 
on total mortality
Papers II & III: 
31.12.2009 on
incident CHD
Paper I: 14y follow-
up
Papers II & III: 11y 
follow-up
Figure 4. Overview of follow-up and age at baseline in all three papers.  
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 Potential covariates  
Covariates are variables that are included in statistical models to adjust for potential 
confounding and to produce more precise effect estimates.217  
A simple definition of confounding is 
defined as the confusion of effects, 
and indicates that the effect of the 
exposure is mixed with the effect of 
another variable (Figure 5).218  
A mediator, also called an 
intermediate variable, is a variable 
that occurs in a causal pathway from 
an exposure to an outcome (Figure 





Confounders → age, sex, physical activity, smoking habits, self-reported diabetes 
mellitus, self-reported use of medication for hypertension, previous MI or/and 
stroke, education*
Mediators → LDL cholesterol*, HDL cholesterol*, triglycerides*, glucose*, systolic 
blood pressure*, diastolic blood pressure*, BMI*, hypertension*, diabetes 
mellitus*, statins*, oral hypoglycemics*, insulin*, anti-hypertensive medications*
Confounders → age, sex, total energy intake, physical activity and smoking habits, 
education* and family history of MI* 
Dietary confounders → energy adjusted intake of alcohol*, fiber from bread, fruit 
and vegetables*, cholesterol*, PUFA* and protein* 
Mediators → BMI*, diabetes mellitus*, hypertension*, serum total cholesterol* and 
statin use*
Confounders→ age, sex, total energy intake, physical activity, smoking habits, 
education, family history of MI* 
Dietary confounders → energy adjusted intake of fiber, folate, SFA and calcium, 
alcohol* 
Figure 5. Confounding 
Figure 6. Mediator 
Figure 7. Overview of mediators and confounders in the three papers 
*Covariates not adjusted for in the main analyses.  
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In Paper I, covariates for which we had data that, based on a priori knowledge, were 
suspected to be confounders and were found to modify the association between 
weight change and total mortality were included in the multivariable models (Figure 
7).  
In nutritional epidemiology, methods for selection of covariates are non-consistent.217 
In Papers II and III, the included covariates were a priori determined to be potential 
confounders and were found to modify the association of the nutrients of interest with 
CHD (Figure 7). In Papers II and III, intermediate variables adjusted for in previous 
studies143-145, 196 were also evaluated to determine consistency in results. We did not 
intend to include these analyses as main analyses, however, in Paper II, they are 
attached as supplementary analyses in order to make the results easier to compare to 
results from previous research in the field. Selecting covariates based on whether it 
modifies the association between exposure and outcome may ignore theoretical and 
empirical understanding of important confounders and this relies heavily on the 
available data.217, 220 However, only covariates we considered as potential 
confounders were included in the primary models. Further, some explanatory 
variables such as age and sex were included in the analyses even if they did not have 
any considerable influence on the association under evaluation.       
When evaluating the number of covariates, we also found it of importance to 
bear in mind that including too many covariates may lead to data sparsity in which 
there are too few subjects at crucial combinations of covariates, with consequent 
inflation of effect estimates.221 In addition, selecting factors highly predictive of the 
exposure can produce multicollinearity, and thus unnecessarily wide CIs and 
potentially inflated effect estimates.220, 222 We found it of particular importance to 
bear this in mind when we evaluated dietary covariates.    
Information collected at the baseline health examination 
Height, weight, waist and hip circumferences, blood pressure, and heart rate were 
measured. Further, blood samples for analyses of serum total cholesterol, HDL 
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cholesterol, triglycerides, and glucose were collected.200, 207 The Friedewald equation 
was used for calculation of LDL-cholesterol.78  
Information from self-administered questionnaires 
 
Myocardial infarction or/and stroke 
Information on whether participants had experienced a previous MI or/and stroke 
came from self-administered questionnaires both in 1992-93 and 1997-99.198 
Information on a history of MI and stroke were combined, such that all who answered 
yes at first and/or second survey to either of the two questions were classified as 
having had an MI or/and stroke.  
Diabetes mellitus 
In Paper I participants were classified as having diabetes mellitus if they answered 
yes at the first measurement in 1992-93 and/or second measurement in 1997-99. 
In Papers II and III participants taking diabetes medications or reported having been 
diagnosed with diabetes mellitus were defined as having diabetes mellitus. Also, 
participants with a serum glucose level >7mmol/L who had not eaten a meal during 
the last 8 hours, or with a glucose level >11.1mmol/L and less than 8 hours since their 
last meal, were defined as having diabetes mellitus.   
 
Hypertension  
In Paper I participants were classified as having hypertension if they reported taking 
blood pressure medication. In Papers II and III, hypertension was defined as present 
if the mean of at least two consecutive measurements of systolic blood pressure was ≥ 
140 mm Hg or diastolic blood pressure ≥ 90 mm Hg or if they reported to use 






Physical activity was self-reported, using two questions, one where participants 
reported how many times per week they performed light physical activity and one 
were they reported how many times per week they performed vigorous physical 
activity. These two questions, which are included in the CONOR questionnaire on 
health behaviours, were used to make one variable on physical activity, categorized in 
none/light physical activity and moderate/vigorous physical activity. In Paper I, those 
who answered that they performed vigorous physical activity one hour or more per 
week were categorized in the group moderate/vigorous, all other were categorized in 
the group none/light physical activity. In Papers II and III, only the question on past-
year vigorous physical activity (none, < 1h/week, 1-2 h/week, or ≥3 h/week) was 
used, and this variable was treated as a categorical variable with none as the 
reference.     
 
Education 
Highest level of education was included as a categorical variable including the 
categories primary school (≤10 years), high school or vocational school, and any 
college or university. Primary school (≤10 years) was used as the reference category.  
Smoking habits 
Participants were categorized into never smokers, former smokers and current 
smokers based on their answers on three questions: “Do you smoke cigarettes, cigars, 
cigarillos/pipe?”  answered both in 1992-93 and 1997-99, and the questions “Never 
smoked daily?” and “Number of years since you stopped smoking daily?” answered 
only in 1997-99. The category with non-smokers was used as the reference.     
Family history of myocardial infarction 
Information on family history of MI came from the question “Has one or more of 
your parents/siblings had a MI before they turned 60 years old?” answered in 1997-
99.    
 45 
3.4 Statistical methods 
The Cox proportional hazard regression model is a regression model for analyses of 
survival data and was used in all three papers. Both survival analyses in general and 
Cox proportional hazard regression will be described below.  
Survival analyses  
Survival analysis methods are used when we are interested in the time until an event 
of interest occurs. The event could for instance be death or an incident case of CHD. 
A key feature of ‘survival-time’ data is the presence of ‘censored’ observations. An 
observation is censored if we do not observe the event of interest for an individual 
during the follow-up time in the study. For most of the individuals this occurs 
because the study is ended before everybody has experienced the event, but censoring 
can also occur if the person is lost to follow-up (e.g withdrawal from a study, 
emigration, death from other causes than the event of interest). For censored 
observations we do not know the exact time until the event occurs, we only know that 
the person was event-free at least until the time of censoring. Statistical methods 
within survival analysis takes censoring into account.223 
The Kaplan Meier survivor estimate of the survivor function S(t) gives the probability 
of survival (not experiencing the event of interest) up to and after time t, and include 
information from both censored and uncensored observations.223 
S(t) = P(T≥t) → P = probability, T = time of event of interest, t = some time point.  
The survival function is thus the probability that the time of an event is later than 
some specified time, t.223  
The estimated survivor function can be presented graphically as a Kaplan Meier 
survival curve with S(t) versus t or as a failure curve with 1- S(t) versus t.  The hazard 
function h(t) gives the probability that the event will occur in a small interval after a 
specified time t, given that an individual has survived up to time t. It is a rate, thus the 
values range between zero and infinity.223 
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Cox proportional hazard regression analyses 
Cox proportional hazard regression models the hazard ratio (HR) as a function of one 
or more covariates:  
h(t) = h0(t) x exp(β1x1 + β2x2 +…+ βpxp) 
Function h0(t) is the baseline hazard functions (i.e the hazard function if all covariates 
are zero) and is only dependent on time. The exponential part (exp) depends on the 
values of the covariates and regression coefficients. The exponentiate of the estimated 
regression coefficient for a given covariate is interpreted as a HR, that is the ratio of 
the hazard rate for those who e.g. experience exposure and hazard rate of those who 
did not experience exposure.223 In the papers of the thesis, it is the hazard rate of 
those who lose or increase in weight to hazard rate of those with stable weight in 
Paper I and hazard rate of those with the higher intake of the specific nutrient to 
hazard rate of those with the lowest intake of the specific nutrient in Papers II and III. 
The model is semi-parametric, meaning that the model has both parametric and non-
parametric components.223  
Cox proportional hazard regression analyses were conducted in all three papers, 
estimating HRs and 95% CIs for each study outcome (Paper I: total mortality; Papers 
II and III: incident CHD), comparing participants with different weight change status 
(Paper I) and nutrient intake (Papers II and III).  
Proportional hazard assumption 
A Cox regression is done on the assumption that the HR between two or more groups 
are constant at all times t, H(t)/H0(t)=h(t)/h0(t)=constant=HR. This does not mean that 
the hazard rate cannot change over time, but the relationship must be constant. This 
was checked by evaluating log-(log) survival plots for all relevant variables and by 
performing the Schoenfeld test.223 
Multivariable analyses  
Multivariable analysis makes it possible to address whether an observed association 
between the specific exposure and event is merely secondary to its correlation with 
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other, causal factors (confounders).224 The HR for a specific variable in a 
multivariable Cox regression is adjusted for all other covariates in the model and can 
be interpreted as the ratio of hazard between different levels of exposure when all 
other covariates in the model are kept constant. In all three papers, multivariable 
analyses were performed. Only possible confounders were included as covariates in 
our main analyses. In supplementary analyses in Paper II, intermediate variables were 
adjusted for as this have been done in previous studies in this field, and it is useful in 
order to compare with previous results.   
Effect modification 
We investigated possible effect modifications, which can be done in two different 
ways. One method is by adding an interaction term in the cox regression analysis, and 
comparing a model with an interaction term with a model without an interaction term 
using likelihood-ratio test, while the second method is to see whether the effect of 
exposure varies in strata of the covariate.225 
Penalized splines 
When modelling continuous variables with standard Cox regression we assume a 
linear association between log(hazard) and the variable, which may not always be 
true. One way of allowing for non-linear associations is to model the variable with 
smoothing splines. Penalized spline is a variant of smoothing spline with more 
flexible choice of bases, knots and penalties. Penalized splines combine the flexibility 
of non-parametric methods with stability and simplicity of parametric smoothers. The 
estimated smooth function can thus be used to plot the relative hazard of the desired 
endpoint against the explanatory variable, and non-linear relationships can thus be 
investigated visually.226 In all three papers, Cox regression with penalized splines 
were used to illustrate the functional form of exposure estimated by a smoothing 
spline, in which the estimated smooth function were used to plot the relative hazard 
of event against exposure as a continuous variable.226 
 48
Missing data 
Missing data on covariates were handled with listwise deletion in analyses included 
in the main manuscript in all three papers. When performing listwise deletion, also 
called complete case analysis, only subjects with complete data are included in the 
analysis.227 Therefore, multivariable-adjusted analyses in Paper I included 2330 
participants and 895 events, in Paper II 2820 participants and 105 CHD events, and in 
Paper III 2792 participants and 100 CHD events.  
However, in supplementary analyses in Paper III, missing values for physical 
activity, smoking and education were imputed using ordinal logistic regression as the 
imputation model in MICE (multiple imputation using chained equation) with 20 
imputations.228 This is a repetitive method for data with several variables with 
missing values in a non-monotone pattern.228 The key concept of multiple imputation 
is to use the distribution of the observed data to estimate a set of plausible values for 
the missing data.228 As described in Paper III, all variables in the Cox regression 
models were included as imputation variables together with total cholesterol, HDL 
cholesterol, triglycerides and BMI as auxiliary variables due to their correlation with 
physical activity, smoking and education.   
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3.4.1 Overview of materials and methods in all three papers  
 Paper I – weight 
change in older people 
and its association with 
total death  
Paper II – 
Carbohydrates and SFA 
and its association with 
CHD 
Paper III – Vitamin K 
and its association with 
CHD 
Main aim  To evaluate the 
importance of weight 
change with regard to 
mortality in older 
people 
To evaluate associations 
and possible interplay of 
carbohydrate and SFA 
intakes with CHD 
To evaluate the 
association between 
intake of both K1 and 
K2 with CHD 
Study design Cohort study Cohort study Cohort study 
Study 
population 
2935 men and women, 
age 71-74y 
2995 men and women, 
age 46-49 y 
2987 men and women, 
age 46-49 y 
Observation 
period 
Time from 1997-99 
until death or 
31.12.2009. 
Time from 1997-99 




Time from 1997-99 












Cox proportional hazard 
regression, Cox 
regression with 
penalized spline.  
Cox proportional hazard 
regression, Cox 
regression with 
penalized spline.  





infarction or stroke. 
Age, sex, energy intake, 
physical activity and 
smoking 
Age, sex, energy intake, 
physical activity, 
smoking and education. 
K1 was adjusted 
additionally for fiber 
and folate; K2 was 




*Figure 1 in Paper I should have been labeled Kaplan-Meier failure curves instead of 
Kaplan-Meier cumulative hazard curves.   
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Paper I Association between weight change and mortality in community living older 
people followed for up to 14 years. The Hordaland Health Study (HUSK) 
In Paper I we excluded from the analyses six participants who emigrated after the 
second measurement, and 369 participants diagnosed with cancer before or between 
the surveys in 1992-93 and 1997-99 (information obtained by linkage to the 
Norwegian Cancer Registry).   
Follow-up time was defined as time from baseline in 1997-99 until they 
experienced death or at 31.12.2012, whichever occurred first.  
Kaplan-Meier failure curves were used to estimate hazard rates and multivariable 
Cox proportional hazard regressions estimated HR with 95% CIs for weight change 
in categories (%). Cox regression with penalized spline was used to evaluate the 
association between weight change (in kg) and mortality. 
In supplementary analysis, Chi-square analyses or t-tests were applied to 
determine whether the survivors and non-survivors in the different weight change 
groups differed significantly on any of the baseline characteristics. Further, in order 
to eliminate early deaths that could be attributed to clinical or subclinical disease, two 
sensitivity analyses were performed after excluding persons who 1) died within two 
years after baseline (n=69), and 2) persons who were diagnosed with cancer within 
two years after baseline (n=136). In addition to percent weight change we also 
examined different measures of weight change, e.g. ± 3 kg and ±2 kg weight change. 
In addition, ± ≥ 5% changes in BMI were examined.   
 
Paper II Intake of carbohydrates and saturated fatty acids and risk of coronary heart 
disease in middle-age adults. The Hordaland Health Study (HUSK) 
In Paper II we excluded from the analyses 22 men and 5 women who reported prior 
CHD, and 4 men and 19 women due to missing information on prior CHD. Further, 
we excluded 27 men and 35 women who reported extreme energy intakes (below the 
1st percentile; or above the 99th percentile).  
The nutrient density method was used to adjust the exposures (nutrients) for 
total energy, giving the exposure as E% intake from the specific nutrient.  
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The coefficients for the nutrient density term represents the relation of the nutrient 
composition of the diet with disease since by adjusting the nutrient for energy, we 
separates the variation in nutrient intake due only to the nutrient composition of the 
diet from the complete variation in nutrient intake, which is due both to composition 
and overall consumption of food.86 Energy adjusted nutrients are uncorrelated with 
total energy intake. Further, additional adjustment for total energy intake as a 
covariate can reduce measurement error (and width of confidence limits). This is 
because both specific nutrients and total energy are calculated from the same foods, 
and the effects of overreporting and underreporting will therefore apply to both 
variables, and an adjustment for total energy will tend to “cancel” these errors.86 
Also, when total energy intake is anticipated to be associated with the outcome as in 
these papers where incident CHD was the outcome, total energy should be included 
in the model in addition to the energy adjusted nutrient.86 
Follow-up time was defined as time from baseline in 1997-99 until they 
experienced CHD, death from other causes, emigration, or at 31.12.2009, whichever 
occurred first. Multivariable Cox proportional hazard regression estimated HRs with 
95% CIs for quartiles of SFA and carbohydrate intake, and also for continuous 
variables (per 2E%). Test for linear trends across quartiles was also performed. Cox 
regression with penalized spline was used to evaluate the association between SFA, 
carbohydrates and SFA minus SFA from cheese (in E%) and CHD.  
When evaluating the association between higher or lower intake of energy 
adjusted nutrients with an endpoint, the higher or lower intake of an energy 
containing nutrient can only be accomplished by the exchange of other dietary 
variables. In substitution models, one dietary variable is replaced by another dietary 
variable, taking energy as the common unit across the dietary factors.229, 230 We 
therefore used theoretical substitution analyses to model the substitution of 
carbohydrates with other nutrients. Variables for the E% (per 5E% unit increments) 
of all macronutrients except carbohydrates (SFA, MUFA, PUFA, protein and 
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alcohol) were included in a Cox model with adjustment for total energy intake, age, 
sex, physical activity and smoking habits. The HR for “the nutrient of interest” is then 
interpreted as the change in estimated risk for each 5E% unit increase in “the nutrient 
of interest” while holding all other variables in the model constant but allowing for 
concomitant decreases in carbohydrate intake as all sources of macronutrients sum to 
100% of energy intake. A key assumption for any substitution analysis is that the 
total consumption of different nutrients under substitution is known and constrained 
to a certain level for each individual since the effect has to be assessed on the basis of 
equal amount of replacement.231  
Supplementary analyses evaluated models adjusted for age, sex and energy 
intake, with additional adjustments for HDL cholesterol, LDL cholesterol, 
triglycerides, glucose, systolic blood pressure, diastolic blood pressure, and BMI; and 
with additional adjustments for diabetes mellitus, hypertension, family history of MI, 
statins, oral hypoglycemics (including metformin) and insulin, and anti-hypertensive 
medications; and additional adjustments for smoking, physical activity, alcohol 
consumption in E%, and education. In additional supplementary analyses, we 
stratified intake of SFA on smoking habits and we also evaluated associations 
between carbohydrates and SFA from other specific food groups and CHD risk. Also, 
sensitivity analyses were conducted where we excluded the first 2 years of 
observation following the baseline assessment in all of the above analyses. 
Further, adjustment for energy-adjusted nutrients were performed but not 
included in the final models. In carbohydrate analyses adjustment for fiber from 
bread, fruit and vegetables were evaluated, while in SFA analyses adjustment for 
intake of cholesterol, PUFA and protein were evaluated. Due to the relatively few 
events, multivariable analyses with dietary factors were performed by including 
standard nondietary risk factors with two dietary factors at a time. This made it 
possible to evaluate whether they have no independent association with CHD and that 
the association with the primary nutrient remains.224   
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Paper III Dietary vitamin K and risk of coronary heart disease in the prospective 
Hordaland Health Study 
In Paper III we excluded from the analyses 27 men and 35 women who reported 
extreme energy intakes (below the 1st percentile: or above the 99th percentile). 
Further, we excluded 22 men and 5 women who had prior CHD. Additionally, 4 men 
and 19 women with missing information on self-reported MI from the Homocysteine 
Study (1992-93) were excluded. Further, we excluded one man and one woman who 
reported use of Warfarin and 2 men and 4 women with missing measurement on 
dietary vitamin K intake.  
Even though vitamin K does not contribute with energy, it is correlated with total 
energy intake. The spearman correlation coefficients between total energy intake and 
total vitamin K, vitamin K1 and vitamin K2 were 0.47, 0.43 and 0.59, respectively. 
We therefore decided to use energy-adjusted residuals as exposure in the main 
analyses. Energy-adjusted residuals were obtained from linear regression models with 
total energy intake as independent variable and K1 or K2 as dependent variables. 
Residuals were then categorized into sex-specific quartiles.  
The residuals measure the difference between actual intake and expected intake 
predicted by total energy intake and thereby provides an assessment of K1 and K2 
intake relative to energy consumed. The residuals will have a mean of zero and 
includes negative values (Figure 8).86  
Figure 8. Nutrient residuals.  
Person a and b have almost the same intake of 
vitamin K, but due to differences in total energy 
intake, person a will have a positive value, 
while person b will have a negative value and 
person a will therefore be in a higher intake 
quartile, as vitamin K will make up a larger 
part of this persons diet.86 
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One possible caveat with nutrient residuals is that they assume that a given residual 
indicates the same effect across the spectrum of energy intakes (i.e., from small to 
large body sizes requiring greater energy intake). Willett emphasized, however, that 
among specific age-sex groups variations in body size and total energy are not 
large.86 In this paper, the age range was narrow, and sex-specific quartiles were used, 
so this is not a major issue.  
The coefficient and the standard error from the residual model in continuous 
analysis is identical to that from the standard multivariable model where only total 
energy intake is included.86 In conducting categorical analyses, however, the 
interchangeability of the two methods does not apply, and statistical power will be 
higher with the residual method. The range in unadjusted vitamin K intake will be 
wider than for energy-adjusted vitamin K intake, and due to the collinearity between 
vitamin K and total energy intake, the CIs will be wider.86 
Follow-up time was defined as time from baseline in 1997-99 until they 
experienced CHD, death from other causes, emigration, or at 31.12.2009, whichever 
occurred first. Multivariable Cox proportional hazard regression estimated HRs and 
95% CIs for quartiles of both sex-specific energy-adjusted and absolute intake of K1 
and K2. K1 and K2 were also evaluated per 10µg increments. Test for linear trends 
across quartiles was performed by using the median residuals for each quartile group 
as a continuous independent variable in the regression models.  
In Cox regression with penalized spline the functional form of the association 
between absolute K2 intake and risk of CHD was estimated by smoothing splines, in 
which the estimated smooth functions were used to plot the relative hazards of CHD.  
Data packages 
In Paper I, statistical analyses were performed using STATA version 14 (Stata Corp. 
LP. College Station, TX), SPSS, version 21 (IBM SPSS, Armonk, NY:IBM) and R 
version 3.1.0 (https://www.r-project.org/), The R Foundation for Statistical 
Computing, Vienna, Austria. In Papers II and III, statistical analyses were performed 
using Stata version 15 (Stata Corp LP, College Station, TX) and R version 3.4.0 
(https://www.r-project.org/), The R Foundation for Statistical Computing, Vienna, 
Austria.   
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In all three papers, a two-sided p-value <0.05 was considered statistically significant.  
3.5 Ethical considerations/approval  
The HUSK study was performed in accordance with the Declaration of Helsinki. All 
participants provided written informed consent. The Regional Committee for Medical 
Research Ethics (REC number: 14580) approved the study protocol. HUSK is 
registered in ClinicalTrials.gov (Clinical trial number: NCT03013725).  
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4. Results  
4.1 Summary of results in Paper I 
We followed 2935 men and women from 1997-99 through 2012, giving a median 
follow-up of 13 years and the average age at start of follow-up was 72.4 years.  
During follow-up, 648 men and 511 women died. Compared to the stable-
weight groups, Kaplan-Meier failure curve for the weight loss groups increased more 
rapidly for both sexes. The curves for the weight stable and weight gain groups 
followed each other closely the first few years, especially among women. The Log 
rank test showed significant differences in hazard between the three weight change 
groups in both sexes.     
In the Cox proportional hazard regression model adjusted for age, sex, 
smoking, physical activity, MI and/or stroke, diabetes mellitus and being under 
treatment for hypertension, the HR was 1.59 (95% CI 1.35, 1.89, p<0.001) when 
comparing the weight loss group to the weight stable group. The excess mortality risk 
associated with weight loss was similar in men and women in the fully adjusted 
model. When evaluating weight gain in the fully adjusted model, weight gain was not 
associated with increased mortality risk, when compared to the weight stable group, 
HR 1.07 (95% CI 0.90, 1.28, p=0.453). Also when stratifying for sex, there were no 
associations between weight gain and mortality in the fully adjusted models. 
When stratifying weight change by BMI categories (<25 kg/m2, 25-29.9 kg/m2, and 
≥30 kg/m2), the fully adjusted model showed that increased risk of mortality 
associated with weight loss persisted in participants with a BMI of <25 kg/m2 and 25-
29.9 kg/m2, but not in participants with a BMI of ≥30 kg/m2. The total group with 
weight gain did not have increased risk of mortality compared to stable weight also 
when stratified by BMI. The multivariable adjusted Cox regression with penalized 
spline of the relationship between weight change and mortality illustrated that both 
major weight gain and minor weight loss was associated with increased mortality in 
comparison with stable weight. 
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4.2 Summary of results in Paper II 
We examined 1282 men and 1713 women from 1997-99 through 2009, providing a 
mean follow-up time of 10.8 years, and 112 incident CHD events. Median baseline 
age was 48 years.  
Higher intake of carbohydrates was associated with higher risk of CHD when 
adjusted for age, sex, energy intake, smoking habits and physical activity and 
comparing the fourth to the first intake quartile (HR 2.10; 95% CI 1.22, 3.63, p-trend 
0.003). Also, continuous analyses (per 2E%) showed higher risk of CHD with higher 
intake of carbohydrates (HR 1.12; 95% CI 1.05, 1.20) in the fully adjusted model. 
Plotting the data with multivariable adjustments indicated a linear relationship.  
A high intake of SFA was associated with lower risk of CHD in the model 
adjusted for age, sex, energy intake, smoking habits and physical activity when 
comparing the fourth to the first quartile (HR 0.44; 95% CI 0.26, 0.76, p-trend 0.002). 
Also, continuous analyses (per 2E%) showed lower risk of CHD with higher intake of 
SFA (HR 0.78; 95% CI 0.66, 0.92) in the fully adjusted model. When plotting the 
data and performing multivariable adjustments, lower risk of CHD with a higher 
intake of SFA were illustrated until an intake of about 13E%, after which the curve 
levelled off.  When examining the association between SFA from various food items, 
only SFA from cheese was significantly associated with a lower risk of CHD.  
We further evaluated the association between SFA and CHD after excluding 
the SFA contribution from cheese and found that intake of SFA after exclusion of 
cheese was associated with lower risk of CHD when comparing the fourth to the first 
quartile (HR 0.58; 95% CI 0.34, 0.98, p-trend 0.030), after adjustment for age, sex, 
energy intake, physical activity and smoking habits. Results from the continuous 
analyses (per 2E%) were in the same direction as the quartile analyses, but we 
observed deviations from linearity in the association between SFA intake and CHD 
risk after excluding SFA from cheese.  
Substitution of 5% of total energy intake from carbohydrates with SFA was 
associated with lower risk of CHD (HR 0.74; 95% CI 0.40, 1.36) in the fully adjusted 
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model. A substitution of carbohydrates with total fat was also associated with lower 
risk of CHD (HR 0.75; 95% CI 0.62, 0.90).  
4.3 Summary of results in Paper III 
We followed 1279 men and 1708 women from 1997-99 through 2009, resulting in a 
mean follow-up time of 10.8 years and 112 incident CHD events. Median baseline 
age was 48 years.  
When adjusting for age, sex, total energy intake, physical activity, smoking habits 
and education, and comparing the fourth to the first quartile of K1 intake, there was 
no association between intake of K1 and CHD (HR 0.92; 95% CI 0.54, 1.57, p-trend 
0.64). Results were similar when evaluating energy-adjusted K1 intake as a 
continuous variable (per 10µg increase). Additional adjustments for energy-adjusted 
fiber and folate did not materially change the results. Results were consistent with the 
above analyses when evaluating sex-specific quartiles of absolute K1.  
When adjusting for age, sex, total energy intake, physical activity, smoking 
habits, and education and comparing the fourth to the first quartile, higher K2 intake 
was associated with lower risk of CHD (HR 0.52; 95% CI 0.29, 0.94, p-trend 0.03). 
Consistency in results were observed in analyses of K2 intake as a continuous 
variable (per 10µg increase). Additional adjustments for energy-adjusted SFA and 
calcium attenuated the risk estimates for the association between K2 intake and CHD 
(HR 0.58; 95% CI 0.28, 1.19, p-trend 0.16).  
  When evaluating sex-specific absolute K2 intake, HRs were similar to those 
observed in the energy adjusted analyses when comparing the fourth to the first 
quartile (HR 0.72; 95% CI 0.36, 1.45, p-trend 0.25), although the association was 
weaker. Similarly, the penalized spline figure for absolute K2 intake and its 
association with CHD adjusting for age, sex, total energy intake, physical activity, 
smoking habits and education showed a tendency toward lower risk of CHD with 
higher K2 intake. 
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5. Discussion  
5.1 Summary of findings 
This project evaluated weight change among older people and nutrients among 
middle-aged people as predictors of total mortality and CHD, respectively.  
In Paper I, we found that in older people, both major weight gain and minor 
weight loss were associated with increased mortality in comparison with stable 
weight. 
In Paper II, there was an inverse association between dietary SFA and CHD 
risk among middle-aged people. For carbohydrates, the opposite pattern was 
observed. When evaluating the association between sources of SFA and 
carbohydrates with CHD, only SFA from cheese associated with lower CHD risk.  
In Paper III, we found no association between dietary vitamin K1 and CHD, 
while there was a lower risk of CHD associated with higher intakes of vitamin K2.  
5.2 Methodological considerations  
 Study design  
All three papers are prospective cohort studies, considered to be the strongest 
observational study design. A cohort study follows a defined group of people over a 
given period of time, prospectively into the future. A subgroup is identified who is, 
has been, or in the future may be exposed, or exposed to different degrees, to a factor 
(exposure) hypothesized to influence the occurrence of an event (endpoint).219  
Two characteristics of observational studies will be addressed: precision and validity.  
 Precision 
Precision is a relative lack of random error and can be evaluated by the standard 
error, the standard deviation or CIs around the effect estimate. Precision can be 
improved by increasing the study population or improving the study design.232 In 
Paper I, the exposure (weight change) was measured (rather than self-reported) and 
there was a relatively large number of participants experiencing total mortality, 
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yielding relatively narrow CIs. The CIs were relatively wider in Papers II and III, due 
to the relatively small number of participants experiencing CHD (n=112). When 
stratifying on confounders the precision weakened even more, and stratification 
became problematic. Further, precision could also have been higher if diet had been 
measured more than once at baseline in Papers II and III, and also with more than 
only one measurement method. Most dietary assessment methods will have errors due 
to unsystematic day-to-day, diurnal, or seasonal variation in a person's diet.233 
However, FFQ used in these papers have lower random within-person variation than 
other methods since it assesses average usual intake over the past year, that is also the 
exposure time of etiologic interest for CHD.234  
 Validity  
Internal validity is the degree to which a study is free from systematic error.219 In 
studies with a large study population, almost all errors of concern are systematic 
errors such as selection bias, information bias, and confounding.218   
Measures of validity are positive predictive value (PPV), negative predictive value 
(NPV), sensitivity and specificity.235   
Selection bias 
Selection bias results from systematic differences in characteristics between those 
who participate in the study and those who do not participate and occurs when the 
association between exposure and disease differs between those who participate and 
not.218 It may result from procedures used to select subjects and from factors that 
influence participation.235  
In HUSK invitations were sent to individuals born between 1925-27 (Paper I) and 
1950-51 (Papers II and III), and who had earlier participated in a population study in 
Hordaland between 1992-93.198  
Individuals who do not respond to an invitation to participate in community-
based studies are often over-represented by people of lower social classes, single-  
households, immigrants, receivers of social security benefits, and people with poor 
self-reported health and an unhealthy lifestyle, and when a considerable number of 
invitees decline to participate, the study may be distorted by selection bias.236 Large 
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prospective cohort studies are generally robust against bias arising from non-
participation.237 In our study, participation rate was 79% for men and 76% for women 
in Paper I, while in Papers II and III, participation rate was 77% in total, and 87% of 
the participants completed a semi-quantitative FFQ.200 However, characteristics of 
participants and non-participants in HUSK based on data obtained in 1992-93 have 
been compared in a previous PhD thesis, where non-participants in 1997-99 had a 
greater proportion of smokers and no regular physical activity in 1992-93 compared 
to the participants in 1997-99.238 Further, a report from HUSK 1997-99 found that the 
educational level was higher among the participants relative to the non-participants, 
for both men and women.239  
In all three papers there was a small number of participants who emigrated during the 
follow-up period (6 participants in Paper I and 15 participants in Papers II and III), 
and they were evenly distributed between the exposure categories. Also, in Papers II 
and III, they contributed with follow-up time until they emigrated. Loss to follow-up 
was therefore not a problem in either of the papers.  
 
In all three papers, missing data on covariates were handled with listwise deletion. 
This can introduce bias in both estimates of exposure-outcome associations, CIs and 
p-values if the variables are not missing completely at random.227 Further, when 
regression analyses of models with different covariates are carried out, the available 
cases will differ between the analyses, and differences in results may be both due to 
the effect of different covariates and also due to different sets of observations.227   
Information bias 
Information bias may occur during data collection if the information collected about 
or from study participants is erroneous. One type is misclassification, and 
misclassification of participants can be differential meaning that the misclassification 
differs according to the value of other study variables or nondifferential, meaning that 
it is unrelated to other study variables.218 Non-differential misclassification may 
reduce the observed effect estimate, while differential misclassification can lead both 
to increased and decreased effect estimates.240 
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 In all three papers, covariates were derived from questionnaires filled out by 
the participants, which may introduce misclassification since participants may give 
the answers they think are the most accepted by the community.241 Especially, in 
Papers II and III, when participants answered on their dietary habits, but also in all 
three papers when answering on smoking habits, underreporting bias may occur.241 
Further, in Papers II and III where the FFQ was used, the number of foods recalled 
tends to be correlated with total intake of both energy and nutrients, thus differential 
misclassification may occur between those with good and poor memories.242  
In order to evaluate the precision of anthropometric measurements in Paper I, 
Bland-Altman plot was used. This is a method of data plotting used to analyze the 
agreement between two methods of clinical measurement, 243 and in Paper I it was 
used to analyze the agreement between the height measurements of men participating 
in 1992-93 and 1997-99. The plot showed that these differences for most of the 
participants were within ±2SD. Most of the men outside this limit were at the minus 
part, as expected due to height reduction in older people. This indicates that 
information on anthropometric values measured with standardized methods207 in 
Paper I, seems not to include information bias. 
In Papers II and III, regression dilution bias may happen because of 
fluctuations in the measured values of exposure, caused by longer-term within-person 
fluctuations. It often results in underestimations of the strength of the real association 
between the “usual” long-term average level of intake of that nutrient during a 
particular exposure period and subsequent CHD risk.244 Processing of nutritional data 
from observational studies is challenging. Dietary variables are hardly ever 
dichotomous and rigid, usually every person is “exposed” to some degree, and dietary 
habits and food composition changes over time. Also, errors in nutrient estimation 
from food composition tables may occur as they often do not account for the fact that 
the nutrient content of food varies with season, location of production, growing 
conditions, storage, processing, and cooking techniques.233, 234 Inter-individual 
variation in bioavailability due to genetic predisposition and the influence of other 
dietary compounds due occur, but is also not considered when estimating nutrient 
intake from food tables.230 Systematic sources of variation include omission of foods 
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consumed due to a lack of the specific food item in food lists used in the studies and 
over- or under-reporting because of socially perceived norms.245, 246 Underreporting 
bias due to underreporting of dietary food intake seems to be largest among women 
and obese persons.86 However, underreporting of total energy intake seems not to be a 
problem when dietary composition is evaluated.224 In addition, correlates of 
underreporting such as age, sex and adiposity are often accounted for during 
statistical adjustments.  
In Paper II, assessment of whole grain intake may have been particularly 
problematic since consumers may have difficulties identifying products containing 
whole grain.247  
Nevertheless, FFQs have been shown to have acceptable validity when 
compared to reference measures,242 with correlation coefficients for individual 
nutrients ranging from 0.4 to 0.7. 234 Relevant to Paper II, a validity study of a similar 
FFQ to that used in HUSK found that the Spearman correlation coefficients between 
intake of SFA and carbohydrates estimated by the FFQ versus weighed food records 
were 0.44 and 0.57, respectively.210 Unfortunately, this validity study did not evaluate 
the validity of K1 and K2 intake. In previous studies, the validity of FFQs have 
shown to be better for K2 than for K1,248 while when Zwakenberg et al validated a 
Dutch FFQ containing questions on past year average consumption of 79 food items, 
they found that FFQ is reproducible to rank subjects for both K1 and K2 intake, and 
further that the relative validity compared to 24-h dietary recalls, to estimate intake of 
K1 and short-chain K2 was low, but that the relative validity for long-chain K2 was 
good.249  
In HUSK, information on exposure came from a 169-item semi-quantitative 
FFQ providing many food items adapted to Norwegian consumption behaviors, and 
information was obtained all year round, and also the large number of participants 
may have offset many of the previously mentioned difficulties when measuring 
nutrient intake.  
Categorization of exposure, performed in all three papers, may introduce non-
differential misclassification, while differential misclassification is not a problem as 
the endpoints are hard, and collected independently of baseline information.240  
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Nutrient biomarkers may be a more objective measures of nutrient status 
compared to FFQ as they also reflect metabolism.250 However, none of the dietary 
exposures in Papers II or III have valid biomarkers that can be assessed. There is an 
absence of objective biomarkers for assessing carbohydrate intake,251 and plasma 
concentrations of SFAs may also reflect carbohydrate intake.252 Further, circulating 
levels of K2 are usually nondetectable,194 and K1 levels correlate with triglycerides 
and vary according to recent intakes.253  
Confounding  
Confounding occurs when the effect of the exposure is mixed with the effect of 
another variable, a confounder.218 A confounder is associated with both the exposure 
and outcome but is not caused by either, and when not accounted for, it introduces 
confounding.233 Recognition of confounders requires knowledge about the causal 
network where exposure and outcome are part,219 and selection of confounders that 
do not integrate knowledge about the topic may introduce bias in the effect 
estimate.254, 255 Even though confounders may be accounted for, there will always be 
unmeasured confounding, and causality can therefore not be established in cohort 
studies.256  
In Paper I we adjusted for age, sex, physical activity, smoking, diabetes 
mellitus, hypertension, and previous MI or stroke. In Paper II we adjusted for age, 
sex, total energy intake, physical activity and smoking habits, while in Paper III we 
adjusted for the same variables as in Paper II in addition to education. Several of the 
covariates were categorical, and a crudely categorized covariate may not fully 
account for the effect of that variable, resulting in possible residual confounding.224 
Further, people with a “healthy” diet are more likely to have higher education, have 
higher income, exercise more, have normal BMI and be non-smokers,257 and the 
combined effects of such characteristics may not be fully accounted for in 
adjustments. 
Reverse causation refers to the possibility that individuals who are at risk for 
CHD change their behaviour with respect to the risk factor under study.219 In Papers 
II and III, it may be that those at risk for CHD at baseline had changed their dietary 
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practices. While reverse causation is difficult to address, we did adjust for family 
history of MI and covariates related to health. 
External validity 
External validity refers to how well results of a study may be generalized to other 
populations in other settings, often referred to as generalizability.235 Internal validity 
is a prerequisite for external validity. If e.g. non-participation selection bias is 
present, the study population might not be representative of the target population, 
further lowering the external validity.235  
The HUSK study population is relatively homogenous, which in terms of the risk of 
confounding is a strength, but the results may not be generalizable to populations of a 
different race or ethnicity, obese or people with specific genetic disorders. Further, all 
three papers included cohorts with a small age range (46-49 or 70-74 years) and 
generalizability to other age groups may be low.  
In Paper I, participants were community-living at baseline in 1997-99, but we 
had no information on whether they moved into an institution during follow-up. 
When comparing results from Paper I to a recently published meta-analysis including 
30 studies on weight loss and 27 studies on weight gain, we got very similar 
estimates,21 indicating reasonably good external validity of our results.  
In 1997-99, the NORKOST2 survey was used to gather knowledge about 
intake of macronutrients in the general Norwegian population.258 They used a FFQ, 
although slightly different from the one used in HUSK. The intake of macronutrients 
in HUSK used as exposures in Paper II, is overall comparable with intake in 
NORKOST2 (Table 4), which may support external validity of the exposure data. 
However, there is no external validity without internal validity, so it also suggests 
that the bias when estimating intake of macronutrient density in HUSK is 
unproblematic.241 Further, similarly as in NORKOST2, intake of carbohydrates was 
highest among women, while intake of total fat was highest among men, although 
intakes were quite similar. Also, in both studies there were no difference between 
intake of SFA among men and women.  However, in 2004 Drevon et al evaluated 
intake of vitamin K in NORKOST2.259 Table 4 shows that intake of vitamin K is 
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estimated to be distinctly lower in NORKOST2 then in HUSK, illustrating the 
difficulties with estimation of vitamin K intake.248  
 
 Effect modification  
Effect modification means that the association an independent variable has with the 
dependent variable varies with the value of a third variable. In this study, this could 
mean that the associations between weight change and total mortality, or nutrients 
and CHD, vary in different strata of the third variable, for example sex.225   
We evaluated possible effect modification in all three papers, but analyses of 
the effect of the exposure in strata of the different covariates showed few events in 
several of the categories, especially in Papers II and III. Due to this, the CIs were 
large, making interpretations difficult. In Paper I, when performing interaction 
analyses, there were no significant interactions with any of the covariates examined. 
In Papers II and III we evaluated possible interactions of age, sex, smoking habits, 
diabetes mellitus, hypertension, physical activity, education, and family history of 
infarction. We found a borderline significant interaction between SFA and diabetes 
mellitus in Paper II. Similarly, in Paper III, we found a significant interaction 
between intake of K2 and diabetes mellitus, but only in model 1. As we had few 
individuals with diabetes mellitus and since diabetes mellitus may be an intermediate 
factor between nutrients and CHD, we found it not appropriate to stratify on this 
variable. 
Table 4. Evaluation of nutrient intake in NORKOST2259 and HUSK 
Mean intake  NORKOST2 HUSK 
Proteins, E% 15.9 15.8 
Carbohydrates, E% 51.6 49.1 
Total fat, E% 30.6 32.6 
SFA, E% 12.1 12.6 
Vitamin K, µg/day, men/women 48.3/39.1 152.2/150.0 
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5.3 Discussion of main findings 
Paper I: Association between weight change and mortality in community 
living older people followed for up to 14 years. The Hordaland Health 
Study (HUSK) 
In Paper I we reported that both major weight gain and minor weight loss were 
associated with increased mortality in comparison with stable weight in older people, 
in agreement with results of other studies.21 Whether weight loss is associated with 
increased mortality also in overweight and obese older people is unclear. Paper I 
found weight loss to be associated with increased mortality among overweight 
participants, while among the obese participants the association went towards 
increased risk. Previous studies have also shown weight loss to be associated with 
higher mortality independent of baseline BMI in older people.32, 51 However, it is still 
unclear whether weight loss in obese older people should be recommended due to 
few studies and the few participants with BMI >30kg/m2 in this and previous studies. 
32, 51    
We found that the weight gain had to be relatively large to increase the risk of 
mortality. Previous studies have shown diverse results on weight gain, indicating that 
a weight gain has to be of at least a certain amount in order to be associated with total 
mortality in older people.21, 30, 31, 33, 35, 37-42, 45, 46, 48-50 The trajectory of the weight gain 
in HUSK was unknown, therefore participants who died may have experienced a 
continuous weight gain, a large weight gain during a short time, or a combination.    
Information on weight cycling may have strengthened the association as it has 
also been shown to be related to increased mortality.21, 38, 54  We also did not 
distinguish between intentional and unintentional weight change as this information 
was not available. Unintentional weight loss seems to be clearly associated with 
increased risk of mortality in older people,260 but it is still unclear whether intentional 
weight loss is just as hazardous.33, 36  
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Paper II:  Intake of carbohydrates and saturated fatty acids and risk of 
coronary heart disease in middle-age adults. The Hordaland Health 
Study (HUSK) 
In Paper II we report that a higher intake of carbohydrates and a lower intake of SFA 
was associated with higher risk of CHD.  
Praagman et al also reported a decreased risk of CHD with higher intake of 
SFA,131 while meta-analyses have concluded on no association between dietary SFA 
and risk of CHD.143-145 Overadjustment may have explained the lack of an 
association, since a number of the included studies adjusted the effect of SFA on 
CHD for intermediate factors.143, 261 In Paper II intermediate factors were only 
adjusted for in the supplementary analysis and did not materially influence the 
results. This may be explained by the fact that the intermediate factors were measured 
only once in HUSK, in a relatively young population. Few participants were taking 
medications for intermediate factors (0.5% for diabetes mellitus and 1.7% for 
hypercholesterolemia), and the median levels of both HDL cholesterol and 
triglycerides were within the recommended levels.262 Further, as in the study by 
Praagman et al,131 the intake ranges were small and there was a high mean intake 
level of SFA, while in the earliest cross-sectional studies that found a positive 
association between SFA intake and CHD, there were large variations in average 
SFA intake.138  
Since the effect estimate of SFA or carbohydrates in the energy-adjusted 
model has a substitution interpretation,86 the effect of either nutrient can be assessed 
only in relation to other nutrients.4 Therefore, although we provide some evidence 
that carbohydrates increase risk of CHD more than SFA, we cannot predict whether 
carbohydrates promote CHD or whether SFA prevent CHD independent of the 
substituting nutrient.4 The fact that the replacement nutrient for SFA is of importance 
in the relation between SFA and CHD, and that the fat-containing foods contain more 
than only SFA,263, 264 may explain why we found an inverse association between SFA 
and CHD.  
Replacement of SFAs with refined carbohydrates has shown to exacerbate 
atherogenic dyslipidemia.149 A change to carbohydrates may also influence other 
important biomarkers of CHD risk,70, 71, 115, 152 and with the current epidemics of 
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obesity,265 sugar-rich carbohydrate sources may be a larger threat with regard to CHD 
than SFA.70 The national guidelines on dietary habits to reduce risk of CHD 
emphasize that among people with a high level of blood glucose and triglycerides, a 
reduction in intake of sugar and refined carbohydrates is of largest importance in 
order to reduce risk of CHD.266 In our study, it is a weakness that it was not possible 
to separate between different kinds of carbohydrates as exposures.  
 When an association with CHD is found for SFA and carbohydrates, it would 
lend support to the nutrient findings if the major food sources of these nutrients are 
also related to risk of CHD.224 Only SFA from cheese associated with decreased risk 
of CHD, and we found no clear associations between sources of carbohydrates and 
risk of CHD. However, the evaluation of each source of carbohydrates separately 
does not control for intake of other sources of carbohydrates nor intake of total 
carbohydrates.  
 Even though no single source of carbohydrates was associated with CHD when 
evaluated separately, we found that the higher intake quartiles contained more sugar-
rich sources than the lower intake quartiles. The g/day per 1,000 kcal provides an 
indication of dietary habit differences by quartiles. Comparing the lowest to the 
highest quartile of carbohydrate intake, the intake of bread was 77 vs. 98 g/day/1,000 
kcal, respectively, while vegetables and fiber intakes were comparable. 
Corresponding results for sugar drinks/soft drinks were 18 vs. 34 g/day per 1,000 
kcal, and juice 12 vs. 23 g/day per 1,000 kcal, respectively. This and other items 
suggest that a higher carbohydrate intake reflects greater intake of low fiber 
carbohydrates and a relatively higher intake of sucrose/fructose carbohydrate sources. 
The latter finding may further partly explain both the positive association between 
carbohydrates and CHD, and also the negative association between intake of SFA and 
CHD. Further, when food sources of carbohydrates in European adults in the 1990s 
were evaluated, the highest percentage of sugar sweetened beverage consumption 
was seen among women in the North and West of Norway.101  
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Table 5. Number of participants in the different carbohydrate and saturated fatty 
acids intake quartiles 
Carbohydrate  Saturated fatty acids  
Quartile 1 Quartile 2 Quartile 3 Quartile 4 
Quartile 1 40 98 208 403 
Quartile 2 74 186 252 237 
Quartile 3 168 270 216 94 
Quartile 4 467 195 72 15 
 
Table 5 illustrates that those with the highest intake of carbohydrates were 
mainly those with the lowest intake of SFA and vice versa. As expected, based on 
this assumption, substitution analysis found that substitutions of carbohydrates with 
both total fat and SFA were associated with decreased risk of CHD, although not 
significant for SFA. Substitution analyses function best when ranges of intakes 
between the nutrients evaluated are reasonably comparable,231 which may explain the 
weaker association for SFA. Substitution models gives a better insight into the health 
implication of changing a diet compared with models that assume a change also in 
energy intake or are unspecific regarding the replacement of the dietary exposure.230 
 
In previous studies, 131, 132 residual confounding due to underestimated TFA 
intakes may be present.267Also in our study, we were unable to measure intake of 
TFA, and margarine was an important contributor to both TFA and unsaturated fat at 
the time just before HUSK baseline.268 We therefore could not reliably include 
unsaturated fat in the analyses, which is a limitation of the study.  
Paper II contributes to an already comprehensive research field. However, it 
contains a comprehensive discussion of the importance of the interplay between SFA 
and carbohydrates and also of the sources of the macronutrients when evaluating the 
association between SFA and carbohydrates with CHD.     
Paper III: Dietary vitamin K and risk of coronary heart disease in the 
prospective Hordaland Health Study 
In Paper III we found dietary K2 to be associated with reduced risk of CHD, while 
we found no association between dietary K1 and risk of CHD, in accordance with 
two previous cohort studies.187, 190 In contrast, two studies found K1 to be associated 
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with risk of CHD or CVD mortality.188, 191 However, K1 intake is an indicator of a 
healthy diet, and it may be difficult to disentangle the effect of K1 from a generally 
healthy lifestyle on CHD outcomes.194 Similarly, K2 correlates with intake of other 
food products also associated with reduced risk of CHD, as for instance cheese and 
yoghurt.165, 269, 270 The relatively weak association for K2 may partly be explained by 
the narrow difference in K2 intake between the highest and lowest categories of 
intake, as the potential protective influence of such differences is uncertain.248  
Unfortunately, intake of vitamin K was not validated in the validation study of 
a similar FFQ, mentioned earlier. However, vitamin K2 are mainly consumed 
together with fat and the spearman correlation coefficient for intake of total fat 
estimated by the FFQ versus weighted food records was 0.46.210 (For comparison,  
when evaluating the validity of other vitamins in the same study, the spearman 
correlation coefficient ranged from 0.46 for vitamin E until 0.62 for vitamin A.210) A 
low validity of K1 assessment with FFQ is found in previous studies,248 and dietary 
K2 intake is especially difficult to assess since there are limited food composition 
data both for total K2 and for certain K2 subtypes.248  Further, studies have shown 
diverse content of vitamin K2 among similar food products but from various 
countries.271, 272 Also, when it comes to the analyses of vitamin K2, it is a weakness 
that we did not have data on specific types of vitamin K2.   
The study reported in Paper III is one of very few studies that has evaluated the 
association between dietary K1 and K2 with incident CHD and thus contributes to a 





In Paper I we report that a weight loss of 5% or above was associated with increased 
mortality in older individuals. Further, linear models revealed that both major weight 
gain and minor weight loss were associated with increased mortality in older people.  
 In Paper II we report that a higher intake of carbohydrates and a lower intake 
of SFA were associated with higher risk of CHD in middle-aged adults. Also, 
substituting carbohydrates with total fat was associated with decreased risk of 
incident CHD. When evaluating sources of SFA and carbohydrates, only SFA from 
cheese showed a clear association with decreased risk of incident CHD.  
In Paper III we report that in middle-aged adults, dietary K2 was associated 
with reduced risk of incident CHD, while there was no association between dietary 
K1 and risk of incident CHD.  
The thesis adds meaningfully to the literature in several ways and speaks to 









7. Future perspectives 
Based upon the results reported in Paper I, an early evaluation of weight loss in older 
individuals would be worthwhile in order to detect possible underlying causes and to 
identify opportunities for hindering further weight loss and it’s health consequences. 
The paper, however, could not thoroughly evaluate the association between weight 
loss and mortality in older overweight and obese individuals given the small number 
of overweight/obese participants and events in the study. Future studies should aim to 
evaluate study populations with sufficient sample size across a wide spectrum of BMI 
and weight changes as they relate to total mortality.  Furthermore, studies 
ascertaining whether weight change is voluntary or involuntary are needed. 
Results from Paper II demonstrate that the pattern of macronutrient intake and 
the specific sources of macronutrients are of importance when evaluating associations 
between single macronutrients and incident CHD. Dietary advice is complex and an 
overly zealous attempt to limit intake of one nutrient or macronutrient may 
inadvertently result in risks associated with the substituting source of calories. Our 
findings support the new direction in nutritional recommendations that focus on foods 
and dietary patterns rather than single nutrients. Additional studies on the association 
between whole food groups and hard endpoints such as CHD are needed to further 
develop dietary recommendations for CHD prevention.   
Based on results reported in Paper III we conclude that more research should 
be performed on the association of vitamin K1 and K2 with incident CHD. Future 
research on the content of vitamin K in food products and the metabolism of vitamin 
K would be valuable as it will contribute to improvements in nutritional assessments, 
cohort study design, and in the interpretation of results. Paper III and the current body 
of knowledge regarding K2 suggests that vitamin K status may become an important 
component of nutritional guidance.  However, greater research is needed. Carefully 
constructed dietary advice regarding diet composition and individual food 
consumption has the potential to be an inexpensive and safe intervention to improve 
vascular health.  
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8. Errata 
Paper I: Figure 1 should have been labeled Kaplan-Meier failure curves instead of Kaplan-Meier 
cumulative hazard curves.   
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Abstract
Objective: Limiting SFA intake may minimise the risk of CHD. However, such
reduction often leads to increased intake of carbohydrates. We aimed to evaluate
associations and the interplay of carbohydrate and SFA intake on CHD risk.
Design: Prospective cohort study.
Setting: We followed participants in the Hordaland Health Study, Norway from
1997–1999 through 2009. Information on carbohydrate and SFA intake was
obtained from a FFQ and analysed as continuous and categorical (quartiles) var-
iables. Multivariable Cox regression estimated hazard ratios (HR) and 95 % CI.
Theoretical substitution analyses modelled the substitution of carbohydrates with
other nutrients. CHD was defined as fatal or non-fatal CHD (ICD9 codes 410–414
and ICD10 codes I20–I25).
Participants: 2995 men and women, aged 46–49 years.
Results: Adjusting for age, sex, energy intake, physical activity and smoking, SFA
was associated with lower risk (HRQ4 v. Q1 0·44, 95 % CI 0·26, 0·76, Ptrend= 0·002).
For carbohydrates, the opposite pattern was observed (HRQ4 v. Q1 2·10, 95 % CI
1·22, 3·63, Ptrend= 0·003). SFA from cheese was associated with lower CHD risk
(HRQ4 v. Q1 0·44, 95 % CI 0·24, 0·83, Ptrend= 0·006), while there were no associa-
tions between SFA from other food items and CHD. A 5 E% substitution of carbo-
hydrates with total fat, but not SFA, was associated with lower CHD risk (HR 0·75,
95 % CI 0·62, 0·90).
Conclusions: Higher intake of predominantly high glycaemic carbohydrates and
lower intake of SFA, specifically lower intake from cheese, were associated with
higher CHD risk. Substituting carbohydrates with total fat, but not SFA, was asso-






According to Ancel Keys ‘diet-heart’ hypothesis, a habitu-
ally high intake of SFA may increase the risk of CHD due
to increases in serum total cholesterol (TC)(1,2). Mensink
& Katan(3) published a meta-analysis in 1992, including
twenty-seven controlled trials, concluding that the most
favourable lipoprotein profile for CHD was achieved if
SFA were replaced by unsaturated fatty acids, keeping
the intake of total fat unchanged.
The discovery of the additional pathways leading from
diet to CHD has made the ‘diet-heart’ hypothesis more
complex(4). Advice to reduce SFA as a means to prevent
CHDmay have, indirectly, increased the intake of carbohy-
drates(5,6). While carbohydrates have been considered a
basis of a healthy diet, with grain products at the base of
the Food Guide Pyramid(7), a diet rich in added sugars
and refined grains promotes visceral adiposity and reduces
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energy expenditure(8–10), raising concerns of the potential
for increased CHD risk. On the other hand, if dietary carbo-
hydrates are replaced by fat, the postprandial rise in blood
glucose and insulin decreases while glucagon secretion
increases, resulting in lower CHD risk(11–14). However,
among adults with obesity, Hall et al.(15) found that restric-
tion of dietary fat was associated with a slightly larger body
fat loss than restriction of dietary carbohydrates. Also of
twenty-nine diets with different macronutrient composi-
tions tested inmice, only high-fat diets led to overconsump-
tion and weight gain(16). A review indicated that greater
high glycaemic index carbohydrate intake was associated
with a higher risk of CVD compared with SFA intake(17).
Further, recent prospective studies and reviews as well
as meta-analyses have shown inconclusive associations
between self-reported intakes of either SFA or carbohy-
drates and fatal and non-fatal CHD(18–23).
Given the inconsistencies in the literature, the objective
of the current study was to evaluate the associations of
carbohydrate and SFA intakes with incident CHD in a sam-
ple of middle-age community-dwelling Norwegian adults,
where the intake of carbohydrates varied from 21 to
74 energy percentage (E%) with a median intake of 49 E%,
and where the intake of SFA varied from 4 to 25 E% with a
median intake of 13 E%.
Participants and methods
Study population
The current study is a prospective cohort study of partici-
pants in the community-based Hordaland Health Study
(HUSK) (https://husk-en.w.uib.no/). The recruitment was
based on a cohort from 1992 to 1993 (The Hordaland
Homocysteine Study). In 1997–1999, all living cohort mem-
bers born 1950–1951 and residing in the city of Bergen
or the neighbouring suburban municipalities were invited
to participate in HUSK. The baseline examinations for the
current study were conducted during 1997–1999 as a
collaboration between the National Health Screening
Service (now The Norwegian Institute of Public Health),
The University of Bergen and local health services.
The participation rate was 77 %. Participants underwent
a brief health examination and provided a non-fasting
blood sample. Information on lifestyle was collected
via self-administered questionnaires. A semi-quantitative
FFQwas completed by 87 % of the participants. A total of
3107 participants aged 46–49 years who answered the
FFQ were eligible to be included in the current study.
We excluded twenty-two men and five women who
reported prior CHD, and four men and nineteen women
due to missing information. Further, we excluded twenty-
seven men and thirty-five women who reported extreme
energy intakes (below the 1st percentile: <4707·8 kJ
for men and 2951·8 kJ for women; or above the 99th
percentile: >18907·9 kJ for men and >14944·0 kJ for
women). The final study population thus included 2995
participants.
Dietary assessment
Information on food intake was obtained at baseline
(1997–1999) using a 169-item past-year semi-quantitative
FFQ, a slightly modified version of a previously described
FFQ(24). The validity study of the previous version of the
FFQ in a younger population found that the Spearman cor-
relation coefficients between intake of SFA and carbohy-
drates estimated by the FFQ v. weighed food records
were 0·44 and 0·57, respectively(24). The FFQ was handed
out on the day of the health examination, filled out at home
and returned bymail to theHUSK project centre. It includes
frequency alternatives (fromonce amonth to several times/
d), the number of units eaten and portion sizes (e.g., slices,
glasses and spoons) to capture the habitual diet during the
past year. The information is presented as individual food
or beverage items, food groups and nutrients. Daily
nutrient intakes were computed from a database and soft-
ware system developed at the Department of Nutrition,
University of Oslo (KBS, version 3 . 2). The nutrient data-
base is primarily based on the official Norwegian food
composition table(25). During dietary data collection in
1997–1999, margarine was undergoing rapid composi-
tional changes where large amounts of trans-fatty acids,
an important contributor to unsaturated fat(5,26), were
being reduced due to legislation in Norway(26). Further,
prospectively, there were other changes to unsaturated
fat sources(5); thus, unsaturated fat was not evaluated
as a primary dietary exposure in the current study.
Measurements used as independent variables in the cur-
rent study are the total dietary amount of SFA and carbohy-
drates, as well as intake of SFA and carbohydrates from
different food items. All are expressed as E%.
Health examination and health habits
Baseline examinations included measurements of height,
weight, waist circumference, blood pressure and non-
fasting blood samples. After at least 2 min seated rest, sys-
tolic blood pressure and diastolic blood pressure were
measured three times (Dinamap 845 XT equipment
(Criticon)). Serum samples of TC, HDL-cholesterol, TAG
and glucose were analysed within 7 d at the Department
of Clinical Chemistry, Ullevål University Hospital, Oslo,
using enzymatic methods with reagents from Boehringer
Mannheim (Roche). The Friedewald equation was used
for the calculation of LDL-cholesterol. Information on edu-
cational level and medication use was self-reported.
Hypertension was considered present if the mean
of at least two consecutive measurements of systolic
blood pressure was ≥140 mmHg or diastolic blood
pressure ≥ 90 mmHg or if the use of medication for
hypertension was self-reported.
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Participants taking diabetes medications or reported
having been diagnosed with diabetes were defined as
having diabetes. Also, participants with a serum glucose
level >7 mmol/l who had not eaten a meal during the last
8 h, or with a glucose level >11·1 mmol/l and <8 h since
their last meal, were defined as having diabetes. Pre-diabetes
was defined as having glucose levels between 5·6 and
7 mmol/l at least 8 h after their last meal or between
7·8 and 11 mmol/l <8 h after their last meal.
Participants answered one question on past-year
vigorous physical activity resulting in sweating or shortness
of breath (none, <1, 1–2 or ≥3 h/week). This variable was
treated as a categorical variable with none as the reference.
Participants were classified as either non-smokers,
former smokers or current smokers with non-smokers
as the reference.
Outcome
The study endpoints were incident (first time) hospitalisa-
tion with CHD (ICD9 codes 410–414 and ICD10 codes
I20–I25) as primary or secondary diagnosis or death with
CHD as the underlying cause of death. Participants
were followed from baseline through 31 December 2009
for CHD events through the Cardiovascular Disease in
Norway project (CVDNOR, http://www.cvdnor.no)(27,28)
and The Cause of Death Registry. There were 107 non-fatal
and five fatal episodes. Follow-up time was calculated as
time from participation until CHD, death from other causes,
emigration or 31 December ·2009, whichever occurred
first.
Statistical analyses
Descriptive characteristics include numbers with percent-
ages and medians (25th, 75th percentiles) for categorical
and continuous variables, respectively. Spearman’s rank
correlation (rho, ρ) was used to evaluate correlations
between quartiles of carbohydrate intake and SFA intake
with baseline characteristics. In addition, Spearman corre-
lations of intake of carbohydrates with total fat and SFA
were evaluated. To evaluate linear trends in baseline char-
acteristics across quartiles of carbohydrate and SFA intakes
as percentage of total energy intake, we used ordinal
logistic regression for categorical outcome variables, logis-
tic regression for dichotomous outcome variables and lin-
ear regression for continuous outcome variables where
median intake as E% within each quartile group was used
as the independent variable in the analyses. Cox propor-
tional hazard models were used to calculate adjusted haz-
ard ratios (HR) with 95 % CI for CHD associated with
continuous and quartile intake of carbohydrates and SFA.
The included covariates were potential confounders asso-
ciated with the intake of carbohydrates and SFA and with
CHD, which also modified the association of either SFA
or carbohydrate with CHD when included in the
multivariable model. Two primary analyses are presented:
model 1 adjusted for age (continuous (years)), sex and total
energy intake (continuous (kcal/d)); model 2 additionally
adjusted for vigorous physical activity (none v. <1 h/week,
1–2 h/week or ≥3 h/week) with none as the reference and
smoking habits (non-smokers v. previous smokers and
non-smokers v. current smokers). The following additional
confounders were also evaluated, but inclusion of the var-
iables did not materially alter the associations of SFA or
carbohydrates with CHD: family history of myocardial infarc-
tion, educational level and alcohol intake (E%). Further,
carbohydrate analyses also evaluated consistency in results
after adjustment for energy-adjusted fibre from bread, fruit
and vegetables. SFA analyses were further adjusted for
energy-adjusted intake of cholesterol, PUFA and protein.
Supplementary analyses evaluated models adjusted
for age, sex and energy intake (model 1), with additional
adjustments for HDL-cholesterol, LDL-cholesterol, TAG,
glucose, systolic blood pressure, diastolic blood pressure
and BMI (model 2); with additional adjustments for
diabetes/prediabetes, hypertension, family history of myo-
cardial infarction, statins, oral hypoglycaemics (including
metformin) and insulin and anti-hypertensive medications
(model 3) and with additional adjustments for smoking,
physical activity, alcohol consumption in E% and educa-
tion (model 4) (see online supplementary material,
Supplemental Table S1). To test for linear trends across
intake quartiles, median intake as E% within each quar-
tile group was used as the independent variable. We also
evaluated SFA from cheese and SFA when excluding the
contribution from cheese for their associations with inci-
dent CHD. In additional supplementary analyses, we
stratified intake of SFA on smoking habits (see online
supplementary material, Supplemental Table S2) and
we also evaluated associations between carbohydrates
and SFA from other specific food groups and CHD risk
(see online supplementary material, Supplemental
Tables S3 and S4). Missing data were handled with list-
wise deletion.
The proportional hazard assumption was evaluated
using Schoenfeld’s test.
To evaluate the continuous association between expo-
sure and outcome, and assess potential non-linear associ-
ations, smoothed penalised splines were plotted(29).
We used theoretical substitution analyses to model the
substitution of carbohydrates with SFA(30). Variables for the
E% (per 5 E% unit increments) of all macronutrients except
carbohydrates (SFA, monounsaturated fat, PUFA, protein
and alcohol) were included in a Coxmodelwith adjustment
for total energy intake, age, sex, physical activity and smok-
ing habits. The HR for SFA is then interpreted as the change
in estimated risk for each 5 E% unit increase in SFA while
holding all other variables in the model constant but
allowing for concomitant decreases in carbohydrate intake
as all sources of macronutrients sum to 100 % of energy
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intake. The same approach was used to evaluate the theo-
retical substitution of carbohydrates with other macronu-
trients: total fat, protein and PUFA intake per 5 E%
unit increase in a model with other macronutrients except
carbohydrates(30).
Sensitivity analyseswere conductedwherewe excluded
the first 2 years of observation following the baseline
assessment in all of the above analyses.
Statistical analyses were performed using Stata version
15 (StataCorp LP) and R version 3.4.0 (https://www.r-
project.org/), The R Foundation for Statistical Computing.
P-values <0·05 were considered statistically significant.
Results
Characteristics of the study population
At baseline, mean age was 48 (SD 0·7) years, median BMI
was 24·9 (25th, 75th percentiles 22·8, 27·4) kg/m2, 33·5 %
smoked daily, 45·9 % reported at least 1 h vigorous physi-
cal activity per week and 25·3 % had indications of reduced
metabolic health defined as having hypertension, pre-
diabetes or diabetes. Intake of total fat ranged from 14 to
53 E% with a median intake of 33 E%. Intake of total carbo-
hydrates ranged from 21 to 74 E% with a median intake of
49 E%. Less than 1 and 6 % had an intake of carbohydrates
at or below 30 and 40 E%, respectively, while 3 and <1 %
had an intake of carbohydrates at or above 60 and 70 E%,
respectively. Intake of protein ranged from 6 to 30 E% with
a median intake of 16 E%, while intake of SFA ranged from
4 to 25 E%with amedian intake of 13 E%. Less than 1 % had
an intake of SFA at or below 6 E%, while 14 % had an intake
at or above 15 E%.
During a mean 10·8 (SD 1·3) years of follow-up, repre-
senting 32 449 person-years among 2995 participants
(1282men and 1713women), we documented 112 incident
CHD events. Due to missing values (2·1 % for smoking
habits and 3·8 % for physical activity), multivariable-
adjusted analyses included 2820 participants (1224 men
and 1596 women) and 105 CHD events. Sixty participants
died due to other causes during follow-up. When evaluat-
ing Spearman correlations between carbohydrate quartiles
and baseline characteristics, all correlations (ρ) were
between −0·2 and <0·1. However, evaluation of baseline
characteristics by quartiles of carbohydrate intake identi-
fied that the proportion of participants performing at least
1 h vigorous physical activity per week was higher in
higher quartiles, while the proportions of men, daily smok-
ers and participants with glucose intolerance were lower in
higher quartiles (Table 1). Also, waist circumference, serum
levels of TC, LDL-cholesterol and HDL-cholesterol were
lower in higher carbohydrate quartile groups. Intakes of
total fat, protein and alcohol were lower with higher
quartiles of carbohydrate intake. Bread was the major con-
tributor to carbohydrates in this population. While intake
(g/d per 1000 kcal) of bread, sweetened beverages, juice,
and fruit and berries (both fresh and canned/preserved)
was higher with higher quartiles of carbohydrate intake,
there were less noticeable differences for other carbohy-
drate sources across quartiles. Vegetable and fibre intakes
(g/d per 1000 kcal), for example, were similar in the various
carbohydrate intake quartiles (Table 1).
When evaluating Spearman correlations between SFA
quartiles and the baseline characteristics, all rhos (ρ) were
between –0·1 and <0·1. However, the percentage daily
smokers were higher with higher quartiles of SFA intake,
while the percentage of participants who were men,
performed at least 1 h vigorous physical activity per week
or had hypertension was lower with higher quartiles
(Table 2). Also, BMI, waist circumference and TAG levels,
as well as the percentage taking medications for hypercho-
lesterolaemia, were lower with higher SFA quartiles. While
intake of cheese was higher with higher quartiles of SFA
intake, there were less noticeable differences for other
SFA sources across quartiles. Family history of myocardial
infarction did not differ between quartiles of carbohydrate
(Ptrend 0·95) or SFA (Ptrend 0·23) intake as percentage of total
energy.
Associations between intake of carbohydrates and
SFA and incident CHD
Higher intake of carbohydrates was borderline significantly
associated with higher risk of CHD in model 1 (adjusted for
age, sex and energy intake) (HRQ(quartile)4 v. Q1 1·63, 95 % CI
0·96, 2·76, Ptrend= 0·056) (Table 3). This association
became stronger and significant after further adjustment
for smoking habits and physical activity (model 2)
(HRQ4 v. Q1 2·10, 95 % CI 1·22, 3·63, Ptrend = 0·003).
Also, continuous analyses (per 2 E%) showed signifi-
cantly higher risk of CHD with higher intake of carbohy-
drates (HR 1·12, 95 % CI 1·05, 1·20), after adjusting for
age, sex, energy intake, smoking habits and physical
activity. Further adjustments for intermediate factors,
relevant medications and potential confounders did
not materially influence the association (see online sup-
plementary material, Supplemental Table S1).
Plotting the data adjusting for model 2 covariates indi-
cated a linear relationship (Fig. 1(a)).
When examining the association between carbohy-
drates from various food items, we found no associations
with risk of CHD (see online supplementary material,
Supplemental Table S3).
A high intake of SFA was significantly associated with
lower risk of CHD in the model adjusted for age, sex and
energy intake (model 1) (HRQ4 v. Q1 0·53, 95 % CI 0·32,
0·90, Ptrend= 0·013) (Table 3). This association became
stronger after further adjustment for smoking habits and
physical activity (model 2) (HRQ4 v. Q1 0·44, 95 % CI
0·26, 0·76, Ptrend= 0·002). Also, continuous analyses (per
2 E%) showed significantly lower risk of CHD with higher
intake of SFA (HR 0·78, 95 % CI 0·66, 0·92), after adjusting
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for age, sex, energy intake, smoking habits and physical
activity. Further adjustments for intermediate factors,
relevant medications and potential confounders did not
materially influence the association (see online supple-
mentary material, Supplemental Table S1).
Figure 1(b) illustrates lower risk of CHD with a higher
intake of SFA until an intake of about 13 E%, after which
the curve levelled off, after adjustment for model 2
variables.
When stratifying on smoking habits, there was a ten-
dency of lower risk of CHD with higher intake of SFA in
all groups, but less so among current smokers (see online
supplementary material, Supplemental Table S2).
When examining the association between SFA from
various food items, we found that only SFA from cheese
was significantly associated with a lower risk of CHD
(Table 3). The median intake of SFA from cheese ranged
from 0·5 E% (Q1) to 4·1 E% (Q4). After adjustments for
age, sex, energy intake, physical activity and smoking hab-
its (model 2), SFA from cheese was significantly associated
with lower risk of CHD in the quartile analyses (HRQ4 v. Q1
0·44, 95 % CI 0·24, 0·83, Ptrend= 0·006). Results from the
evaluation of SFA from cheese as a continuous variable
(per 1 E%) were similar.
We further evaluated the association between SFA and
CHD after excluding the SFA contribution from cheese, and
in the quartile analyses, we found that intake of SFA after
exclusion of cheese was associated with lower risk of
CHD (HRQ4 v. Q1 0·58, 95 % CI 0·34, 0·98, Ptrend= 0·030),
after adjustment for age, sex, energy intake, physical activity
and smoking habits (model 2, Table 3). Results from the con-
tinuous analyses were in the same direction as the quartile
analyses. Upon further evaluation (Fig. 1(c)), we observed
deviations from linearity in the association between SFA
intake and CHD risk after excluding SFA from cheese.
Higher intake of total carbohydrates correlated signifi-
cantly with lower intake of SFA (ρ = −0·6, P< 0·001) and
lower intake of total fat (ρ = −0·8, P< 0·001). Results from
the theoretical substitution analyses are shown in Fig. 2.
Substitution of 5 % of total energy intake from carbohy-
drates with SFA was associated with a 26 % lower risk of
CHD (model 2 HR 0·74, 95 % CI 0·40, 1·36), although not
statistically significant. A substitution of carbohydrates with
total fat was also associated with lower risk of CHD (model
2 HR 0·75, 95 % CI 0·62, 0·90). To further evaluate whether
substitution analyses of carbohydrates with SFA or with
total fat could be attributed to an underlying beneficial
effect of PUFA, we evaluated results of analyses substitut-
ing carbohydrates with PUFA in which we found a non-
significant association with incident CHD (model 2 HR
1·42, 95 % CI 0·82, 2·47). Further, the substitution of carbo-
hydrates with protein was not associated with the risk of
CHD (model 2 HR 1·09, 95 %CI 0·71, 1·68). When adjusting
for age, sex and energy intake only, results of all substitu-
tion models were in the same direction as in the fully
adjusted model, but were non-significant.
Exclusion of events occurring during the first 2 years of
follow-up yielded no material differences in results.
Discussion
In this community-based study population, high intake of
carbohydrates and low intake of SFA were associated with
higher risk of incident CHD. Intake of SFA from cheese was
significantly associated with lower CHD risk. When evalu-
ating SFA intake after excluding the contribution of SFA
from cheese, the association becameweaker, but remained
significant. Substituting 5 % of total energy intake from car-
bohydrateswith SFA and total fat was associatedwith lower
CHD risk (HR of 0·74 and 0·75, respectively), but was sta-
tistically significant only for total fat. The lack of a sta-
tistically significant finding for SFA may reflect, in part,
the narrower range of SFA intake compared with total fat
and carbohydrate intake.
Carbohydrates reflect a variety of sources including
sucrose, fructose and refined cereals, as well as fibre-rich
whole grains, vegetables and legumes. Refined carbohydrates
and added sugar accounted for a large part of carbohydrate
intake in the Norwegian diet at the time of HUSK baseline
in 1997–1999(5). Even today, few Norwegians comply with
the Nordic nutrition recommendations for fibre intake(31,32).
Per capita sales data indicate that intake of sugar-containing
foods and beverages peaked at the end of the 1990s(5). In
addition, a nationwide diet survey among men and women
16–79 years of age (1997–1999) found that their diet con-
tained inadequate amounts of food products rich in fibre
and that the intake of added sugar was 10 and 9 E% among
men and women, respectively(33). When evaluating baseline
characteristics in this cohort, the intake of fruit and berries,
sugar-sweetened beverages and juice doubled from the low-
est to the highest quartile of carbohydrate intake. In contrast,
intake of rice, pasta, flour and cereals was only modestly
higher and vegetable intake did not differ across quartiles
of total carbohydrate intake. Also,while recommended intake
of fibre is ≥25 g/d in women and ≥35 g/d in men(31), the
median intake of fibre in the total study population was
24 g/d and the median fibre intake in the highest quartile
of carbohydrate intake was 26 g/d. However, FFQ are
affected by systematic errors and do not precisely estimate
dietary intake; therefore, these data should be interpreted
with caution.
Previous cohort studies and meta-analyses have shown
diverse results regarding the association between intake of
carbohydrates and CHD when evaluating total carbohy-
drates. A study of men and women 30–59 years of age
found that carbohydrate intake was associatedwith a lower
CHDmortality risk (RR 0·96, 95 % CI 0·94, 0·99)(34). However,
a large cohort study of individuals aged 35–70 years found
that higher carbohydrate intake was not associated with
the risk of CVD (HR 1·01, 95 % CI 0·88, 1·15) or myocardial
infarction (HR 0·90, 95 % CI 0·73, 1·10)(23). Carbohydrate
intake was not consistently associated with CHD when
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different sources of carbohydrates were considered sepa-
rately. Li et al.(35) found in a cohort study that higher intake
of carbohydrates from whole grains was associated with
lower risk of incident CHD (HR 0·90, 95 % CI 0·83, 0·98),
while carbohydrates from refined starches/added sugars
were positively associated with higher risk of CHD
(HR 1·10, 95 % CI 1·00, 1·21).
Fung et al.(36) studied the association between con-
sumption of sugar-sweetened beverages and the risk of
CHD in the Nurses’ Health Study and found that regular
consumption of sugar-sweetened beverages was associ-
ated with a higher CHD risk. In addition, a meta-analysis
of cohort studies reported that intake of sugar-sweetened
beverages was associated with increased risk of myocardial
Table 3 Associations between macronutrients and risk of incident CHD, The Hordaland Health Study. Mean follow-up time 10·8 years
Intake of macronutrients (range in E%)* n
CHD Model 1† Model 2‡
n % HR 95 % CI HR 95 % CI
Carbohydrates 2995 112
Q1 (21, 45) 749 23 3·1 1 (ref) 1 (ref)
Q2 (45, 49) 749 25 3·3 1·11 0·63, 1·96 1·09 0·60, 1·98
Q3 (49, 53) 748 29 3·9 1·30 0·75, 2·24 1·67 0·96, 2·89
Q4 (53, 74) 749 35 4·7 1·63 0·96, 2·76 2·10 1·22, 3·63
Ptrend§ 0·056 0·003
Continuous (per 2 E%) 2995 112 1·08 1·01, 1·15 1·12 1·05, 1·20
Saturated fat 2995 112
Q1 (4, 11) 749 44 5·9 1 (ref) 1 (ref)
Q2 (11, 13) 749 24 3·2 0·55 0·34, 0·91 0·46 0·27, 0·78
Q3 (13, 14) 748 23 3·1 0·55 0·33, 0·92 0·47 0·28, 0·79
Q4 (14, 25) 749 21 2·8 0·53 0·32, 0·90 0·44 0·26, 0·76
Ptrend§ 0·013 0·002
Continuous (per 2 E%) 2995 112 0·82 0·70, 0·97 0·78 0·66, 0·92
Saturated fat from cheese 2995 112
Q1 (0, 1) 749 45 6·0 1 (ref) 1 (ref)
Q2 (1, 2) 748 28 3·7 0·68 0·43, 1·10 0·78 0·49, 1·27
Q3 (2, 3) 749 25 3·3 0·64 0·39, 1·04 0·60 0·35, 1·03
Q4 (3, 18) 749 14 1·9 0·38 0·21, 0·70 0·44 0·24, 0·83
Ptrend§ 0·002 0·006
Continuous (per 1 E%) 2995 112 0·84 0·74, 0·97 0·87 0·75, 0·99
Saturated fat after excluding saturated fat from cheese 2995 112
Q1 (3, 9) 748 34 4·6 1 (ref) 1 (ref)
Q2 (9, 10) 750 29 3·9 0·85 0·51, 1·39 0·71 0·42, 1·20
Q3 (10, 12) 748 20 2·7 0·56 0·32, 0·98 0·46 0·26, 0·81
Q4 (12, 21) 749 29 3·9 0·81 0·49, 1·34 0·58 0·34, 0·98
Ptrend§ 0·277 0·030
Continuous (per 2 E%) 2995 112 0·94 0·79, 1·12 0·85 0·71, 1·02
E%, energy percentage; CHD, incident CHD; n, number of participants; HR, hazard ratio; Q, quartile.
*Minimum and maximum intake of the macronutrient.
†Cox proportional hazard regression analysis adjusted for age, sex and energy intake.
‡Adjusted in addition for physical activity and smoking habits.
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Fig. 1 Cox proportional hazards regression with penalized splines, The Hordaland Health Study. Distribution of partial hazard (black
line) with 95%CI (shadow) for CHD across the distribution of a) intake of carbohydrates in E%, b) intake of saturated fatty acids (SFA)
in E% and c) intake of SFA after excluding contribution from cheese in E%. The model includes age, sex, energy intake, physical
activity and smoking habits. Intake above the 5thth percentile and below the 95th percentile is included in the figure
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infarction(37). In randomised controlled trials, dietary sugar
intake has been found to increase blood pressure and
serum TAG, TC and LDL-cholesterol(38). While we did
not identify any one particular source of carbohydrates
to contribute to the overall carbohydrate association with
CHD,we did note differences in the quality of carbohydrate
sources between low to high carbohydrate intake quar-
tiles where intake of fibre, vegetables and many carbo-
hydrate sources remained essentially stable, while
bread, sugar-sweetened beverages, juice, and preserved
and fresh fruit and berries increased across the quartiles of
carbohydrate intake. Thereby indicating that increased
carbohydrate intake in the current study population rep-
resented increases in low-fibre and higher sucrose/fruc-
tose carbohydrates.
SFA intake in our study population came primarily from
dairy products, especially cheese. The intake of cheese
more than doubled from the lowest to the highest quartile
of SFA intake, and cheese was also the main contributor to
SFA intake in the highest quartile. As dairy products are
important contributors of SFA, the general recommenda-
tion in Norway has been to reduce the intake of high-fat
dairy products(39). However, studies do not consistently
support that this recommendation would reduce risk of
CHD(40–42). A systematic review and meta-analysis did
not report a statistically significant association between
total dairy intake and CHD (Summary RR 0·91, 95 % CI
0·80, 1·04)(41). Further, the only dairy product significantly
associated with lower CHD risk was cheese (Summary RR
0·82, 95 % CI 0·72, 0·93)(41). In addition, Qin et al.(42)
reported no association between dairy intake and CHD
(RR 0·94, 95 % CI 0·82, 1·07), and CHD risk was lowered
by cheese consumption also in this study (RR 0·84, 95 %
CI 0·71, 1·00).
We found that intake of SFA from cheese was the only
food source associated with a lower risk of CHD. Under-
lying mechanisms for a potential CHD protective effect
of cheese may relate to (i) fermentation which may influ-
ence dairy fat’s contribution to LDL-cholesterol(43) and
(ii) menaquinones (vitamin K2) which comes primarily
from cheese in European diets(44). Geleijnse et al.(45) found
that menaquinone intake was inversely associated with
serum TC and aortic calcification and positively associated
with serum HDL-cholesterol. Menaquinones transported
together with SFA may, therefore, be associated with lower
CHD risk. Also, as most cheeses are not homogenised, they
still contain milk fat globule membranes. Rosqvist et al.(46)
reported that intake of milk fat enclosed by milk fat globule
membranes did not impair the lipoprotein profile when
compared with butter oil. When evaluating the association
between SFA and CHD after excluding the contribution
from cheese, intake of SFA was still associated with lower
risk of CHD. The penalised spline illustrates almost the
same pattern as for total SFA, but with a tendency of higher
risk at higher intakes.
A systematic review and meta-analysis found that when
comparing the highest v. lowest intake of SFA, there was
no association observed between SFA intake and CHD
0
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Fig. 2 Theoretical substitution analyses, illustrating an isocaloric substitution of 5E% from carbohydrates with total fat, saturated fatty
acids (SFA), polyunsaturated fatty acids (PUFA) or protein and its association with CHD. Adjusted for age, sex, energy intake, physi-
cal activity and smoking habits. Mean 10·8 years follow-up of the Hordaland Health Study participants
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(RR 1·03, 95 % CI 0·98, 1·07)(18). Another meta-analysis of
cohort studies found that the highest v. lowest quintile
intake of SFA had a weak association with the risk of
CHD (RR 1·06, 95 % CI 0·95, 1·17)(19). However, the quality
of the documentation was regarded as very low, and in an
analysis not adjusted for cardiovascular risk factors such as
serum cholesterol, there was a significantly higher risk of
CHD mortality comparing the highest v. lowest intake of
SFA (RR 1·20, 95 % CI 1·02, 1·41)(19).
Our results differ from these meta-analyses and likely
reflect that, in the current study population, cheese was
the predominant contributor to SFA, there was a narrow
range of median SFA intake in the four quartiles, and there
was an inverse association between SFA and carbohydrate
intake.
Theoretical substitution analyses
Analysing the effect of one nutrient when considering the
nutrients it substitutes provides another means of under-
standing the observed associations(30). Another study sug-
gested that reducing the intake of carbohydrates from
refined grains and added sugars may produce beneficial
metabolic effects that may decrease the risk of CHD(22).
Jakobsen et al.(21) showed that when substituting 5 E%
from SFA by carbohydrates, there was no association with
fatal CHD (RR 0·96, 95 % CI 0·82, 1·13), but a statistically
significant increase in the overall CHD risk (RR 1·07,
95 % CI 1·01, 1·14). When separately evaluating carbohy-
drates with high and low glycaemic index, only a substitu-
tion of SFA with high glycaemic index carbohydrates was
associated with a higher risk of myocardial infarction
(HR 1·33, 95 % CI 1·08, 1·64)(22). Chen et al.(47) evaluated
the association between dairy fat and CHD in US adults
and found no significant benefit of replacing dairy fat with
the same energy intake from refined starch and added
sugar. However, the substitution of 5 % of energy from
dairy fat by carbohydrates from whole grains was associ-
ated with a significantly lower risk of CHD (RR 0·66,
95 % CI 0·62, 0·70).
The tendency for a lower risk of CHD when replacing
carbohydrates with total fat and SFA may reflect a combi-
nation of the beneficial association observed between
cheese consumption and CHD as well as the deleterious
association between low-fibre carbohydrate intake and
CHD. Total fat and SFA intake in the context of high-cheese
consumption may not be generalisable to total fat and SFA
intake in a low-cheese consumption context.
Strengths and limitations
Strengths of our study include a community-based sample
of men and women with a relatively long follow-up time.
Only sixty participants died due to other reasons until
2009; therefore, there was minimal competing risk from
other causes of death. Linkage to the CVDNOR project
database assured as good as complete follow-up. Also,
we had information on health status,medication use, health
habits and history of CHD at baseline, enabling us to evalu-
ate incident CHD. Further, the FFQ captured the major
sources of carbohydrates and SFA expected in the current
study population, and energy adjustment of the statistical
models is a well-established approach for reducing the bias
related to self-reported dietary data.
Theoretical substitution analyses were performed, mod-
elling the substitution of carbohydrates with PUFA, SFA,
protein and total fat. Another strength is the robustness
of the results which were similar frommodel to model after
various adjustments.
Limitations include the relatively small number of
participants and events limiting stratified analyses and
multivariable adjustments.
Another limitation is the lack of information on possible
changes over time in diet, medications and other risk fac-
tors. Both dietary habits and food products have changed
during the study period, due to the recommendations on
reducing intake of SFA as the source of fat and increasing
intake of whole grains as the source of carbohydrates(31,48).
Intake of cooking oil has tripled from the late 1990s to about
2013, and the consumption of vegetables also increased,
while intake of margarine and sugar-containing food
decreased according to per capita sales data(5).
Blood samples were non-fasting. Since postprandial
TAG remain elevated for several hours, and the
Friedewald equation, used for the calculation of LDL-
cholesterol, assumes fasting TAG values, LDL-cholesterol
may be underestimated(49). Also, most reference values for
serum lipids and glucose are established on fasting blood
specimen.
Further, a common problem with FFQ is systematic
under- or overreporting of nutrient and energy intake, limit-
ing the estimation of absolute intake. However, the FFQ is
well suited to rank participants by dietary intake for evalu-
ation of associations with health endpoints(50). Given that
FFQ are not optimal for determining absolute nutrient
intake, caution is required in the interpretation of the theo-
retical substitution models(51).
There may also be other limitations. A large proportion
(75 %) of the participants reported zero intake of butter,
likely reflecting underreporting. Also, we did not have
extensive information on carbohydrate quality particularly
for bread due to lack of historical food recipes, lack of
food label details and type of carbohydrate content for
the recipes from the dietary database at the end of
the 1990s.
Nevertheless, whenwe adjusted for estimated fibre from
bread, vegetables and fruit intake, total carbohydrate intake
remained a statistically significant predictor of higher CHD
risk. Another limitation of the current study is that the
results cannot be generalisable to populations with a
greater range in carbohydrate or SFA intake. In the current
study, the intake of SFA varied from 4 to 25 E% and the
intake of carbohydrates varied from 21 to 74 E% resulting
12 TR Haugsgjerd et al.
in a narrower range of intake when we evaluated the
median intake between the lowest and highest quartiles
(i.e., 10–15 E% for SFA and 43–56 E% for carbohydrates),
precluding our ability to generalise to lower and higher
intake values. The current study can therefore not be com-
pared with previous studies that have shown higher all-
cause and cause-specific mortality associated with much
lower carbohydrate intakes than our study population(52,53).
Finally, the available data were not appropriate for studying
unsaturated fat, given the changing trans-fatty acid compo-
sition of unsaturated fat during the study period.
While reverse causation is a general concern in observa-
tional studies of dietary habits and disease outcomes, we
noted a similar percentage of participants with a family
history of CHD and similar baseline BMI values across
quartiles of carbohydrate and SFA intake. Further, adjusting
for family history of CHD andBMI did not alter our findings.
Although we performed multivariable analyses, residual
confounding may still be present.
Lastly, it is of note that at the end of follow-up, partici-
pants’ age was generally lower than the mean age of acute
myocardial infarction in Norway which is 73·8 years for
men and 79·1 years for women(54). Thus, our findings may
reflect mechanisms involved in early-onset CHD and may
not necessarily be generalisable to older populations.
Conclusion
The focus of the current study was to evaluate the impor-
tance of the interplay between SFA and total carbohydrates,
including SFA sources, when evaluating the association
between SFA and CHD. A high intake of carbohydrates,
reflecting low-fibre and relatively higher sucrose/fructose
dietary sources, and a low intake of SFAwere associated with
higher CHD risk in the current study population. Substituting
carbohydrates with total fat was associated with lower risk.
Also, SFA from cheesewas associatedwith lower risk of CHD.
Further research evaluating potential benefits of dairy
products and their nutritional constituents is warranted.
Also, there is a need to clarify the relative health trade-offs
between replacing carbohydrate intake with fat intake in
study populations with diverse dietary habits and a wider
range in carbohydrate and SFA intakes. In addition, results
of our study suggest that dietary guidelines development
and their communication to the public, especially regard-
ing reductions in certain foods and nutrients, need to con-
sider the potential health impact of alternative sources of
energy.
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ABSTRACT
Objective The role of vitamin K in the regulation of 
vascular calcification is established. However, the 
association of dietary vitamins K1 and K2 with risk of 
coronary heart disease (CHD) is inconclusive.
Design Prospective cohort study.
Setting We followed participants in the community- based 
Hordaland Health Study from 1997 - 1999 through 2009 
to evaluate associations between intake of vitamin K and 
incident (new onset) CHD. Baseline diet was assessed by 
a past- year food frequency questionnaire. Energy- adjusted 
residuals of vitamin K1 and vitamin K2 intakes were 
categorised into quartiles.
Participants 2987 Norwegian men and women, age 
46–49 years.
Methods Information on incident CHD events was 
obtained from the nationwide Cardiovascular Disease in 
Norway (CVDNOR) Project. Multivariable Cox regression 
estimated HRs and 95% CIs with test for linear trends 
across quartiles. Analyses were adjusted for age, sex, total 
energy intake, physical activity, smoking and education. A 
third model further adjusted K1 intake for energy- adjusted 
fibre and folate, while K2 intake was adjusted for energy- 
adjusted saturated fatty acids and calcium.
Results During a median follow- up time of 11 years, 
we documented 112 incident CHD cases. In the adjusted 
analyses, there was no association between intake of 
vitamin K1 and CHD (HRQ4vsQ1 = 0.92 (95% CI 0.54 to 
1.57), p for trend 0.64), while there was a lower risk of 
CHD associated with higher intake of energy- adjusted 
vitamin K2 (HRQ4vsQ1 = 0.52 (0.29 to 0.94), p for trend 
0.03). Further adjustment for potential dietary confounders 
did not materially change the association for K1, while the 
association for K2 was slightly attenuated (HRQ4vsQ1 = 0.58 
(0.28 to 1.19)).
Conclusions A higher intake of vitamin K2 was 
associated with lower risk of CHD, while there was no 
association between intake of vitamin K1 and CHD.
Trial registration number NCT03013725
INTRODUCTION
Vitamin K is a fat- soluble vitamin including 
vitamin K1 (K1; phylloquinone) from green 
leafy vegetables and vegetable oils as the 
main dietary sources, and vitamin K2 (K2; 
menaquinones) from dairy products, meat 
and egg yolk as the main dietary sources in 
Europe.1–3 K2 has a longer half- life in the 
circulation than K1.4 Both are absorbed 
from the small ileum and jejunum. K1 and 
K2 are incorporated into chylomicrons and 
delivered to the liver. K2 is also transported 
via low- density lipoprotein and high- density 
lipoprotein (HDL) particles to extrahepatic 
tissue.4 5
Vitamin K functions as a cofactor for the 
enzyme gamma- glutamyl carboxylase which 
converts protein- bound glutamate residues 
into gammacarboxyglutamate (Gla).6 7 Gla- 
containing proteins are involved in, for 
example, the coagulation of blood,8 inhi-
bition of arterial calcification (Matrix Gla 
Protein) and vascular smooth muscle cell 
apoptosis and movement that is considered 
protective against vascular injury (Gas-6).9 
Matrix Gla Protein is involved in both medial 
and intimal calcification, and low vitamin K 
status has been associated with both types 
of calcification.10–14 In addition, a study that 
examined the effect of warfarin (a vitamin 
K antagonist) on medial and intimal plaque 
Strengths and limitations of this study
 Ź The study had a long follow- up time with minimal 
competing risk from other causes of death.
 Ź Linkage to a nationwide database assured complete 
cohort follow- up.
 Ź We had information on history of coronary heart dis-
ease (CHD) at baseline which enabled us to evaluate 
incident (new onset) CHD.
 Ź The Food Frequency Questionnaire was not validat-
ed for intake of vitamin K.
 Ź It was not possible to differentiate the various sub-
types of vitamin K2.
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calcification in apoE−/− mice concluded that warfarin 
accelerates both medial and intimal calcification of 
atherosclerotic plaque.15 Patients with both medial and 
intimal calcification have a higher cardiovascular risk 
when compared with similar patients without calcifi-
cation.16 17 Therefore, an inverse association between 
vitamin K intake and coronary heart disease (CHD) 
could be expected. Results from observational studies 
on the association between intake of vitamin K and CHD 
are inconsistent.18–24 Among the identified studies, three 
found reduced risk of CHD in multivariable adjusted 
analyses at higher dietary K219 20 or K1.24
Nordic Nutrition Recommendations include a provi-
sional recommended intake of vitamin K of 1 µg/kg body 
weight per day,3 while adequate intake is 90 µg/day for 
women and 120 µg/day for men.25 However, these recom-
mendations may not be sufficient to attain complete 
carboxylation of extrahepatic vitamin K- dependent 
proteins.26 27
Given the limited number of epidemiological 
studies,18–24 and the fact that dietary vitamin K sources and 
content differ between countries,28–31 further research is 
warranted. The purpose of the current study was to eval-
uate the association between intake of both K1 and K2 
and subsequent CHD events among community- living 
middle- age adults in Norway.
SUBJECTS AND METHODS
Study population
The current study is a prospective, community- based 
cohort study of participants living in Hordaland County, 
Norway (known as The Hordaland Health Study (HUSK); 
https:// husk. w. uib. no/). The recruitment was based on a 
cohort from 1992 - 1993 (The Hordaland Homocysteine 
Study), where eligible subjects (Hordaland County resi-
dents born 1950–1951) were identified from the National 
Population Register on 31 December 1992.32 33 In 1997–
1999, all living Homocysteine Study cohort members 
born 1950–1951 and residing in the city of Bergen or 
the neighbouring suburban municipalities were invited 
to participate in HUSK. The baseline examinations were 
conducted during 1997–1999 as a collaboration between 
the National Health Screening Service (now The Norwe-
gian Institute of Public Health), The University of Bergen 
and local health services. Participation rate was 77%. 
Participants underwent a brief health examination and 
provided a non- fasting blood sample. Information on life-
style was collected via self- administered questionnaires. A 
semiquantitative Food Frequency Questionnaire (FFQ) 
was completed by 87% of the participants yielding 3107 
men and women age 47–49 years eligible for the current 
study.
We excluded from the analyses 27 men and 35 
women who reported extreme energy intakes (below 
the first percentile: <1125 kcal for men and <705 kcal 
for women; or above the 99th percentile: >4519 kcal for 
men and >3571 kcal for women). Further, we excluded 
27 participants (22 men and 5 women) who had prior 
CHD based on self- reported information and/or prior 
CHD hospitalisations during 1994–1999. Additionally, 
those with missing information on self- reported myocar-
dial infarction from the Homocysteine Study (1992–
1993; 4 men and 19 women) were excluded. Further, we 
excluded two participants (one man and one woman) 
who reported use of warfarin and six participants (two 
men and four women) with missing measurement on 
dietary vitamin K intake. The final study population thus 
included 1279 men and 1708 women.
Patient and public involvement
Participants were not involved in designing the research 
question, conducting the study, or in the interpretation, 
or writing of the results. There are no plans to involve 
participants or relevant patient communities in dissemi-
nation of results. Results are disseminated to study partic-
ipants via website (https:// husk. w. uib. no).
Dietary assessment
Information on food intake was obtained at baseline 
(1997–1999) using a slightly modified version of a previ-
ously described34 past- year 169- item semiquantitative 
FFQ. The FFQ was handed out on the health examination 
day, filled out at home and returned by mail to the HUSK 
project centre. The questionnaire included frequency 
alternatives (from once a month to several times per day), 
the number of units consumed and portion sizes (eg, 
slices, glasses, spoons) to capture the habitual diet during 
the past year. The dietary information presented includes 
individual food or beverage items, food groups and 
nutrient intakes. Daily nutrient intakes were computed 
from a database and software system developed at the 
Department of Nutrition, University of Oslo (KBS, V.3.2). 
The nutrient database is primarily based on the offi-
cial Norwegian food composition table35 and available 
literature.28 Data for K1 are mostly developed by public 
authorities in Finland,36 Sweden37 and USA.38 For some 
Norwegian food products, analyses were performed using 
high performance liquid chromatography of fermented 
foods.39 K2 was evaluated as one entity with no distinction 
between the different menaquinones. At time of study, 
the most commonly used dietary supplements in Norway 
did not contain vitamin K. Thus, vitamin K intake reflects 
only dietary sources. Measurements used as independent 
variables in this study are the total dietary amount of K1 
and K2, expressed as energy- adjusted residuals.40
Health examination and health habits
Baseline examinations included measurements of height, 
weight, waist circumference, resting blood pressure 
(Dinamap 845 XT equipment (Criticon)) and non- fasting 
venous blood samples for evaluation of serum lipids and 
glucose. Serum samples of total cholesterol, HDL choles-
terol, triglycerides and glucose were analysed within 
7 days at the department of Clinical Chemistry, Ullevål 
University Hospital, Oslo, using enzymatic methods with 
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reagents from Boehringer Mannheim (Roche, Basel, 
Switzerland).
Information on educational level and medication use 
was collected through self- administered questionnaires.
Hypertension was considered present if the mean of 
at least two consecutive measurements of systolic blood 
pressure was ≥140 mm Hg or of diastolic blood pres-
sure ≥90 mm Hg or if use of medication for hypertension 
was reported.
Diabetes was diagnosed according to diagnostic criteria 
at the time of the screening/survey. Participants taking 
diabetic medications or who reported a diagnosis of 
diabetes were defined as having diabetes mellitus. Also, 
participants with a serum glucose level >7 mmol/L who 
had not eaten a meal during the last 8 hours, or with 
glucose level >11.1 mmol/L and less than 8 hours since 
their last meal, were defined as having diabetes. Pre- 
diabetes was defined as having glucose levels between 
5.6 and 7 mmol/L at least 8 hours after their last meal or 
between 7.8 and 11 mmol/L less than 8 hours after their 
last meal.
Participants answered one categorical question on past- 
year vigorous physical activity resulting in sweating or 
breathlessness (none, <1 h/week, 1–2 h/week, or ≥3 h/
week). This variable was treated as a categorical variable 
with none as the reference.
Participants were classified as non- smokers, former 
smokers or current smokers and this variable was treated 
as a categorical variable with non- smokers as reference.
Outcome
The study endpoints were incident (first time) hospital-
isation with CHD (International classification of diseases 
(ICD)9 codes 410–414, ICD10 codes I20–I25) as primary 
or secondary diagnosis or death with CHD as the under-
lying cause of death. Participants were followed from base-
line through 31 December 2009 for CHD events through 
the Cardiovascular Disease in Norway project database 
(CVDNOR, www. cvdnor. no)41 42 and The Cause of Death 
Registry. Follow- up time represented time from baseline 
(1997–1999) until CHD, death from other causes, emigra-
tion or 31 December 2009, whichever came first. During 
follow- up, there were 107 non- fatal and 5 fatal events of 
interest while 60 participants died due to other causes 
and were censored at date of death.
Statistical analyses
Energy- adjusted residuals were obtained from linear 
regression models with total energy intake as indepen-
dent variable and K1 or K2 as dependent variables. The 
residuals measure the difference between actual intake 
and expected intake predicted by total energy intake40 
and thereby provides an assessment of K1 and K2 intake 
relative to energy consumed. Residuals were then catego-
rised into sex- specific quartiles.
Descriptive characteristics included counts with 
percents and medians (interquartile range) for cate-
gorical and continuous variables, respectively. Trends in 
dichotomous, categorical and continuous baseline char-
acteristics across energy- adjusted quartiles of K1 and K2 
were evaluated using logistic, ordinal logistic and linear 
regression analyses, respectively. The median residuals 
for each quartile group was specified as a continuous 
independent variable in the regression models.
Cox proportional hazards models were used to calcu-
late adjusted HR and 95% CIs for CHD associated with 
sex- specific energy- adjusted quartiles and per 10 µg incre-
ments of K1 or K2 intake. The covariates included were 
either those associated with intake of K1 or K2 and with 
CHD, or those that modified the association of either 
K1 or K2 with CHD when included in the multivari-
able model. Analyses included adjustments for sex, age 
(years) and total energy intake (kcal/day) (model 1), 
with additional adjustment for categories of vigorous 
physical activity (none vs <1 hour/week, 1–2 hours/week 
and ≥3 hours/week), smoking habits (previous smokers 
and current smokers, respectively vs non- smokers) and 
education (high school or vocational school, and any 
college or university, respectively vs primary school(≤10 
years)) (model 2). In a third model, K1 was adjusted addi-
tionally for energy- adjusted intake of fibre (g/day) and 
folate (mg/day); K2 was additionally adjusted for energy- 
adjusted intake of saturated fatty acids (SFA)(g/day) 
and calcium (mg/day) (model 3). The following addi-
tional potential confounders were also evaluated but not 
included in the tables as they did not noticeably alter the 
vitamin K1 or K2 coefficients for CHD: family history of 
myocardial infarction and energy- adjusted alcohol intake 
(g/day). Further, adjusting for the following intermediate 
factors: body mass index (BMI, kg/m2), diabetes mellitus 
(pre- diabetes and diabetes, respectively, vs no diabetes), 
hypertension, serum total cholesterol (mmol/L) and 
statin use, only attenuated the association to a small 
degree.
To test for linear trends across energy- adjusted quartiles 
of K1 and K2 intakes, the median value of the residuals 
within each quartile group was entered as a continuous 
independent variable. Supplementary analyses re- evalu-
ated K1 and K2 intake as sex- specific quartiles of absolute 
intake rather than energy- adjusted residuals.
Missing data on physical activity (3.8%), education 
(0.8%) and smoking habits (2.1%) were handled with 
listwise deletion in all analyses included in the main 
manuscript. In supplementary analyses, missing values for 
physical activity, smoking and education were imputed 
using ordinal logistic regression as the imputation model 
in MICE (multiple imputation using chained equation) 
with 20 imputations. All variables in the Cox regression 
models were included as imputation variables together 
with total cholesterol, HDL cholesterol, triglycerides and 
BMI as auxiliary variables due to their correlation with 
physical activity, smoking and education.
The proportional hazards assumption was evaluated 
using Schoenfeld’s test and log–log test.
In Cox regression with penalised splines, the functional 
form of the association between absolute K2 intake (not 
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residuals) and risk of CHD was estimated by smoothing 
splines, in which the estimated smooth functions were 
used to plot the relative hazards of CHD.43 Intakes above 
the 95th percentile and below the 5th percentile are 
excluded in the figure.
To test for sex interactions between K1 and K2, we 
compared models with and without an interaction term 
using likelihood- ratio test.
Statistical analyses were performed using Stata V.15 
(Stata Corp LP) and R V.3.4.0 (https://www. r- project. 
org/, The R Foundation for Statistical Computing, 
Vienna, Austria). P<0.05 were considered statistically 
significant.
Consent to participate
All subjects gave their written consent to participate in 
the study.
RESULTS
Reported intake of energy- adjusted K1 ranged from 8 to 
1063 µg/day/1000 kcal (median 48 µg/day/1000 kcal) 
and were higher for women compared with men. Intake 
of energy- adjusted K2 ranged from 1 to 31 µg/day/1000 
kcal (median 7 µg/day/1000 kcal) and were slightly 
higher for women compared with men.
The major dietary sources of K1 were vegetables (64%), 
fruits and berries (6%) and milk and milk products (6%), 
while sources of K2 were cheese (40%), other dairy prod-
ucts (14%), meat (24%) and eggs (13%).
In the evaluation of baseline characteristics associated 
with K1 intake, the concentration of HDL cholesterol and 
the proportion of participants who were highly educated 
and reported at least 1 hour of vigorous physical activity 
per week were higher with higher quartiles of K1 intake 
(table 1). Further, intakes of energy- adjusted total vitamin 
K, folate and fibre were higher with higher K1 intake 
quartiles. In contrast, a lower proportion with a family 
history of CHD and lower energy- adjusted K2, SFA and 
carbohydrate intakes were noted with higher K1 intake. 
In addition, intake of fruit and berries and vegetables 
were higher with higher K1 intake quartiles, while intake 
of cheese, milk and milk products and soft drinks with 
sugar were lower with higher intake quartiles of energy- 
adjusted K1 intake.
Evaluation of baseline characteristics by quartiles of 
energy- adjusted K2 intake identified that the proportion 
of participants highly educated, and the concentration 
of HDL cholesterol were higher with higher quartiles of 
K2 intake, while the concentration of triglycerides was 
lower (table 2). Further, intake of energy- adjusted total 
fat, SFA and calcium was higher with higher K2 intake 
quartiles. In contrast, lower intake of energy- adjusted K1 
and carbohydrates was noted with higher K2 intake. In 
addition, intake of butter, eggs, cheese, meat and minced 
meat were higher with higher quartiles, while intake of 
soft drinks with sugar and fruit and berries were lower 
with higher quartiles of energy- adjusted K2 intake.
Association between dietary vitamin K1 and CHD
During a mean 10.8 (SD 1.3) years follow- up, representing 
32 362 person years among 2987 participants, we docu-
mented 112 incident CHD events. Due to listwise dele-
tion of missing values (2.1% for smoking habits, 0.8% for 
education and 3.8% for physical activity), multivariable- 
adjusted analyses included 6.5% fewer participants 
compared with model 1 analyses (ie, 2792 (1213 men and 
1579 women) participants and 100 CHD events).
When adjusting for age, sex and total energy intake, 
there was no association between intake of energy- 
adjusted K1 and CHD comparing the fourth to the first 
quartile and there was no trend (table 3, model 1). The 
results were similar when further adjusting for physical 
activity, smoking habits and education (HRQ4vs.Q1=0.92 
(0.54 to 1.57), p for trend 0.64; table 3, model 2). In anal-
yses of energy- adjusted K1 intake as a continuous variable 
(per 10 µg increase), there was no association between K1 
and CHD in the adjusted analysis (table 3, model 2). Addi-
tional adjustments for energy- adjusted fibre and folate 
did not materially change the results (table 3, model 
3). In supplementary analyses, where missing data were 
handled with multiple imputation, results were similar to 
those presented in table 3 (online supplementary table 1, 
models 2 and 3).
Results were consistent with the above analyses in the 
supplemental analyses evaluating sex- specific quartiles of 
absolute K1 intake rather than energy- adjusted residuals 
(online supplementary table 2).
Association between dietary vitamin K2 and CHD
When adjusting for age, sex and total energy intake, 
there was a lower risk of CHD with energy- adjusted K2 
in the fourth compared with the first quartile (HRQ4vs.
Q1=0.50 (0.28 to 0.88), p for trend 0.02; table 3, model 
1). Results were consistent when further adjusting for 
physical activity, smoking habits and education (HRQ4vs.
Q1=0.52 (0.29 to 0.94), p for trend 0.03; table 3, model 
2). Consistency in results was observed in analyses of 
K2 intake as a continuous variable (per 10 µg increase; 
HR=0.74 (0.52 to 1.05), p=0.09). Additional adjustments 
for energy- adjusted SFA and calcium slightly attenuated 
the risk estimates for the association between K2 intake 
and CHD (HRQ4vs.Q1=0.58 (0.28 to 1.19), p for trend 0.16; 
table 3, model 3). Similar results were found in supple-
mentary analyses where missing data were handled with 
multiple imputation (model 2: HR per 10µg increase=0.70 (0.50 
to 0.98), p=0.04) (online supplementary table 1, models 
2 and 3).
When evaluating sex- specific absolute K2 intake rather 
than energy- adjusted residuals, HRs were similar to those 
observed in the primary analyses (HRQ4vs.Q1=0.72 (0.36 
to 1.45), p for trend 0.25; online supplementary table 2, 
model 2). Similarly, the penalised spline figure for abso-
lute K2 intake and its association with CHD adjusting for 
model 2 covariates showed a tendency towards lower risk 
of CHD with higher K2 intake (figure 1).
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Table 1 Baseline characteristics by sex- specific quartiles of energy- adjusted residuals of vitamin K1 intake: the Hordaland 
Health Study
Total Q1 Q2 Q3 Q4 P trend*
Subjects, n 2987 746 747 748 746
Age, years 48 (47 to 48) 48 (47 to 48) 48 (47 to 48) 48 (48 to 49) 48 (47 to 49) 0.135
Men 1279 (42.8) 319 (42.8) 320 (42.8) 321 (42.9) 319 (42.8) 0.993
Any college and/or university 
education
1136 (38.3) 265 (36.0) 288 (38.9) 289 (38.8) 294 (39.6) 0.018
Family history of CHD 1183 (40.9) 314 (43.3) 309 (42.6) 286 (39.3) 274 (38.4) 0.034
Smoking habits 0.104
  Previous smokers 914 (31.3) 214 (29.4) 227 (30.8) 237 (32.4) 236 (32.5)
  Current smokers 978 (33.5) 239 (32.8) 231 (31.4) 261 (35.7) 247 (34.0)
Physical activity <0.001
  None 741 (25.8) 198 (27.8) 201 (28.0) 188 (26.0) 154 (21.4)
  <1 hour/week 810 (28.2) 226 (31.7) 192 (26.7) 201 (27.8) 191 (26.5)
  1–2 hours/week 907 (31.6) 207 (29.0) 239 (33.3) 226 (31.3) 235 (32.6)
  ≥3 hours/week 415 (14.4) 82 (11.5) 86 (12.0) 107 (14.8) 140 (19.4)
Hypertension 707 (23.7) 172 (23.1) 176 (23.6) 185 (24.7) 174 (23.3) 0.945
Glucose intolerance 0.875
  Pre- diabetes 66 (2.2) 24 (3.2) 12 (1.6) 14 (1.9) 16 (2.2)
  Diabetes 27 (0.9) 8 (1.1) 4 (0.5) 5 (0.7) 10 (1.4)
Body mass index, kg/m2 24.9 (22.8 to 27.4) 25.0 (22.8 to 27.4) 25.0 (22.8 to 27.6) 24.9 (22.9 to 27.5) 24.7 (22.6 to 27.2) 0.148
Waist circumference, cm 85.0 (77.0 to 94.0) 85.0 (77.0 to 94.0) 85.0 (77.0 to 94.0) 85.0 (77.0 to 93.0) 85.0 (76.0 to 93.0) 0.266
Serum cholesterol, mmol/L 5.65 (5.06 to 6.30) 5.58 (5.05 to 6.25) 5.70 (5.11 to 6.44) 5.66 (5.05 to 6.27) 5.65 (5.03 to 6.25) 0.331
Serum LDL- C, mmol/L 3.56 (3.01 to 4.17) 3.53 (2.98 to 4.14) 3.65 (3.06 to 4.29) 3.56 (3.02 to 4.11) 3.54 (2.94 to 4.10) 0.072
Serum HDL- C, mmol/L 1.28 (1.06 to 1.53) 1.27 (1.04 to 1.52) 1.28 (1.07 to 1.51) 1.27 (1.05 to 1.53) 1.31 (1.07 to 1.58) 0.004
Serum triglycerides, mmol/L 1.40 (1.01 to 2.03) 1.43 (1.01 to 2.02) 1.39 (1.00 to 1.99) 1.39 (1.04 to 2.11) 1.38 (0.98 to 2.05) 0.462
Energy intake, kcal/day 2057 (1690 to 
2550)
2152 (1712 to 2671) 1944 (1608 to 2353) 2032 (1627 to 2485) 2171 (1775 to 2687) <0.001
Dietary intake
  Total vitamin K, µg/day 120 (85 to 175) 78 (58 to 99) 95 (76 to 118) 137 (111 to 161) 234 (189 to 301) <0.001
  Total vitamin K, µg/day/1000 kcal 56 (43 to 79) 36 (31 to 42) 49 (44 to 55) 65 (57 to 76) 105 (84 to 144) <0.001
  Vitamin K2, µg/day 15 (11 to 21) 16 (12 to 22) 14 (11 to 20) 15 (11 to 20) 15 (12 to 20) 0.336
  Vitamin K2, µg/day/1000 kcal 7 (6 to 9) 8 (6 to 9) 7 (6 to 9) 7 (6 to 9) 7 (6 to 9) <0.001
  Vitamin K1, µg/day 103 (69 to 157) 61 (44 to 77) 81 (63 to 101) 121 (99 to 143) 218 (172 to 282) <0.001
  Vitamin K1 µg/day/1000 kcal 48 (35 to 71) 29 (23 to 33) 41 (37 to 47) 58 (50 to 67) 98 (77 to 136) <0.001
  Total fat, E% 32 (29 to 36) 32 (28 to 35) 33 (29 to 36) 33 (30 to 37) 33 (29 to 36) <0.001
  SFA, E% 13 (11 to 14) 13 (11 to 14) 13 (11 to 14) 13 (11 to 14) 12 (11 to 14) 0.004
  PUFA, E% 7 (6 to 8) 6 (5 to 7) 7 (6 to 8) 7 (6 to 9) 7 (6 to 9) <0.001
  MUFA, E% 10 (9 to 12) 10 (9 to 11) 10 (9 to 12) 11 (9 to 12) 10 (9 to 12) 0.357
  Protein, E% 16 (14 to 17) 16 (14 to 17) 16 (14 to 17) 16 (14 to 17) 16 (15 to 18) <0.001
  Carbohydrates, E% 49 (46 to 53) 50 (47 to 54) 50 (46 to 53) 49 (45 to 52) 48 (45 to 52) <0.001
  Alcohol, E% 1 (0 to 3) 1 (0 to 3) 1 (0 to 3) 2 (0 to 3) 2 (1 to 3) 0.001
  Folate, µg/day/1000 kcal 110 (95 to 133) 99 (88 to 113) 105 (93 to 121) 112 (98 to 131) 135 (113 to 164) <0.001
  Fibre, g/day/1000 kcal 11 (10 to 13) 10 (9 to 12) 11 (10 to 13) 11 (10 to 13) 13 (11 to 16) <0.001
Intake of food items, g/day/1000 kcal
  Butter† 0 (1.2) 0 (1.3) 0 (1.1) 0 (1.1) 0 (1.2) 0.749
  Margarine 3 (2 to 8) 2 (1 to 3) 3 (2 to 8) 3 (2 to 11) 3 (2 to 9) <0.001
  Cheese 13 (7 to 21) 15 (8 to 24) 13 (7 to 22) 12 (7 to 19) 12 (6 to 20) <0.001
  Yoghurt 5 (0 to 18) 6 (0 to 21) 5 (0 to 16) 6 (0 to 18) 5 (0 to 17) 0.740
  Milk and milk products 129 (65 to 205) 157 (86 to 230) 134 (71 to 220) 127 (57 to 193) 105 (51 to 174) <0.001
  Sausages 20 (2 to 49) 17 (1 to 47) 18 (1 to 47) 21 (4 to 53) 21 (5 to 53) 0.067
  Meat 55 (41 to 70) 54 (39 to 68) 55 (42 to 73) 56 (43 to 70) 53 (40 to 67) 0.651
Continued
 on M







pen: first published as 10.1136/bm
jopen-2019-035953 on 21 M
ay 2020. Downloaded from
 
6 Haugsgjerd TR, et al. BMJ Open 2020;10:e035953. doi:10.1136/bmjopen-2019-035953
Open access 
Total Q1 Q2 Q3 Q4 P trend*
  Minced meat 24 (16 to 34) 25 (15 to 35) 25 (16 to 35) 25 (16 to 34) 22 (14 to 31) <0.001
  Soft drinks with sugar 25 (0 to 65) 31 (3 to 76) 28 (2 to 69) 24 (0 to 61) 18 (0 to 51) <0.001
  Fruit and berries 104 (65 to 154) 91 (56 to 132) 103 (67 to 150) 105 (68 to 167) 114 (71 to 164) <0.001
  Vegetables 85 (54 to 131) 49 (35 to 72) 74 (53 to 101) 98 (67 to 134) 154 (104 to 212) <0.001
Values are presented as N (%) and median (interquartile range) for continuous and categorical data, respectively.
*Logistic regression for dichotomous categories, ordered logistic regression when more than two categories and linear regression for continuous variables where median residuals 
within each quartile group was used as the independent variable in the analyses.
†Mean (median) are reported due to a large proportion with zero intake.
CHD, coronary heart disease; E%, energy per cent; HDL- C, high- density lipoprotein cholesterol; LDL- C, low- density lipoprotein cholesterol; MUFA, monounsaturated fatty acids; 
PUFA, polyunsaturated fatty acids; Q, quartile; SFA, saturated fatty acids.
Table 1 Continued
DISCUSSION
Among community- dwelling middle- age adults in Western 
Norway, a higher energy- adjusted reported intake of 
K2 was associated with a lower risk of subsequent CHD 
events, whereas intake of K1 was not associated with inci-
dent CHD. Similar direction of associations was observed 
when further adjusting for potential dietary confounders.
Strengths and weaknesses
Strengths of our study include a long follow- up time with 
minimal competing risk from other causes of death in 
this relatively young study population. Linkage to the 
CVDNOR project database assured complete follow- up. 
In addition, we had information on several possible 
confounders including baseline health status, medication 
use, health habits and history of CHD which enabled us 
to evaluate incident CHD.
Weaknesses include self- reported information on 
dietary intake, health habits and medication use which 
may lead to misclassification in covariates used in the 
analyses. Furthermore, we lack information on changes 
in diet including intake of vitamin K, medications and 
risk factors over time. Inherent problems with FFQs are 
systematic under- reporting and over- reporting. However, 
the FFQ is well suited to rank individuals when adjusting 
for total energy intake.44 This FFQ is not validated specif-
ically for intake of vitamin K. Vitamin K content of foods 
differs according to production conditions, and the 
bioavailability is dependent on preparation, fat content of 
meals, the food matrix and subtypes of vitamin K. There-
fore, although the rank ordering of participants may be 
valid, the absolute vitamin K intake based on FFQ is likely 
inaccurate.5 29 30 45 46 In addition, K2 can be produced 
by intestinal gut microbiota, but little is known about 
its contribution to vitamin K status since the majority is 
located in bacterial membranes in the colon and is prob-
ably not available for absorption.26
Further, vitamin K2 intake may be underestimated in 
this study population since much of the information on 
vitamin K content of food used in this study comes from 
a Dutch study,28 and recent research have shown that 
Norwegian cheeses are especially rich in vitamin K2.29 47 
In addition, we could not differentiate the subtypes of 
vitamin K219 in our study.
Although we performed multivariable analyses, residual 
confounding may still be present.
Results in relation to other studies
This study did not find an association between intake 
of K1 and CHD, in line with results from most previous 
studies.19 20 22 23 However, Erkkilä et al concluded that 
high K1 intake may be a marker of low CHD risk, but that 
dietary patterns associated with K1 intakes, rather than 
intake of K1 itself might account for this association.21 
Similarly, Juanola- Falgarona et al studied the association 
between dietary K1 and K2 with mortality in a cohort with 
high cardiovascular disease (CVD) risk, and found that an 
increase in dietary intakes of both K1 and K2 were associ-
ated with a reduced risk of all- cause mortality, while only 
K1 was associated with a reduced risk of CVD mortality.24 
However, since participants came from a Mediterranean 
country in which the consumption of fruit, vegetables 
and vegetable oils was quite high, K1 could be regarded 
as a marker of adherence to a healthy diet.24
Regarding vitamin K2, Geleijnse et al found a 41% lower 
risk of CHD comparing the highest with the lowest tertile 
of K2 intake in the Rotterdam study,20 similar to our 
results. Gast et al found a dose–response relationship with 
a 9% lower CHD risk with each 10 µg higher K2 intake, 
with the strongest association shown for long- chain K2.19 
Opposite from this study where the association atten-
uated when further adjusting for SFA and calcium, the 
association became stronger in both these studies in their 
multivariable models.19 20 Adjusting for SFA and calcium, 
however, may be an overadjustment as dairy products 
rich in SFA and calcium are also major sources of K2.24 
Zwakenberg et al found that only intake of long- chain K2 
(per10µg) was borderline significantly inversely associated 
with CHD mortality (p for trend 0.06).23 This discrepancy 
compared with our study may be because lifestyle factors 
such as diet may have a larger impact on total CHD events 
(fatal and non- fatal) given the underlying mechanisms of 
reducing calcification. Treatment, however, is probably of 
larger importance for CHD mortality.48
In the western diet, cheese is the most important source 
of long- chain K2, and hard cheese is, in general, richer 
in K2 than soft cheese.28 29 Fu et al showed that vitamin K 
concentrations in cheese ranged from 40 µg to 850 µg per 
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Table 2 Baseline characteristics by sex- specific quartiles of energy- adjusted residuals of vitamin K2 intake: the Hordaland 
Health Study
Total Q1 Q2 Q3 Q4 P trend*
Subjects, n 2987 746 747 747 747
Age, years 48 (47 to 48) 48 (47 to 49) 48 (47 to 48) 48 (47 to 49) 48 (47 to 48) 0.600
Men 1279 (42.8) 319 (42.8) 320 (42.8) 320 (42.8) 320 (42.8) 0.977
Any college and/or university 
education
1136 (38.3) 261 (35.3) 272 (36.8) 284 (38.3) 319 (42.9) 0.001
Family history of CHD 1183 (40.9) 292 (40.7) 308 (42.1) 284 (39.3) 299 (41.6) 0.904
Smoking habits 0.267
  Previous smokers 914 (31.3) 217 (29.7) 241 (33.1) 229 (31.2) 227 (31.1)
  Current smokers 978 (33.5) 239 (32.7) 244 (33.5) 240 (32.7) 255 (34.9)
Physical activity 0.114
  None 741 (25.8) 185 (25.8) 181 (25.5) 194 (26.9) 181 (25.0)
  <1 hour/week 810 (28.2) 189 (26.3) 179 (25.2) 224 (31.0) 218 (30.2)
  1–2 hours/week 907 (31.6) 214 (29.8) 244 (34.4) 224 (31.0) 225 (31.1)
  ≥3 hours/week 415 (14.4) 130 (18.1) 106 (14.9) 80 (11.1) 99 (13.7)
Hypertension 707 (23.7) 185 (24.8) 180 (24.1) 184 (24.6) 158 (21.2) 0.100
Glucose intolerance 0.543
  Pre- diabetes 66 (2.2) 18 (2.4) 15 (2.0) 17 (2.3) 16 (2.2)
  Diabetes 27 (0.9) 6 (0.8) 7 (0.9) 2 (0.3) 12 (1.6)
Body mass index, kg/m2 24.9 (22.8 to 27.4) 24.8 (22.7 to 27.4) 25.1 (23.0 to 27.5) 25.0 (22.9 to 27.3) 24.8 (22.6 to 27.4) 0.830
Waist circumference, cm 85 (77 to 94) 84 (77 to 93) 85 (77 to 94) 85 (77 to 94) 85 (76 to 93) 0.724
Serum cholesterol, mmol/L 5.65 (5.06 to 6.30) 5.66 (5.02 to 6.30) 5.64 (5.07 to 6.36) 5.7 (5.1 to 6.32) 5.57 (5.05 to 6.20) 0.124
Serum LDL- C, mmol/L 3.56 (3.01 to 4.17) 3.57 (3.00 to 4.14) 3.58 (2.99 to 4.19) 3.60 (3.07 to 4.24) 3.52 (2.97 to 4.09) 0.227
Serum HDL- C, mmol/L 1.28 (1.06 to 1.53) 1.27 (1.03 to 1.52) 1.27 (1.07 to 1.54) 1.30 (1.06 to 1.55) 1.30 (1.06 to 1.54) 0.043
Serum triglycerides, mmol/L 1.40 (1.01 to 2.03) 1.44 (1.04 to 2.16) 1.40 (1.00 to 2.05) 1.39 (1.01 to 1.99) 1.36 (0.97 to 1.96) 0.022
Energy intake, kcal/day 2057 (1690 to 2550) 2098 (1682 to 2645) 1976 (1603 to 2398) 2014 (1653 to 2469) 2215 (1795 to 2637) 0.002
Dietary intake
  Total vitamin K, µg/day 120 (85 to 175) 119 (82 to 179) 116 (78 to 169) 114 (83 to 165) 133 (94 to 186) 0.728
  Total vitamin K, µg/day/1000 
kcal
56 (43 to 79) 56 (40 to 80) 55 (42 to 81) 55 (43 to 76) 59 (46 to 80) 0.011
  Vitamin K2, µg/day 15 (11 to 21) 10 (8 to 13) 13 (11 to 16) 16 (14 to 19) 24 (21 to 29) <0.001
  Vitamin K2, µg/day/1000 kcal 7 (6 to 9) 5 (4 to 5) 7 (6 to 7) 8 (8 to 9) 11 (10 to 13) <0.001
  Vitamin K1, µg/day 103 (69 to 157) 109 (72 to 167) 101 (67 to 155) 97 (67 to 149) 104 (71 to 156) 0.329
  Vitamin K1, µg/day/1000 kcal 48 (35 to 71) 51 (36 to 78) 49 (35 to 74) 46 (35 to 67) 47 (34 to 68) 0.038
  Total fat, E% 32 (29 to 36) 30 (27 to 34) 31 (29 to 35) 33 (30 to 36) 35 (32 to 38) <0.001
  SFA, E% 13 (11 to 14) 11 (19 to 12) 12 (11 to 13) 13 (12 to 14) 14 (13 to 16) <0.001
  PUFA, E% 7 (6 to 8) 7 (6 to 9) 7 (6 to 8) 7 (6 to 8) 6 (6 to 8) <0.001
  MUFA, E% 10 (9 to 12) 10 (8 to 11) 10 (9 to 11) 11 (10 to 12) 11 (10 to 12) <0.001
  Protein, E% 16 (14 to 17) 15 (13 to 16) 16 (14 to 17) 16 (15 to 17) 16 (15 to 18) <0.001
  Carbohydrates, E% 49 (46 to 53) 53 (49 to 57) 50 (47 to 53) 48 (45 to 51) 46 (43 to 49) <0.001
  Alcohol, E% 1 (0 to 3) 1 (0 to 3) 1 (0 to 3) 1 (0 to 3) 1 (0 to 3) 0.387
  Calcium, mg/day/1000 kcal 385 (313 to 468) 332 (264 to 410) 373 (302 to 448) 389 (329 to 464) 443 (374 to 538) <0.001
  Fibre, g/day/1000 kcal 11 (10 to 13) 12 (11 to 15) 12 (10 to 13) 11 (9 to 13) 11 (9 to 12) <0.001
Intake of food items, g/
day/1000 kcal
  Butter† 0 (1.2) 0 (0.5) 0 (1.0) 0 (1.3) 0 (1.9) <0.001
  Margarine 3 (2 to 8) 3 (2 to 10) 3 (2 to 7) 3 (2 to 8) 3 (2 to 5) <0.001
  Egg 8 (4 to 11) 5 (3 to 8) 8 (5 to 11) 8 (5 to 12) 8 (4 to 11) <0.001
  Cheese 13 (7 to 21) 7 (3 to 12) 10 (6 to 15) 14 (9 to 20) 25 (17 to 34) <0.001
  Yoghurt 5 (0 to 18) 4 (0 to 15) 5 (0 to 17) 6 (0 to 19) 5 (0 to 19) 0.456
  Milk and milk products 129 (65 to 205) 127 (51 to 209) 144 (82 to 213) 135 (69 to 209) 112 (55 to 181) <0.001
Continued
 on M
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Total Q1 Q2 Q3 Q4 P trend*
  Sausage 20 (2 to 49) 21 (2 to 53) 22 (3 to 53) 21 (3 to 50) 17 (2 to 42) <0.001
  Meat 55 (41 to 70) 47 (33 to 58) 56 (43 to 71) 61 (46 to 77) 58 (42 to 76) <0.001
  Minced meat 24 (16 to 34) 19 (12 to 28) 24 (16 to 33) 27 (18 to 37) 27 (17 to 36) <0.001
  Soft drinks with sugar 25 (0 to 65) 29 (1 to 72) 26 (0 to 66) 26 (2 to 64) 23 (0 to 54) <0.001
  Fruit and berries 104 (65 to 154) 116 (74 to 174) 105 (67 to 162) 100 (64 to 149) 93 (57 to 135) <0.001
  Vegetables 85 (54 to 131) 85 (50 to 133) 90 (58 to 139) 82 (55 to 125) 84 (53 to 122) 0.006
Values are presented as N(%) and median (interquartile range) for categorical and continuous variables, respectively.
*Logistic regression for dichotomous categories, ordered logistic regression when more than two categories and linear regression for continuous variables where median residuals 
within each quartile group was used as the independent variable in the analyses.
†Mean (median) are reported due to a large proportion with zero intake.
CHD, coronary heart disease; E%, energy per cent; HDL- C, high- density lipoprotein cholesterol; LDL- C, low- density lipoprotein cholesterol; MUFA, monounsaturated fatty acids; 
PUFA, polyunsaturated fatty acids; Q, quartile; SFA, saturated fatty acids.
Table 2 Continued
















Q1 63 (25) 746 33 (4.4) 1 (ref) 1 (ref) 1 (ref)
Q2 83 (27) 747 18 (2.4) 0.47 (0.27 to 0.85) 0.50 (0.27 to 0.93) 0.48 (0.26 to 0.89)
Q3 122 (32) 748 31 (4.1) 0.84 (0.51 to 1.39) 0.89 (0.53 to 1.51) 0.83 (0.49 to 1.41)
Q4 269 (191) 746 30 (4.0) 0.91 (0.55 to 1.49) 0.92 (0.54 to 1.57) 0.69 (0.38 to 1.27)
P for trend** 0.64 0.64 0.59
Continuous, per 
10 µg
1.00 (0.99 to 1.02),
p=0.57
1.00 (0.99 to 1.02),
p=0.62




Q1 10 (4) 746 35 (4.7) 1 (ref) 1 (ref) 1 (ref)
Q2 13 (4) 747 30 (4.0) 0.79 (0.48 to 1.29) 0.79 (0.47 to 1.34) 0.83 (0.49 to 1.43)
Q3 17 (4) 747 29 (3.9) 0.77 (0.47 to 1.26) 0.77 (0.45 to 1.31) 0.84 (0.47 to 1.48)
Q4 26 (8) 747 18 (2.4) 0.50 (0.28 to 0.88) 0.52 (0.29 to 0.94) 0.58 (0.28 to 1.19)
P for trend** 0.02 0.03 0.16
Continuous, per 
10 µg
0.71 (0.50 to 0.99),
p=0.04
0.74 (0.52 to 1.05),
p=0.09
0.82 (0.51 to 1.30),
p=0.39
Sex- specific quartiles with 1279 men and 1708 women. The Hordaland Health Study.
*HR are presented as Q2 versus Q1, Q3 versus Q1, Q4 versus Q1.
†Cox proportional hazards regression analysis adjusted for age, sex and total energy intake.
‡Adjusted in addition for physical activity, smoking habits and education.
§Analyses were based on a reduced number of participants (n=2792) and CHD events (n=100) due to listwise deletion when covariates were missing.
¶Vitamin K1 is adjusted in addition for energy- adjusted fibre and folate, while vitamin K2 is adjusted in addition for energy- adjusted calcium and 
saturated fatty acids.
**P trend, to test for linear trends across quartiles, we modelled the median intake of each quartile as a continuous variable.
N, number of participants; Q, quartile.
100 g, and that reduced- fat products contained 5%–22% 
of the vitamin K found in full- fat equivalents.30 K2 in 
cheese originates from bacterial processes present at the 
start of the cheese- making process.26 As different lactic 
acid bacteria are used in cheese making, a large variability 
in K2 content is found. Cheeses from Norway are among 
those with the highest long- chain K2 content.29 47
A meta- analysis including only two published studies of 
sufficient quality did not conclude that there is a lower 
risk of cardiovascular events with higher intake of K2.49 
However, a systematic review and meta- analysis found that 
supplementation with vitamin K (K1 and K2) significantly 
reduced vascular calcification, but not vascular stiffness, 
compared with controls.50 However, Shea et al studied 
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Figure 1 Cox proportional hazards regression with 
penalised splines, The Hordaland Health Study. Distribution 
of partial HR (solid line) with 95% CI (shadow) for coronary 
heart disease across the distribution of dietary vitamin K2 
in μg per day (not energy- adjusted residuals). The model 
includes adjustment for age, sex, total energy intake, physical 
activity, smoking habits and education. Intakes above the 
95th percentile and below the 5th percentile are excluded in 
the figure.
supplementation with K1 on coronary artery calcifica-
tion progression in older men and women and found no 
difference between the control and treatment groups in 
the main analyses. Less progression of coronary artery 
calcification was found in participants who were ≥85% 
adherent to supplementation and in those with pre- 
existing coronary artery calcification.51
Potential mechanisms
The lower risk of CHD with a high intake of K2 may have 
different explanations. Jakobsen et al showed that intake 
of SFA seems to be preferable compared with intake of 
carbohydrates with high glycaemic index in order to 
reduce risk of myocardial infarction.52 Further, intake 
of K2 correlates positively with intake of SFA, especially 
dairy sources as cheese, and negatively with intake of 
carbohydrates, especially sugar- rich sources as soft drinks 
with sugar and fruit and berries (both fresh and canned). 
Further, cheese has been associated with lower risk of 
CHD,53 and the median intake of cheese more than 
triples between the first and fourth quartile of K2 intake. 
This may also partly explain why adjusting for SFA and 
calcium attenuated the association between intake of K2 
and CHD (table 3, model 3).
The lower risk of CHD with a high intake of K2 may 
further be explained by carboxylation of vascular Matrix 
Gla Protein and consequently less arterial calcification.54 
Intimal calcification starts in the inner layer of large 
arteries, is associated with dyslipidaemia and may cause 
ischemia and arterial infarction, while calcification of the 
medial layer occurs even in small arteries and may lead to 
arterial stiffness, hypertension and left ventricular hyper-
trophy that further increases risk of CHD.55
The observed association for K2 only may be due to the 
fact that in addition to being cleared by the liver, it is also 
transported to extrahepatic tissues.5 However, extrahe-
patic vitamin K- dependent proteins seem to be of lower 
priority compared with those in the liver.26 27 Thus, one 
hypothesis is that intake of vitamin K has to be of a certain 
magnitude in order to have an effect on CHD. The 
different results on K1 and K2 may also be due to biolog-
ical differences between K1 and K2 or to lower ability of 
the FFQ to estimate K1.4 26 56 Due to different bioavail-
ability, the contribution of K2 to vitamin K status is at least 
equal to that of K1 even though dietary K1 contributes to 
the majority of the total vitamin K intake.26 46 57
Alternatively, our findings may reflect that K2 may be a 
marker of another nutrient or food constituent that has 
heart- healthy properties.
Implications and future research
Our findings contribute to the sparse literature relating 
dietary vitamin K to future CHD risk. Current dietary 
guidelines are based on insufficient knowledge with 
regard to vitamin K metabolism and the different char-
acteristics of K1 and K2. Therefore, our results indicate a 
need for more studies on the association between K2 and 
CHD. In addition, more knowledge about the absorption, 
transport and bioactivity of K2 is warranted.
Conclusion
In this Norwegian community- based study population, we 
observed that intake of K2 was associated with lower risk 
of CHD, while there was no association between intake of 
K1 and CHD. These results are considered generalisable 
to other middle- aged Western populations in which dairy 
products are the primary source of K2.
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Food Frequency questionnaire in  
 

















I dette skjemaet spør vi om dine spisevaner slik de vanligvis er.
Vi er klar over at kostholdet varierer fra dag til dag. Prøv derfor 
så godt du kan å gi et "gjennomsnitt" av dine spisevaner. Ha det
siste året i tankene når du fyller ut skjemaet. Der du er usikker,
anslå svaret.
Skjemaet skal leses av en maskin, og derfor er det viktig at du
setter et tydelig kryss i avmerket rute.
Riktig markering er slik:
Bruk helst bløt blyant. Feil kan da rettes med viskelær.
Kulepenn og svart tusjpenn kan også brukes.
Av hensyn til den maskinelle lesingen pass på at arkene ikke blir brettet.
Alle svar vil bli behandlet strengt fortrolig.
EKSEMPEL PÅ UTFYLLING AV SPØRSMÅL 1.
Kari Nordmann spiser daglig 5 skiver brød og ett
knekkebrød. Hun spiser vanligvis kneippbrød, men i helgene
blir det en del loff. I tillegg spiser hun ett knekkebrød hver
dag. Hun fyller ut første spørsmål slik:
1.HVOR MYE BRØD PLEIER DU Å SPISE?
Legg sammen det du bruker til alle måltider i løpet av en dag.
(1/2 rundstykke = 1 skive, 1 baguett = 5 skiver, 1 ciabatta = 4 skiver)
Fint brød
(loff, baguetter, fine rundstykker o.l.)
Mellomgrovt brød
(lys helkorn, lys kneipp, lyst hj.bakt o.l.)
Grovt brød
(fiberkneipp, mørk kneipp, mørkt hj.bakt o.l.)
Knekkebrød
(kavring, grov skonrok o.l.)
0 1/2 1 2 3 4 5 6 7 8 9 10 11 12+
Antall skiver pr. dag
Sum skiver pr. dag = ____
Antall skiver pr. uke: _______ = ____  Tallet brukes i spørsmål 5.
6
6 x 7 42
2.HVA PLEIER DU Å SMØRE PÅ 
BRØDET?
Merk av både for hverdag og helg, selv
om du bruker det samme.
3.OM DU BRUKER 
FETT PÅ BRØD, HVOR
MYE BRUKER DU?
4.MELK SOM DRIKK
(1 glass = 1,5 dl)
1.HVOR MYE BRØD PLEIER DU Å SPISE?
Legg sammen det du bruker til alle måltider i løpet av en dag.
(1/2 rundstykke = 1 skive, 1 baguett = 5 skiver, 1 ciabatta = 4 skiver)
Fint brød
(loff, baguetter, fine rundstykker o.l.)
Mellomgrovt brød
(lys helkorn, lys kneipp, lyst hj.bakt o.l.)
Grovt brød
(fiberkneipp, mørk kneipp, mørkt hj.bakt o.l.)
Knekkebrød
(kavring, grov skonrok o.l.)
0 1/2 1 2 3 4 5 6 7 8 9 10 11 12+
Antall skiver pr. dag
Sum skiver pr. dag = ____
Antall skiver pr. uke: ____ x 7 = ____. Tallet brukes i spørsmål 5.
Hverdager Lørdager, søndager En porsjonspakning på 12 g
rekker til antall skiver
Bruker ikke












Smør   (meierismør)
Bremykt, Smøregod
Brelett












Skummet melk, søt, sur
61852
5.PÅLEGGSSORTER
Bruk sum skiver pr. uke fra spørsmål 1.
Brun ost, prim
Hvit ost, helfet, 27% fett (Jarlsberg,
Norvegia o.l., smøreost; eske, tube)
Hvit ost, halvfet, 16% fett (Jarlsberg,
Norvegia o.l., smøreost; eske, tube)










Sardiner, sursild, ansjos o.l.









Frukt som pålegg (banan, eple o.l.)
Salater med majones
(kokt, stekt, eggerøre, omelett)
6.EGG
0
Til antall skiver pr. uke
1/2 1 2-3 4-5 6-7 8-14 15-21 22-28 29-35 36+
0 1/2 1 2-3 4-5 6-7 8-14 15-21 22-28 29-35 36+
0 1/2 1 2-3 4-5 6-7 8-14 15-21 22-28 29-35 36+
0 1/2 1 2-3 4-5 6-7 8-14 15-21 22-28 29-35 36+
0 1/2 1 2-3 4-5 6-7 8-14 15-21 22-28 29-35 36+





8. KAFFE OG TE
(1 kopp kaffe = 1,2 dl    1 kopp te = 2 dl)
7. FROKOSTGRYN, GRØT OG YOGHURT
Svar enten pr. måned eller pr. uke. <1 betyr sjeldnere enn 1 gang.
Melk søt, sur på gryn,
grøt og dessert
Havregryn, kornblandinger


















Kunstig søtstoff til kaffe eller te
0 1/2 1 2 3
Antall teskjeer eller biter pr. kopp
4+
1/2 1 3-42 5-6






Gang pr. måned Gang pr. uke Mengde pr. gang
4-5 6-7 8+1321<10
1 1 1/2 2 3+
1 1 1/2 2 3+
1-2 3-4 5-6 7+
1 2 3-4 5+
1/2 1 1 1/2 2+
1/2 1 1 1/2 2+
1/2 1 1 1/2 2+














Kjøttdeigretter (saus eller gryte
med kjøttdeig, lasagne o.l.)
9. ANDRE DRIKKER?
Svar enten pr. måned eller pr. uke.  < 1 betyr sjeldnere enn 1 gang.
Merk at porsjonsenhetene er forskjellige. 1/3 liter tilsvarer en halvflaske øl 
og 2/3 liter tilsvarer en helflaske.
Vann
Appelsinjuice




Brus, Cola, Solo o.l.,
med sukker
Brus, Cola, Solo o.l.,
kunstig søtet






















Gang pr. måned Gang pr. uke Mengde pr. gang














1/2 1 2 3 4
1/2 1 2 3 4
1/2 1 2 3 4
1/2 1 2 3 4
1/2 1 2 3 4
1/4 1/3 1/2 2/3 1
1/4 1/3 1/2 2/3 1
1/4 1/3 1/2 2/3 1
1/4 1/3 1/2 2/3 1
1/4 1/3 1/2 2/3 1
1 2 3 4 5















Vi spør både om middagsmåltidene og det du spiser til andre måltider. Tell til slutt
sammen antall retter du har merket for og se om summen virker sannsynlig.
En "dl" tilsvarer omtrent mengden i en suppeøse. Med "ss" menes en spiseskje.
Mengde pr. gang
1/2 2/3 1 2+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+





Koteletter (lam, okse, svin)
Biff (alle typer kjøtt)
Stek (elg, hjort, reinsdyr o.l.)
Stek (lam, okse, svin)











Torsk, sei, hyse (stekt, panert)
Sild (fersk, speket, røkt)
Makrell (fersk, røkt)















































1<10 3 4 5-6 7-8 9+
1/8 1/4 1/2 3/4 1+
21<10 3 4 5-6 7-8 9+
21<10 3 4 5-6 7-8 9+
21<10 3 4 5-6 7-8 9+
1/2 1 1 1/2 2 2 1/2+
1-2 3-4 5-6 7-8 9+
1/4 1/3 1/2 3/4 1+
1 2 3 4 5+
1/2 1 1 1/2 2 3+
1-2 3-4 5-6 7-8 9+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1/2 1 1 1/2 2 2 1/2+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-9 10+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1/2 1 1 1/2 2 2 1/2+
7
61852
11. POTETER, RIS, SPAGHETTI, GRØNNSAKER
Svar enten pr. måned eller pr. uke. <1 betyr sjeldnere enn 1 gang.
Disse spørsmålene dreier seg først og fremst om tilbehør til middagsretter, men
spiser du for eksempel en rå gulrot eller salat til lunsj, skal det tas med her. 
0
Gang pr. måned Gang pr. uke Mengde pr. gang





























Hvor mange ganger om dagen spiser du vanligvis

























1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1/2 1 2 3 4+
1/2 1 2 3 4+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1/2 1 1 1/2 2 3+
1/4 1/2 3/4 1 1 1/4 +
1/2 1 1 1/2 2 3+
0 1 2 3 4 5+
8
61852
12. TYPE FETT TIL MATLAGING
13. FRUKT
Svar enten pr. måned eller pr. uke. < 1 betyr sjeldnere enn 1 gang.
Hvor mange frukter spiser du vanligvis pr. dag?





























Gang pr. måned Gang pr. uke









1/2 1 2 3+
1/2 1 2 3+
1/2 1 2 3+
1/2 1 2 3+
1/2 1 2 3+
1/2 1 2 3+
1/2 1 2 3+
1/2 1 2 3+
Multer (dl)
1/2 1 2 3+
7 8 9+
61852
14. DESSERT, KAKER, GODTERI














(Cookies, Bixit, Hob Nobs)
Sjokolade (60 g)
Drops, lakris, seigmenn o.l.
Smågodt (1 hg = 100g)
Potetgull (1 pose 100g = 7 dl)
Annen snacks (skruer, crisp,
saltstenger, lettsnacks o.l.)
Peanøtter, andre nøtter
(1 pose 100g = 4 never)
Gang pr. måned Gang pr. uke Mengde pr. gang




























































Hvis annet, hvilket? ..................................................................
Hvis annet, hvilket? ..................................................................





























1 ts 1 bs 1 ss
1 2+
1-2 3-4 5-6 7+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+
1 2 3 4+







16. NÅR SPISER DU PÅ HVERDAGER?
17. MENER DU SVARENE I SPØRRESKJEMAET GIR
ET BRUKBART BILDE AV KOSTHOLDET DITT?
18. ER DU FORNØYD MED KROPPSVEKTEN DIN SLIK DEN ER NÅ?
19. KJØNN
Vennligst se etter at du har svart på alle spørsmål.
Takk for innsatsen!
HOVEDMÅLTIDER som frokost, formiddagsmat, middag, kvelds.
MELLOMMÅLTIDER som kaffe, frukt, godteri, snacks m.v.
Er det matvarer/produkter du regelmessig bruker, og som ikke er nevnt i skjemaet?
.................................................................................................................................
.................................................................................................................................
6 8 10 12 14 16 18 20 22 24 2 4
6 8 10 12 14 16 18 20 22 24 2 4
Ja Nei
Ja
Nei, jeg ønsker å slanke meg
























Protocol for baseline health examination 
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